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Chapter 1 
A Review of Mass Spectrometry-based Hydroxyl Radical 
Footprinting: Methodology and Application of Fast 
Photochemical Oxidation of Proteins (FPOP) 
  
	 2	
1.1 Introduction 
The conformations of proteins when alone or complexed with other molecules (e.g., metal 
ion, small peptide, protein) are an essential basis for understanding many biological 
processes and developing protein therapeutics. Traditional approaches for assessing 
protein conformations include X-ray crystallography and nuclear magnetic resonance 
(NMR) spectroscopy, both of which provide high resolution structural information. 
Developments in cryo-electron microscopy (cryo-EM), more recently, provides 
unprecedented opportunities for high-resolution characterization of protein conformations. 
Some “global” information can also be obtained by low resolution methods (e.g., 
fluorescence, infrared, UV-Vis, circular dichroism, and differential scanning calorimetry). 
Recent advances in mass spectrometry (MS)-based approaches have paved a new 
avenue to elucidate protein structures and interactions, providing coarse-grained protein 
conformations by fast-turnaround, high sensitivity, reproducible methods that require 
relatively small sample sizes. Protein footprinting coupled to mass spectrometry is one of 
the most developed of these MS-based strategies. 
1.1.1 General Approaches for Mapping Protein Conformations 
Although there are several approaches affording low resolution protein structural 
information [1-5], high order structures (HOS) of proteins and their interactions require 
more detailed characterizations with higher resolution. Techniques including X-ray 
crystallography [6], NMR [7], and cryo-electron microscopy (cryo-EM) [8] provide 
structural information of macromolecules at atomic or near-atomic resolution. Mass 
spectrometry-based techniques, in contrast, offer intermediate-level resolution [9]. 
	 3	
Although they are more recently developed, ultimately they may provide constraints for 
high resolution structure. 
X-ray crystallography generates a static view of three-dimensional electron density maps 
of protein structures [10]. It is currently the favored techniques extensively used in 
determining protein structures and protein-protein interactions, since its debut in late 
1950s when it was first used to reveal the 3-D structure of myoglobin [11]. The use of X-
ray crystallography is, nevertheless, impeded by a large amount of highly homogeneous 
protein sample [12, 13], and slow turnaround [14]. Further, proteins with high flexibility, 
low stability, or are intrinsic membrane proteins are difficult to crystalize [15]. 
NMR spectroscopy complements X-ray crystallography by allowing measurements of 
three-dimensional protein structures in solution [16]. Because NMR is often applied to 
proteins in solution, it is a robust tool for investigating protein folding/unfolding [17], fast 
dynamic motions [18], and conformational equilibria [19]. Similar to X-ray crystallography, 
NMR demands protein samples at high amounts [20, 21]. There are problems, however, 
in resolving overlapping peaks of large proteins, restricting applications of NMR to 
relatively small proteins [22, 23]. 
1.1.2 Mass Spectrometry-based Approach 
Mass spectrometry was restricted only to small and thermostable molecules, owing to a 
lack of gentle ionization and ion transportation [9]. The marriage of electrospray ionization 
(ESI) and mass spectrometry [24, 25], however, has greatly advanced mass 
spectrometry-based approaches as powerful tools in assessing larger molecules 
including peptides and proteins.  This new capability was recognized by the 2002 Nobel 
	 4	
prize in chemistry. Today, mass spectrometry has increasingly become the method of 
choice for complicated proteomic analyses, owing to the multi-disciplinary improvements 
including instrumentation [26-28], sample preparation [29-32], and informatics [33-36]. 
Not only does mass spectrometry access protein structural information from a global level 
(whole protein), but it can screen peptides, upon proteolysis, with high sensitivity (fmol 
level) and throughput when coupled to liquid chromatography [37]. With fragmentation 
methods including collision-induced dissociation (CID) and electron-capture/transfer 
dissociation (ECD and ETD), sequence information at residue level from the product-ion 
spectra can be obtained [38-40]. This sequence information is useful for establishing 
peptide identity and locating post-translational modifications (PTMs) [41]. 
Mass spectrometry-based protein footprinting has evolved as an effective analytical 
technique for characterizing protein HOS, albeit with lower resolution than X-ray 
crystallography and NMR spectroscopy [42, 43]. MS typically examines conformational 
changes of proteins, by monitoring solvent accessibility of either backbones or sidechains, 
based on their sensitivity to chemical labeling [44]. Such experiments are best utilized in 
a comparative analysis where the extent of labeling is indicative of the changes of solvent 
accessibility of two or more protein states (e.g., bound and unbound). 
Protein footprinting techniques can be classified based on the nature of modifications 
(e.g., reversible labeling and irreversible labeling). Numerous footprinting techniques 
have emerged over the past few decades [45-51], among which hydrogen deuterium 
exchange (HDX) is probably the most widely used and extensively developed [46, 52-56]. 
HDX probes the solvent accessibility and hydrogen bonding environments of amide 
	 5	
backbone hydrogens [57, 58]. Differential deuterium uptake of a protein, upon folding, 
ligand-binding, or oligomerization, can be monitored by MS measurements at both the 
global and peptide levels. It is noteworthy, however, that by taking advantage of the 
sequentially overlapping peptide fragments from pepsin digestion, resolution level of 
individual amino acid can also be achieved in HDX [59, 60]. 
Hydroxyl radical (HO•) footprinting, which covalently labels protein sidechains, represents 
the second class of protein footprinting techniques. It is emerging for studying protein 
structure and dynamics in part because hydroxyl radical is readily formed and highly 
reactive [61]. The size of a HO• closely approximates that of a water molecule, enabling 
its reactivity to be a faithful map of protein solvent accessibility. Advantageously, the 
irreversible nature of HO• modifications permits more rigorous sample handling 
procedures downstream of the labeling process and prior to MS detection, including 
sample cleanups, proteolysis, and chromatography. Hydroxyl radicals label protein 
sidechains with a residue-specific mechanism, which leads to various products, and rate 
constants [62]. Nevertheless, the major modification products are the +16, +32, and +48 
species, etc., corresponding to the labeled protein with one or more substitutions of H for 
OH [63]. Shown in Table 1-1 are the rate constants of various amino-acid residues 
towards HO• and the mass shifts associated with primary oxidative modifications 
observed in HO• footprinting. 
	 6	
 
Table 1-1. Rate constants of amino acids towards hydroxyl radical and mass shifts for 
primary oxidative products [44, 64]. 
 
1.2 Generation of Hydroxyl Radicals 
1.2.1 Fenton and Fenton-like Chemistry 
In 1876, H. J. H. Fenton observed a violet-colored product obtained by mixing tartaric 
acid with hydrogen peroxide and a low concentration of ferrous salt [65]. This experiment 
is known as “Fenton chemistry” today and is one of the earliest approaches to generate 
hydroxyl radicals. In Fenton chemistry, tartaric acid is oxidized to dihydroxymaleic acid by 
hydrogen peroxide under the catalysis of ferrous ion(II), and it is the complex formed 
between iron and dihydroxymaleic acid that’s responsible for the “violet color” in Fenton’s 
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observation. Fenton established the molecular formula of this complex [65, 66], but did 
not propose any reaction schemes involving hydroxyl radicals. The notion of free radicals 
in solution was not generally accepted until 1930s, when Michaelis et al. [67-69] 
characterized radicals from one-electron reduction of quinones, flavins and bipyridinium 
compounds. The reaction described in Eq. 1 is typically referred to as the “Fenton 
reaction”, which shows the oxidation (abstraction of H from tartaric acid) initiated by HO• 
generated in the reaction between Fe(II) and H2O2. The Fenton reaction has been 
mechanistically studied later by Haber, Weiss, and Willstätter [70, 71]. 
    Fe II +	H'O' 	→ Fe III + 	HO• + OH+   (1) 
Besides Fe(II), many other transition metal ions in lower oxidation states (e.g., Ti(III), 
Cr(II), Co(II), Cu(I)) are capable of “Fenton-like” chemistry, as generalized in Eq. 2. This 
oxidation can occur naturally in the microenvironment of cells and is associated with aging 
and various diseases [72-74].  
    M(.) +	H'O' 	→ 	M(.01) + 	HO• +	OH+                           (2) 
Based on Eq. 2, one might speculate that HO• can be generated for oxidative footprinting 
by simply mixing hydrogen peroxide with the salt of transition metals in their lower 
oxidation states, preferably under acid conditions [75]. The secondary order rate of these 
reactions, however, is approximately 60 M-1s-1[70], which is practically too slow for any 
oxidative footprinting experiments. To address this issue, Tullius and Dombroski [76, 77] 
developed a Fenton system that incorporates Fe(II) chelation, by EDTA for example, that 
exhibits a rate increases of approximately two orders of magnitude [78]. Under 
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appropriate conditions, other transition metals with proper chelates could also undergo 
this Fenton-like chemistry at increased rates [79-81].  
Various Fenton approaches were adopted to produce HO• for biological footprinting 
studies in nucleic acid/ligand interactions [82-84]. In 2003, Sharp et al. [85] introduced 
protein footprinting with a Fenton reagent. A 5-min-oxidation was required to obtain 
sufficient oxidative labeling for mass spectrometry analysis. Fenton chemistry can also 
probe protein-metal interactions whereby the protein-bound metal can reduce H2O2 to 
HO• for footprinting nearby [86-89]. These approaches, however, suffer from slow rate in 
generating radicals and lack of control in the reaction time. Brenowitz et al. [90] developed 
a faster Fenton footprinting method that incorporates a stop-flow apparatus to initiate and 
quench the Fenton reaction with 44 mM H2O2 and 5 mM Fe2+-EDTA, on the ms timescale. 
The high concentrations of metal salts and EDTA required for such reactions, however, 
raise concerns about maintaining protein structural integrity during the reaction [91, 92]. 
Moreover, the interactions between metal ions and biological samples, or between 
chelates and biological samples, can bias the reactivity [93, 94].  
1.2.2 Electron Pulse Radiolysis 
Electron pulse radiolysis of water is an ionizing process that generates hydroxyl radicals 
(and many other radicals) by accelerating electrons to the MeV range [95-98]. The first 
step of this process is the ionization of water, producing a water radical cation and an 
electron (Eq 3). 
    H'O	 → 	H'O0• +	e+      (3) 
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The products in Eq 3 will then quickly undergo the following reactions (on the picosecond 
time scale) and turn to primary radicals that are highly reactive. The electron may 
recombine with a water molecule and form an excited water molecule. 
    H'O0• +	H'O	 → 	HO• +	H2O0     (4) 
    e+ +	H'O	 → 	 e34+        (5)  
Given the short time scale (10-12 s) and the typical width of each pulse (ranging from 1 to 
100 ns), the radiation window should be mostly filled with hydroxyl radicals (HO•) and 
hydrated electrons (567+  ) after each pulse. By definition, 567+  is free radical because it is 
an unpaired electron. These two radicals recombine at diffusion-controlled rate under the 
condition of pure water [64, 95]: 
    HO• +	e34+ 	→ OH+       (6) 
    HO• + 	HO• 	→ 	H'O'                (7) 
Besides hydroxyl radicals and hydrated electrons, a small amount of hydrogen radical 
may also be formed during radiolysis, owing to deactivation of an excited water molecule 
[95]. In practice, aqueous solutions are saturated with dissolved oxygen (~0.3 mM), which 
itself is a reactive di-radical. The hydrogen radicals and hydrated electrons can react with 
dissolved oxygen, generating hydroperoxyl radicals and superoxide radicals, respectively, 
with rate constants close to the diffusion-rate limit [97]. 
    H• +	O' 	→ HO'•        (8) 
    e34+ +	O' 	→ 	O'+•       (9) 
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Therefore, in most oxygenated biological systems, the primary free radical is superoxide 
radical, which is in equilibrium with its protonated form—hydroperoxyl radical [99]. Both 
radicals are not as reactive towards amino acids, as is hydroxyl radical [44, 100, 101]. 
The relative amount of these two is determined by its acid-base equilibrium equation with 
a pKa of 4.8 [102]. 
    HO'• 	↔ 	H0 +	O'+•       (10) 
As shown in Table 1-2, except for cysteine and cystine, hydrated electrons (567+ ) react 
with most amino acids far slower than reacting with oxygen (Eq 9). Alanine is the major 
product of hydrated electrons reacting with cysteine; however, in the presence of oxygen, 
alanine hydroperoxide also forms [103, 104]. 
The co-presence of hydrated electrons and hydroxyl radicals in pulse radiolysis of water 
can be problematic for protein footprinting because each radical undergoes multiple 
reactions, which could either potentially complicate the reaction pathways, or interfere 
with the measurements of free-radical products. To address this issue, hydrated electrons 
are converted to hydroxyl radicals in the presence of gaseous N2O per Eq 11: 
    e34+ +	N'O	 → 	HO• + OH+ +	N'     (11) 
The rate constant of this conversion is 9 × 109 M-1s-1 [95], rendering a solution of hydroxyl 
radicals on the ns timescale. The rapid generation of hydroxyl radical is overwhelmingly 
advantageous for protein footprinting to insure there is minimal perturbation of the protein 
structure. 
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Table 1-2. Rate constants of amino acids towards hydrated electrons [44].  
 
1.2.3 High Voltage Electrical Discharge 
Downard and coworkers [105, 106] developed a source of hydroxyl radicals by using high 
voltage electrical discharge in a mass spectrometer ion source and used it to footprint 
proteins. In the discharge, the protein solution (µM concentration) is introduced to 
conventional atmospheric pressure electrospray ionization (ESI) source of with typical 
flow rates between 1-5 µL/min. High electrical voltage ranging from 4 to 8 kV is applied 
to electrospray emitter so the discharge occurs, generating HO• in solution [107]. Oxygen 
is typically used as the nebulizer gas at a regular pressure of 250-350 kPa, corresponding 
to an approximate flow rate of 10 L/min [108]. After oxidation, the droplets are introduced 
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into the mass spectrometer or are collected by condensation for subsequent enzymatic 
digestion and mass spectrometry analysis. 
Using oxygen as nebulizer gas greatly enhances the yield of oxygen-containing reactive 
species, including the hydroxyl radical and the hydroperoxyl radical [106]. The production 
rates of these radicals under various conditions are known [109, 110]. By adjusting the 
discharge conditions (e.g., voltage of emitter, flow rate of protein solution, nature of 
nebulizer gas), one can control the production of radicals, although a systematic dose-
response study has yet been done.  
Although the high-voltage electrical discharge method of protein footprinting can probe 
protein structures and protein-protein interactions [108, 111, 112], there are caveats. 
Protein structure is determined by not only its primary sequence but also by other factors 
including the hydrogen-bonding network [113, 114], disulfide-bonding pattern [115-117], 
external ligand binding condition [118-120], and the solution environment the protein 
stays [119, 121-125]. Our view is that protein footprinting should be performed in a near-
native environment where the labeling can faithfully report the protein solvent accessibility. 
The effect of high voltage on proteins, however, raise concerns regarding the protein 
structural integrity and conformational equilibrium. For example, numerous voltage-
sensitive proteins can undergo conformational shifts within a voltage increase of 1 kV 
[126-128].  It’s also clear that, the electrospray process unfolds some proteins while 
others stay properly folded [129-131], indicating that unfolding depends on the protein 
and on the experimental conditions as many proteins analyzed by electrospray appear to 
maintain their structural integrity under carefully controlled conditions [132]. The fact that 
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large protein complexes can be transferred intact into the gas phase indicates some level 
of preservation of solution conformation [133, 134]. Moreover, ion mobility MS has 
demonstrated the conformational integrity of proteins footprinted by high voltage electrical 
discharge [112]. It’s likely, however, that some proteins do not maintain their structures 
during electrospray ionization, and one cannot yet predict the effects of ESI on protein in 
advance. We prefer a method that’s free from these uncertainties. 
1.2.4 Synchrotron X-ray Radiolysis of Water 
One of the most effective ways of generating hydroxyl radicals, pioneered by Chance and 
coworkers [44, 62, 135, 136], is the radiolysis of water by high-energy X-ray synchrotron 
beamline that produces approximately 1014 to 1015 photons per second with energies 
ranging from 3 to 30 keV. During this process, the energy of an incoming photon is 
transferred to ionize water molecules or other targets. The electrons are thermalized and 
deposit their energy to ionize other water molecules. As shown in 2.2 Eq 4, an ionized 
water molecule reacting with another water molecule generates the hydroxyl radical forthe 
subsequent oxidative reactions in footprinting to occur. Similar to electron-pulse radiolysis, 
the oxidation reactions by synchrotron radiolysis of water involves multiple radical species, 
including hydroxyl radical, hydroperoxyl radical, and superoxide radical; among which 
hydroxyl radical is the most reactive and predominant species. Although the photon flux 
from the synchrotron is continuous, the exposure time and dose is tunable via an X-ray 
electronic shutter that controls the exposure time yielding a steady-state, micromolar dose 
of HO• within ms [137] [138]. 
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Synchrotron X-ray radiolysis of water has been extensively used for footprinting, owing to 
its high flux density, short labeling timescale, high reproducibility and ease of varying the 
dose [139-142]. Chance et al. [143, 144] first used synchrotron HO• footprinting to probe 
the solvent exposure of oligonucleotides and their protein interactions (e.g., with RNA 
polymerase) in real time. The radical cleaves the phosphodiester backbone of nucleotides 
by abstracting hydrogen from the C-4 position of ribose, giving a free tertiary hydroxyl that 
leads to backbone cleavage [145]. Gel electrophoresis can capture the radical-cleaved 
nucleotides, the gel strands of which can be used to distinguish the protected and 
unprotected regions on nucleic acids, allowing the mapping of interaction interfaces.  
The coupling of synchrotron radiolysis and mass spectrometry has expanded the 
synchrotron footprinting to more structural proteomics studies with improved robustness 
and sensitivity (Figure 1-2). This method has been extensively used to monitor protein 
folding and unfolding [143, 146, 147], to measure the protein-protein interaction interfaces 
and to determine the solvent-accessible regions and side chains [148, 149]. Regions 
involved in interactions typically show decreased reactivity. Remarkably, this approach 
can locate water molecules within a transmembrane GPCR protein, rhodopsin [150], 
providing opportunities to both in vivo and in vitro studies of membrane proteins. 
Nevertheless, the synchrotron footprinting method is limited by its lack of accessibility to 
the ever-increasing number of users and the high cost of operation [90]. 
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Figure 1-1. (A) Photo of National Synchrotron Light Source II (NSLS-II) in Brookhaven 
National Laboratory; (B) Schematic showing the NSLS-II beamline hutches. Retrieved 
from https://www.bnl.gov/ps/. 
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Figure 1-2. Coupling of synchrotron hydroxyl radical labeling and mass spectrometry for 
protein footprinting. (A) Hydroxyl radical generation by X-ray radiolysis and labeling on 
proteins; (B) Subsequent proteolysis and using of liquid chromatography for peptides 
separation; (C) Mass spectrometry detection and identification of HO• modified and 
unmodified peptide; (D) Quantitation of modification extent using extracted ion 
chromatograms (XICs); (E) Kinetic curve plotted as the fraction unmodified of each 
peptide versus the exposure time. Reprinted with permission from Ref. [150] 
 
1.2.5 Photolysis of Hydrogen Peroxide 
A more convenient way of generating hydroxyl radicals is through the photolysis of 
hydrogen peroxide. The light absorption by hydrogen peroxide (H2O2) reaches maximum 
at wavelength of 253.7 nm, leading to homolytic dissociation of hydrogen peroxide that 
generates two hydroxyl radicals per molecule with primary quantum yield of 0.4-0.5 [151, 
152]. Different from radiolysis approaches where energy is deposited in the solvent water, 
the photolysis relies on absorption of photons by hydrogen peroxide per Eq 12: 
     H'O' 	 ;< 	2HO•     (12) 
The generated hydroxyl radicals undergo Haber-Weiss reactions as shown in Eq. 2 and 
3, at rate constants of 2.7 × 107 and 7 × 109 M-1s-1, respectively [153, 154] or undergo 
the diffusion-controlled self-quenching reaction (Eq 13) with a rate constant of 4.7 × 109 
M-1s-1 at room temperature [155, 156].  
     2HO• → 	H'O'      (13) 
The UV light-induced photolysis of hydrogen peroxide was first used for nucleic acids 
footprinting studies [157, 158]. Sharp and Hettich [159] demonstrated that this method 
can be extended to protein footprinting studies. In their method, apomyoglobin with 5 M 
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H2O2 in an Eppendorf tube was subjected to a 254-nm UV-light irradiation for 5 min. The 
high concentration of H2O2, however, can trigger direct protein oxidation [160]; and the 
long exposure time may compromise the integrity of protein structures, owing to radical-
induced protein degradation or conformational changes [161].  
To overcome this, two pulsed-laser approaches were developed in 2005 independently. 
Aye et al. [162] developed an UV laser-induced photodissociation method for protein 
footprinting, where a pulsed Nd:YAG laser (operating at 266 nm and 30 Hz) with an output 
of 2 mJ/pulse was used to photolize H2O2 at final concentration of 0.3-1.0% to generate 
hydroxyl radicals. The use of the UV laser enhances the yield of photolysis, allowing a 
significant decrease of H2O2 concentration (from 5 M to 100 mM). The protein solution, 
however, was still held in an Eppendorf tube and subjected to 1-100 laser shots, 
resembling Sharp’s method [159]. The oxidation of protein was quenched by freezing in 
liquid nitrogen and lyophilizing in a vacuum chamber at 10-3 Torr for 30 min. The results 
show that, compared to non-oxidized ubiquitin, the singly oxidized ubiquitin was more 
susceptible to further oxidations by subsequent laser shots, owing to a conformational 
change of ubiquitin induced by oxidation. This experiment underscores the importance of 
using single laser shot and rapid generation of hydroxyl radicals to avoid secondary 
protein oxidations that can give unreliable footprinting [160, 161, 163].  
Hambly and Gross [164], in the same year, developed a similar methodology that was 
later elaborated as “fast photochemical oxidation of proteins (FPOP)”. FPOP highlights 
the generation of hydroxyl radicals through homolytic cleavage of H2O2 in a flow cell, 
permitting footprinting of protein to take place in a “microenvironment” or a “plug”, and 
	 18	
allows multiple laser shots for sequential plugs of protein solution. Such design effectively 
reduces the hydrogen peroxide concentration in solution even further (15-20 mM H2O2). 
More importantly, at any given laser frequency, nearly single irradiation of fresh protein 
solution can be achieved by adjusting flow rates. 
Both the latter two methods involve pulsed, nanosecond fluxes of UV laser to generate 
rapidly HO•; there are some experimental differences, however, between them. Aye’s 
method requires 100 mM of H2O2 to guarantee sufficient yield of HO• with single laser 
pulse; those extra HO• are solely quenched via self-recombination [155, 156, 165]. The 
method by Hambly and Gross uses lower concentrations of H2O2 and its design permits 
even further minimizing of the exposure by mixing the H2O2 just prior to irradiation region 
[166].  Importantly, it also introduces the idea of a radical scavenger to limit the lifetime of 
primary radical to microsec [164]. Further, the adjustment of scavenger identity and/or 
concentration makes possible the tuning of reaction times [165, 167].   
1.3 Fast Photochemical Oxidation of Proteins (FPOP) 
FPOP utilizes a 248 nm KrF excimer laser (GAM Laser Inc., Orlando, FL, USA) to 
photolyze H2O2 (15 mM) with an energy of approximately 45 mJ per pulse. The UV 
spectrum of H2O2 shows that its UV absorption wavelength spans from 300 nm to the 
beginning of the Rydberg transition region at 124 nm, with the absorption maximum 
around 250 nm [151, 152]. Thus, the 248 nm KrF excimer laser is an ideal light source 
for FPOP. We recently acquired an optical parametric oscillation (OPO) Nd:YAG laser, 
the fourth harmonic of which can yield UV light with wavelength of 266 nm. To conduct 
FPOP experiment, typically 50 µL of solution with protein concentrations ranging from 2 
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to 10 µM in PBS buffer (10 mM, pH 7.0) is submitted to approximately 1000 laser shots 
(Figure 1-3 A). The laser beam is focused with a convex lens (Edmunds Optics, 
Barrington, NJ, USA) onto a 150 µm i.d. fused silica tubing (Polymicro Technologies, 
Phoenix, AZ, USA), giving a 2.5-3.0 mm irradiation window (Figure 1-3 B). The pulse 
frequency was externally controlled by a pulse generator (B&K Precision, Yorbal Linda, 
CA, USA). The irradiation window width, pulse frequency, and sample flow rate are 
adjusted prior to irradiation to insure a fraction of 20-25% of protein solution unexposed 
to light, avoiding repeated exposure of radicals (Figure 1-3 B) [164, 168]. To limit the 
labeling time (i.e., lifetime of primary radicals), a radical scavenger is added to the protein 
solution. Typically, we chose a simple amino acid (e.g., histidine, glutamine, 
phenylalanine) that have a variety of reactivities towards HO• as radical scavenger; 
different identity and concentration of scavengers can be adjusted to control the FPOP 
labeling time, ranging from hundreds of ns to a few µs [165, 167, 169]. The labeled 
samples are collected in an Eppendorf containing 50 nM catalase and 70 mM methionine, 
preventing further oxidation by residual H2O2 and other remaining reactive oxygen 
species (ROS) (Figure 1-3 A). We always incorporate a positive control that is handled in 
the same manner without laser irradiation to keep track of background oxidations. Post 
footprinting, the sample is usually subjected to sample cleanup, proteolysis, 
chromatography, and mass spectrometry analysis. 
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Figure 1-3. Schematic showing the apparatus for conducting an FPOP experiment. (A) 
The protein solution with H2O2 and radical scavenger in syringe was advanced by a 
syringe pump, irradiated by pulsed KrF laser, and collected in Eppendorf containing 
methionine and catalase; (B) Zoom-in view of the irradiation window on silica tubing 
where the laser passes through. Each plug of irradiated solution is ideally sandwiched by 
non-irradiated plugs to guarantee an exclusion volume fraction of 20-25%. 
 
1.3.1 FPOP Footprints Faster than Protein Folding/Unfolding 
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The rates of protein folding/unfolding are protein-specific and depend on protein size and 
structure. Protein folding into its native state is a complicated process that takes multiple 
intermediate steps; each of these steps occurs on a different timescale [170-172]. For 
instance, some proteins form secondary structures in an early step, which is followed by 
the formation and consolidation of tertiary structures as the late step. The formation of the 
secondary structures takes ns to µs; that of the tertiary structures, however, spans from 
tens of µs and even longer [173, 174]. In a fast relaxation kinetics measurement, Vu et al. 
[175] observed a two-step folding process for a protein, B-domain of staphylococcal 
protein A (BdpA), in which the first step is dominated by the fast formation of individual 
helices (90 ns), followed by the second step representing the packing of the helices 
together with squeezing out of water molecules to form the three-helix bundle (9 µs). For 
some proteins, the folding steps include hydrophobic collapse (µs) and tertiary structure 
formation (tens of µs and longer) [176]. Protein unfolding is likely the reverse of protein 
folding, including the breakdown of the tertiary structures and the admission of water 
molecules [177, 178]. The timescale of this process can be tens of µs or even longer.  
To corroborate experimentally the claim that FPOP labels a protein faster than its 
unfolding, Gau et al. [179] applied FPOP to three oxidation-sensitive proteins (i.e., β-
lactoglobulin, apo-calmodulin, and lysozyme), to test whether the population distribution 
of 0, +16, +32…products constitutes a Poisson distribution.  The hypothesis is that if a 
single conformation of the protein exists during the labeling, the distribution of products 
should constitute a Poisson distribution. The fit to a Poisson distribution was poorer in the 
absence of the radical scavenger or if residual H2O2 was not removed after laser 
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irradiation; pointing to sampling of multiple protein conformations induced by repeated 
oxidation. The results strongly suggest that the Poisson model is applicable to protein 
footprinting when the protein population has an invariant conformation and undergoes 
non-cooperative modification, verifying that footprinting is faster than protein 
conformational change. 
1.3.2 FPOP Dosimetry 
Although the timescale of FPOP is sufficiently short to sample a single conformational 
state of the protein, as shown by Gau et al. [179], this approach doesn’t provide a 
quantitative description of the radical concentration or lifetime. To assess the radical 
lifetime, knowledge of the initial concentration of hydroxyl radical produced by laser 
photolysis is a prerequisite to adjust the yield of HO•, to control the extent of modifications, 
and to provide a basis for simulations and kinetic measurements [165].  
A dosimetry experiment that measures the dose delivered to samples can be exploited 
for hydroxyl radical quantitation. Chance et al. [44] performed a systematic dosimetry 
study using a fluorescent dye, Alexa Fluor 488, as a chemical dosimeter to investigate 
the effects of experimental and sample conditions on the generation of hydroxyl radicals 
by synchrotron radiolysis.  The assay depends on the dosimeter’s fluorescence intensity 
of, which decreases linearly with exposure time. This approach allows the measurement 
of the rate at which the dosimeter is oxidized (the rate at which HO• is generated); this 
rate is a reference rate that can be compared to those measured under other conditions. 
Sharp et al. [180] used a similar approach, which incorporates an adenine-fluorescence-
based dosimeter to measure quantitatively the effective hydroxyl radical dose. 
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These methods afford convenient and reliable means to compare the HO• dose from 
sample to sample, enabling reproducible experimental results across a variety of 
platforms and applications. A defined initial concentration of hydroxyl radicals, however, 
is not obtainable by them. Quantitation of HO• generated in FPOP is difficult because the 
radicals are short-lived. Hambly and Gross [164] estimated the initial concentration of 
hydroxyl radicals to be 1 mM, allowing for the molar absorptivity of H2O2 and the quantum 
yield of HO•. Chen et al. [181] reported an experimental measurement of the initial 
concentration of HO• by LC/MS using phenylalanine as a dosimeter, and measured in a 
preliminary way a concentration of 0.42 mM. Recently, Niu et al. [165] described a 
determination of the initial hydroxyl radical concentration upon laser photolysis by using 
an isotope dilution GC/MS method, which provides good accuracy and sensitivity [182], 
and corrects for analyte loss during handling [183] (see details in Chapter 2). The method 
utilizes undeuterated phenylalanine (d0-Phe) and deuterated phenylalanine (d5-Phe) as 
dosimeter molecule and internal standard, respectively. Upon laser photolysis, we 
monitored and quantified the decrease of d0-Phe signals, which correspond to the amount 
of HO• generated, as no radical scavenger was present. We determined quantitatively 
that the initial HO• concentration (from 15 mM H2O2 for a laser pulse of 40 mJ) in FPOP 
was 0.95 mM, a dose comparable to our previous estimate [164]. 
Further with this isotope dilution GC/MS approach, we were able to measure the effective 
hydroxyl radical concentrations in the presence of different radical scavengers (i.e., 
histidine, glutamine, methionine), and probed the changes of [HO•] as a function of 
scavenger concentration and identity. The outcome provides direct evidence that the 
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radical dose, and therefore the primary radical lifetime, is adjustable by using radical 
scavengers. 
1.3.3 Primary Radical Lifetime and Adjustment of Radical Scavengers 
In the absence of radical scavenger, most hydroxyl radicals generated after each laser 
pulse undergo self-recombination, with a rate constant of 4.7 × 109 M-1s-1 [155, 156]. 
Hambly and Gross [164] demonstrated that the protein was heavily modified if no 
scavenger was present, indicating a prolonged lifetime of primary radicals. In the 
presence of 20 mM glutamine as scavenger, however, the extent of protein modification 
became less, consistent with a reduced radical lifetime. The attenuation of protein 
modification extent continued when 20 mM phenylalanine, instead of glutamine, was used 
as radical scavenger. The reaction time under this condition must be extremely short, 
because the rate constant of phenylalanine reacting with HO• is approximately 10 times 
greater than that of glutamine [44]. The time courses of HO• concentration can be 
obtained by numerical simulations, which are based on a series of non-linear differential 
equations solved with an adaptive step-size Runge-Kutta method implemented in 
MathCAD software [184]. The simulations model three reactions with differential 
equations: the first reaction is that of the hydroxyl radical with scavenger (e.g., glutamine, 
histidine, phenylalanine), taking advantage of the known scavenger rate constant and 
initial concentration; the second reaction is the self-recombination of hydroxyl radical with 
a rate constant of 4.7 × 109 M-1s-1 and an initial concentration that can be determined 
from the dosimetry experiment (details see Chapter 2) [165]; the third reaction is the 
Haber-Weiss chain reaction that generates HO• from H2O2 [71, 153, 154]. 
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Figure 1-4 shows the plot of simulated HO• concentration versus time based on an initial 
HO• concentration of 0.95 mM in FPOP. From the plot, we can interrogate the lifetime of 
primary radical (we assign the lifetime to be that at which the concentrations of •OH are 
100 times less than that of the protein). For example, we show that with 20 mM glutamine 
as radical scavenger, the concentration of hydroxyl radical is less than 10-8 M in about 1 
µs, similar to the earlier estimation of Hambly and Gross [164]. Glutamine at a 
concentration of 20 mM was originally used as radical scavenger in FPOP [116, 185, 186]. 
The scavenger, however, is not limited to glutamine. We show in Figure 1-4 that, with 
varied identity/concentration of radical scavengers, the time range available to primary 
radicals in FPOP can be shifted from either ~1 µs to ~100 ns (using scavengers of higher 
reactivity or concentration), or to high µs (using scavengers of lower reactivity or 
concentration). For example, with 20 mM of histidine or methionine as scavenger, the 
lifetime of primary radical can be as low as 0.1 µs.  
Using amino acid as radical scavenger adds great flexibility in FPOP, as the rate 
constants of amino acids towards HO• can vary by up to three orders of magnitude [44]. 
We took advantage of this flexibility and tuned the FPOP labeling times by adjusting the 
identity and/or the concentration of scavengers [165]. As shown in Figure 1-4, with 2 mM 
phenylalanine as radical scavenger, we can achieve nearly the same labeling time as that 
from 20 mM glutamine. This observation can be significant, because in some scenarios 
the identity of scavenger must be different while the labeling time needs to be maintained 
constant. For example, histidine, often used in protein formulation buffers in the 
biopharmaceutical industry, owing to the “histidine stabilizing effect” [187, 188], is now 
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commonly used as radical scavenger as a surrogate for glutamine [169, 185, 189]. 
Histidine is a more efficient radical scavenger compared to glutamine because it is 
intrinsically more reactive with HO• [44]. Yan et al. [169] in a series of FPOP comparisons 
of WNV E DIII, found that, the FPOP labeling time with 350 µM histidine as scavenger is 
very similar to that with 20 mM glutamine.  
Adding radical scavengers in FPOP to limit the reaction time minimizes protein 
conformational isomerism while being oxidized [190]. The adjustment of radical 
scavengers (i.e., concentration, identity) enables footprinting over a wide timescale, 
providing a flexible approach suitable for various protein conformational characterization, 
and a foundation for compensating for differential scavenging. 
 
Figure 1-4. Numerical simulations of HO• concentration versus time. FPOP labeling 
time is adjustable depending on the identity and concentration of radical scavenger. 
Reprinted with permission from Ref. [165] 
	 27	
 
1.3.4 Differential Scavenging and Reporter Peptide in FPOP 
Hydroxyl radicals are highly reactive with many species [191, 192].  In FPOP, our 
preference is they react mainly with proteins under study in competition with the radical 
scavengers (e.g., histidine, glutamine, phenylalanine).  Given their reactive nature, they 
also modify other species in solution including formulation buffer components, protein 
ligands, and sample detergents [167]. The presence of these species, sometimes 
adventitious, affects the lifetime of hydroxyl radicals, giving rise to unpredictable and 
misleading extents of modifications. In Chapter 5, for example, we report that 
trifluoroethanol (TFE) in solution is an adventitious radical scavenger that causes biased 
FPOP comparisons between TFE-treated and untreated samples [193]; in Chapter 7, we 
describe the footprinting of proteins associated with a Nanodisc, which contains abundant 
phospholipids and membrane scaffold proteins [194, 195].  The presence of these 
materials also results in differential scavenging between Nanodiscs-bound and unbound 
protein. 
The consequence of differential scavenging is an unpredictable number of hydroxyl 
radicals delivered to the protein samples under comparison [44, 167, 180, 196], affording 
a misleading FPOP fraction modified. The extent of protein modifeid is not only 
determined by its solvent accessibility and residue-specific reactivity but also by the 
effective dose of hydroxyl radicals, as shown in Eq 14. 
>?@ABCDE	FDGCHC5G	 ∝ (JDKL5EB	@AA5MMCNCKCBO) ∗ (J5QR5EA5) ∗ (SHH5ABCL5	GDM5)	  Eq 14 
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We recently incorporated Leu-enkephalin as a reporter peptide to disentangle the 
complication of differential scavenging, because the extent of modification of the reporter 
is a measure of the radical dose for the protein under study.  Furthermore, its modification 
extent at various labeling times, achieved by varying concentrations of histidine as 
scavenger [167] (details discussed in Chapter 3) is an approximate measure of the time 
of reaction. That is, the fraction modified of Leu-enkephalin serves as a “timer” of the 
primary radical lifetime.  Longer reaction times, as controlled by the concentration of the 
scavenger, afford more FPOP modifications on the reporter peptide, and on the protein 
under study as well. By plotting the fraction modified of Leu-enkephalin at each histidine 
concentration versus the corresponding fraction modified of peptide from protein digest 
on the y-axis, we obtain a time-dependent output similar to that of HDX kinetic curves. 
The dependence between the time and yield of reporter peptide, however, does not follow 
a simple, linear relationship [167]. 
A time-dependent measurement of FPOP provides assurance that the modification 
reactions are occurring normally, and adds statistical weight to the data and confidence 
to the measurements [167, 197]. It is especially useful when adventitious radical 
scavengers are present. We aim to enlarge the library of reporter peptides, based on the 
following criteria: the reporter should be (1) soluble, with some hydrophobicity, to avoid 
eluting with solvent front; (2) unstructured, so that its fraction modified is not confounded 
by structural changes; (3) moderately reactive towards HO•, to monitor its lifetime; (4) 
non-interacting with the proteins under study; and (5) readily available. Ideally, a short 
peptide with one FPOP-reactive site is preferred, because this can simplify the 
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quantitation of reporter modification and the normalization. Xie and Sharp [180] recently 
reported a fluorescence-based reporter, adenine, which also allows monitoring of radical 
dose and correcting the differential scavenging in FPOP experiments.   
The incorporation of a reporter peptide in FPOP paves the way to quantitative measures 
of residue and peptide reactivity, analogous to the “protection factors” in HDX [198]. This 
will require calibration of a reporter peptide’s rate constant against a standard reference 
reaction. Chance and co-workers have identified a similar goal for the synchrotron 
footprinting [199]. This would facilitate cross-laboratory comparisons of FPOP results and 
enable its use to determine coarse-grained, high-order structures of proteins. 
1.3.5 New Reagents for FPOP Platform 
To footprint a protein with chemical reactions, it is critically important to initiate and quench 
the reaction rapidly to ensure that the footprinted protein is not additionally modified [200]. 
The FPOP platform largely meets this requirement by using a flow system and a pulsed 
laser to footprint; when the laser irradiation is off, no additional radical is formed and the 
solution moves out of the laser beam. The reaction is quenched chemically by scavengers 
in solution. To establish a footprinting platform applicable to multiple types of protein 
problems (e.g., transmembrane protein, globular protein), and to afford a toolbox with 
various radicals targeting different amino acids with different selectivity and specificity, 
we seek to expand the current FPOP platform and increase its versatility by exploring 
reagents other than hydroxyl radicals. 
Gau et al. [49] described a new footprinting design with the FPOP platform using the 
sulfate radical anion SO4-•, generated photochemically from a low amount of sodium 
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persulfate (NaO3SO-OSO3Na). This persulfate system is more reactive in footprinting, 
requiring 3-5 times less persulfate to give similar extent of protein modifications as seen 
with the original HO• design, probably owing to the high reduction potential of SO4-• 
compared to that of HO• (2430 mV vs. 1900 mV) [201]. Gau et al. showed that, with 
apomyoglobin and calmodulin as model proteins, the modification products and residue 
selectivity of this approach highly resemble that of hydroxyl radical footprinting, including 
the substitution by OH, not SO4, with minor exception.  
Chen et al. [202] developed, contemporaneously, an FPOP-based footprinting method by 
photochemically dissociating iodobenzoic acid at 248 nm to give •I and •C6H4COOH. The 
iodine radical species generated in this method is relatively unreactive, long-lived, and 
targets only histidine and tyrosine residues of protein, as opposed to •OH that modifies 
three quarters of the 20 amino acids [44, 164]. The high specificity greatly simplifies the 
post-footprinting processes, including LC/MS feature detection, data processing, and 
labeling-site identification. 
Carbene chemistry has recently been used as a labeling method for structural proteomics 
[203, 204]. Zhang et al. [205] adapted the current FPOP platform to utilize carbenes as 
the footprinting reagent in flow cell, where a Nd-YAG laser, at its third harmonic 
(wavelength of 355 nm) photolyzes photoleucine as the carbene precursor (Figure 1-5).  
This carbene FPOP platform highlights the complementarity of those residues that are 
relatively “FPOP-silent”, including Ser, Thr, Glu, and Asp. Further, owing to the rapid 
quenching with water in protein solution, the lifetime of carbene diradicals during 
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footprinting is estimated to be on ns timescale, obviating the need to add any chemical 
scavenger [206]. 
 
Figure 1-5. Schematic of the custom-built flow system for carbene footprinting on an 
FPOP platform where a pulsed Nd:YAG laser is used to photolyze carbene precursor. 
Reprinted with permission from Ref. [205] 
 
1.4 Applications of FPOP 
1.4.1 Protein-protein Interactions and Protein Therapeutics:  Epitope Mapping 
Now that we’ve covered described various methods of footprinting and their advantages 
and methodology, we turn to various applications to illustrate problem solving in 
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biochemistry and biomedicine.  We will restrict the application to those with FPOP, and 
applications with other approaches were reviewed elsewhere.   
Protein-protein interactions (PPIs) play a central role in regulating many biological 
processes [207]. Malfunction of PPIs leads to multiple diseases [208, 209]. 
Characterization of PPIs provides pivotal insights about the protein-protein interface, 
which is essential in guiding drug discovery and development [210]. Determining protein-
protein interfaces can be challenging, because the interfaces typically incorporate large 
amorphous surface area [211, 212], comprise a linear (continuous sequence) or 
conformational (discontinuous residues proximal in tertiary structure) epitope [213, 214], 
and are generally less well-defined. There are increasing interests in designing protein 
therapeutics (e.g., monoclonal antibodies, a.k.a., mAbs) to modulate PPIs [215-218], as 
the interacting region of an antigen with mAb (i.e., epitope) is the key to successfully 
disrupt and inhibit PPIs [213, 219, 220]. 
Owing to the high sensitivity, fast turnaround, and low sample consumption [9, 37, 221], 
mass spectrometry-based methods have been recently used for characterizing protein 
therapeutics, by monitoring the changes of high order structures (HOS) and the effects of 
post-translational modifications (PTMs). Although top-down approaches for protein 
therapeutics are emerging [222], the more accepted and well-developed strategy is 
protein footprinting coupled to bottom-up approaches (e.g., HDX, FPOP), which allow 
interrogation of solution-phase protein conformations. HDX has been widely used in 
protein therapeutics to, for example, provide HOS information of mAbs [223-226]. FPOP 
footprinting, which is a more recent development compared to HDX, has emerged as an 
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alternative to not only complement the HDX results, but also to afford potentially more 
reproducible and reliable outcome, owing to the irreversible nature of modifications on 
protein. The short labeling time (µs timescale) of FPOP makes it advantageous to probe 
dynamic conformational changes, which might not be resolved using HDX.  
To demonstrate that FPOP is sensitive to conformational changes in protein therapeutics, 
we chose disulfide isomeric IgG2 antibodies, and used FPOP to assess the different 
conformations between the wild-type IgG2 and disulfide mutants [186]. The footprinting 
results were further corroborated with top-down experiments including ion-mobility (IM)-
MS and native ESI with ECD fragmentation [222]. FPOP shows that the light-chain region 
of IgG2 antibodies undergoes more modifications, suggesting a higher solvent 
accessibility. This finding concurs well with the top-down ECD results, where we observed 
extensive fragmentations of the light-chain region. Moreover, FPOP reveals the 
conformational differences of the hinge region between the WT and mutant IgG2 
antibodies. This hinge region, interestingly, is exactly where the major differences of 
disulfide bonding pattern occur. The decreased FPOP yield in hinge region of disulfide 
mutants indicates more compact structures for mutants as opposed to WT. Such compact 
structures of mutants were further confirmed using IM-MS that showed apparently longer 
drift times for mutants compared to WT IgG2. 
Epitope mapping, which is the process of experimentally determining the binding sites of 
antibodies on their target antigens, aids in the discovery and development of new 
therapeutics and diagnostics [227]. The epitope of serine protease thrombin, when 
complexed with antibody, was footprinted using FPOP and analyzed by mass 
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spectrometry-based bottom-up approach, marking the first time hydroxyl radical labeling 
is applied to epitope mapping [116]. Both antibody-bound and unbound protein samples 
were subjected to FPOP footprinting and proteolysis, resulting in 34 tryptic peptides with 
a sequence coverage of 86%. The FPOP results show, at residue-level, two regions 
protected upon binding to antibody, consistent with the HDX results by Komives and co-
workers [228]. FPOP further identified, however, two loop regions (i.e., 99-loop and 148-
loop) with increased solvent accessibility, as represented by increased FPOP 
modifications upon binding. This observation was not previously seen with HDX, there 
are several aspects of HDX and FPOP footprinting, however, pertaining to ascribing 
differences in their outcomes. First, the timescale in between HDX and FPOP is 
significantly different: FPOP snapshots the protein conformation on µs timescale, 
whereas HDX takes an averaged ensemble of protein conformations over seconds. 
Second, HDX monitors the backbone of amides, whereas FPOP focuses on protein 
sidechains. We attribute this increased solvent accessibility, exclusively observed by 
FPOP, to the ligand-induced allosteric changes of thrombin loop regions, which likely 
switch a number of different conformations in a short time and therefore, difficult to be 
captured by HDX [229, 230]. An alternative possibility is the changes of sidechain 
orientations of the loop regions where sidechain rotations are generally facile and can 
only be reported by FPOP. This unique observation by FPOP underscores the level of 
sensitivity FPOP can reach when applied to epitope mapping, making FPOP a promising 
tool in identifying those “hidden” epitopes. 
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For example, in the scenario where we employed FPOP to characterize the epitope of 
human exEGFR-Adnectin 1 complex [169], we compared FPOP yield between the two 
states of exEGFR (Adnectiin 1-bound and unbound). The differential FPOP yield should 
reflect the changes of solvent accessibility of human exEGFR, corresponding to either 
intermolecular interactions or allosteric changes. We identify, at residue level, 5 amino 
acids with decreased FPOP modification upon binding (Figure 1-6), 4 of them (Leu14, 
Leu17, Phe20, and Leu69) fall into the putative EGFR-Adnectin 1 interface according to 
the previously determined X-ray structure [231]. The additionally identified residue Phe24, 
although locates proximally to Leu17 and Phe20, was not revealed as epitope site in X-
ray structure. The structures by X-ray crystallography are often deemed as the “reference” 
structures, the static contact interfaces determined as such, however, might not 
necessarily be identical to those identified with solution-phase methods (e.g., FPOP) [232, 
233]. 
We recently presented the mapping of interface between vascular endothelial growth 
factor (VEGF) and a fragment antigen binding region of an antibody (Fab-1) using FPOP 
[185]. The results of FPOP, complemented by previous carboxyl-group footprinting and 
native top-down MS analysis [234, 235], are consistent with the predicted binding 
interface as determined by crystallography and alanine-scanning [236]. We also observed, 
however, residues with reduced modification that are distal to the binding region, 
suggesting occurrence of remote conformational changes. That both FPOP and carboxyl-
group footprinting showing epitopes and remote conformational changes reinforces the 
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capability of protein footprinting techniques of revealing structural mechanisms that may 
not be resolved by static techniques such as X-ray crystallography.  
 
Figure 1-6. Crystal structure of the exEGFR (colored in grey) complexed with Adnectin 
(colored in red), PDB code: 3QWQ. The five residues with reduced FPOP modifications 
upon binding are shown and colored in yellow. Reprinted with permission from Ref. [169] 
 
1.4.2 Protein Aggregation / Oligomerization 
The phenomenon of protein aggregation is a special case of protein-protein interactions 
where, instead of interacting with other proteins or ligands, the protein self-associates 
and forms higher molecular-weight molecules. The accumulation of protein aggregates is 
often related with diseases [237-241]. In fact, protein aggregates have been implicated in 
a wide variety of diseases known as amyloidosis, including Alzheimer’s disease (AD), 
Parkinson’s disease (PD), Huntington’s disease (HD), amyotrophic lateral sclerosis (ALS), 
and prion diseases [242, 243]. Currently, there are no effective cures for amyloidosis, 
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partially owing to a lack of means to characterize the protein aggregates at different 
stages, and a poor understanding of the aggregation mechanisms [244]. Therefore, a 
platform that enables fast and accurate characterization of protein aggregates, an in-
depth knowledge of protein-specific aggregation pathway, and a more detailed 
understanding of the factors that trigger and stabilize aggregate formation are required 
for future development of diseasing-curing therapies. 
Owing to the vast heterogeneity and propensity to oligomerize, aggregation-prone 
proteins are challengingly amenable to traditional high-res approaches including X-ray 
crystallography and NMR. Fluorescence-based methods, and atomic force microscopy 
(AFM) have been recently utilized [245-247], but only low structural resolutions are 
attainable. Mass spectrometry-based techniques have emerged as alternative 
approaches to characterize protein aggregations. Top-down analysis coupled to native 
ESI, which preserves the solution-conformation and non-covalent interactions of protein 
aggregates by spraying the sample at near-native environment, has enabled detection of 
protein aggregates as large as hundreds of kDa [248-250]. Protein footprinting 
approaches interfaced with bottom-up analysis, on the other hand, provide opportunities 
to obtain regional information on aggregates. Two exemplary approaches are HDX [251, 
252] and oxidative footprinting. For example, we have implemented the pulsed HDX 
technique to probe the conformational changes of amyloid beta (Aβ) peptides aggregation 
at various stages [52]. The successful use of HDX requires constrained downstream 
processes including sample cleanup, enzymatic proteolysis, and peptides separation, in 
order to prevent back-exchange issues [253]. Hydroxyl radical footprinting, 
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advantageously, is free of such concerns, owing to the nature of irreversible modifications. 
Chance and co-workers have used synchrotron radiolysis-based hydroxyl radical 
footprinting method for structural analysis of multiple protein aggregates, including 
proinsulin hexamer assembly [254],  Aβ1-40 fibril [255].   
We recently described a platform with fast photochemical oxidation of proteins (FPOP) 
and mass spectrometry to follow a time-dependent aggregation of Aβ1-42, putatively the 
most pathologically relevant species in Alzheimer’s disease [256]. Essentially, pretreated 
samples, at various incubation time points with different extents of oligomerization, were 
submitted to FPOP for fast, irreversible labeling. We hypothesized that the FPOP 
modifications respond sensitively to the solvent accessibility changes of Aβ protein as it 
aggregates progressively. Mass spectrometry analysis of intact, HO• footprinted Aβ 
samples show that the fraction modified decreases as incubation time increases (Figure 
1-7). Peptide and residue-level information were achieved by implementation of Lys-N 
rapid digestion and LC-MS/MS. The FPOP results suggest that the middle domain and 
C-terminal domain of Aβ1-42, as represented by peptides 16-27 and 28-42 that show 
significant decrease of FPOP yield over time, are involved in the self-association. 
Specifically, we observed a 6-fold decrease in rate from Aβ1-42 monomers to fibrils for 
peptide 16-27, which convincingly suggests the pivotal role of this region in forming the 
aggregates. A recent MD simulation study also suggests that the middle region of Aβ1-42 
is involved in the formation of nucleation interface [257]. In contrast, the FPOP yield of 
the N-terminal domain (represented by peptide 1-15) stays high (~85%) throughout the 
aggregation, indicating this region is structurally flexible with little self-association and 
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little loss of solvent accessibility as Aβ1-42 self-associates. This finding agrees well with 
the previous solid-state NMR results that show a disordered N-terminal region in multiple 
Aβ1-42 oligomers and fibrils [258]. 
Most aggregation-prone proteins follow a nucleation-dependent pathway to aggregate 
[259-261]. The protein-protein interface that induces the aggregation functions like a 
“scaffold core”, excludes solvent, and promotes the formation of larger molecular weight 
molecules. The aggregation interface should exhibit decreased FPOP modifications as it 
is less solvent accessible. For instance, we reported the successful FPOP 
characterization of structural differences between tetrameric apolipoprotein of WT ApoE3 
and its monomeric mutant (ApoE3MM), aiming to identify the aggregation interface of 
ApoE3 protein [197]. FPOP localizes, at residue level, that the C-terminal tail domain is 
involved in the ApoE3 oligomeric interaction, because the FPOP yield of monomer is 
significantly higher than that of tetramer in C-terminal tail. We also employed, parallelly, 
the carboxyl-group footprinting (i.e., GEE), which specifically modifies solvent-accessible 
carboxyl sidechain of aspartate and glutamate [262], and reached a similar conclusion as 
FPOP, although the two footprinting approaches are different regarding the reaction 
timescale and residue specificity. 
Reinforced by numerous biophysical techniques [263-265], the conclusion that the C-
terminal domain is the aggregation interface of ApoE3 is demonstrated, at amino acid 
resolution, with two protein footprinting techniques (i.e., FPOP and GEE). FPOP further 
identifies, however, a dynamic hinge region (amino acids 183-205) that is possibly also 
involved in the oligomeric interaction, evidenced by several residues in this region with 
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increased FPOP modifications for monomer. Some previous studies indicated that the 
hinge region is required for the inter-domain interactions [266, 267]. The carboxyl-group 
footprinting, however, is not sensitive enough to resolve changes in dynamic region, likely 
owing to the dramatically longer labeling timescale (a few minutes) compared to FPOP 
(µs). As discussed in previous section (4.1), a longer labeling time renders sampling of 
an ensemble of protein conformations over time, and compromises the capability of 
probing protein dynamic motions.  
 
Figure 1-7. Mass spectra of intact, FPOP-labeled Aβ1-42 (+5 charge) as a function of 
incubation time: (A) Control: Aβ1–42 monomer with all reagents, including H2O2, flowed 
through the FPOP tubing but without laser irradiation; (B) Extensively hydroxyl radical-
modified, unstructured Aβ1–42 monomers; (C–E) decreasing FPOP modification extents 
of Aβ1–42 aggregates, reflecting increasing structural protection to FPOP modification; (F) 
minimal Aβ1–42 modification, reflecting solvent-inaccessible, highly ordered core structure 
of the fibrillar aggregates that resist FPOP modification. Reprinted with permission from 
Ref. [256] 
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1.4.3 FPOP Probing Dynamic Motions of Proteins  
As discussed earlier, FPOP footprinting platform harbors the advantages of ultrafast 
labeling, high sensitivity, and low selectivity, which have enabled the finding in ApoE3MM 
that a dynamic hinge region (amino acids 183-205) is also involved in oligomerization, 
besides the C-terminal region (amino acids 232-251). It has been well acknowledged that 
protein functions are not only determined by its structure, but also by the dynamic motions 
it undergoes [268-270]. The dynamic properties intrinsic to a protein structure may 
provide information on the location and the energetics of the conformation change 
process, and are thus the focus of many biophysical studies [16]. These dynamics span 
from secondary to higher order structures, and range from picoseconds to hours in 
timescale [271, 272].  
Despite the obvious importance of dynamic motions to protein function, determining the 
dynamics of protein motion has long been an area largely unstudied, owing to lack of 
suitable experimental and theoretical probes. Relaxation experiments, such as the use of 
temperature-jump relaxation spectroscopy, can provide a means for protein dynamic 
studies with low structural resolution [273, 274]. X-ray crystallography, on the other hand, 
presents atomic-level structural information; it is not amenable, however, to protein 
dynamics because it typically represents an averaged protein conformations over 
seconds to hours [10, 14]. NMR spectroscopy techniques, in contrast, can be used to 
monitor the dynamic behaviors of proteins with high resolution on a broad range of 
timescales [16]. Paralleling the NMR developments, multiple mass spectrometry-based 
methods have also been developed to monitor protein dynamics [275]. Contemporaneous 
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with these experimental methodologies, recent advances in computations have led to the 
development of increasingly successful molecular simulations of protein structural 
dynamics that are intrinsic to biological process [276, 277]. 
TEM β-lactamase (TEM) endows bacteria with resistance to numerous antibiotics, by 
rapidly evolving to mutant TEM variants that are capable of degrading new drugs [278]. 
TEM-52, for example, which carries mutations of E104K, G238S, and M182T, can 
hydrolyze cefotaxime 2300-fold more efficiently than the wild-type TEM-1 [279]. Despite 
mutational changes in amino acid sequence, the crystal structures of TEM-52 and TEM-
1, however, are surprisingly similar [280]. We hypothesized, based on the prediction of 
extensive MD simulations, that there are hidden dynamic conformations of TEM,  eluded 
by X-ray crystallography, accounting for the functions of TEM with these effects of 
mutations [281]. To experimentally confirm the presence of hidden conformational states 
of TEM, we resorted to rapid mass spectrometric footprinting (FPOP), because the µs 
labeling timescale of FPOP is much faster than TEM unfolding [282], and similar to the 
timescale of some secondary structural motions of WT and mutant TEM [281]. Specifically, 
FPOP identified restricted motions of W-loop in TEM-52, as represented by reduced 
modification extents in regions proceeding the W-loop and the W-loop itself. This finding 
supports the modelling prediction that the increased cefotaxime hydrolysis activity of 
TEM-52 is associated with the reduced W-loop mobility. 
1.4.4 FPOP Accessing Protein Folding 
The fast labeling of FPOP not only allows probing of protein dynamic motions, but also 
paves the avenue to elucidate protein folding mechanisms, which remain challenging in 
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structural biology, owing partially to the short-lived folding intermediates formed along the 
pathway [283]. Conventional means such as rapid mixing have been used to study the 
folding of many two-state or multi-state systems [284, 285]. The mixing dead time, 
however, presents a major limitation for many fast-folding events. Recent advances in 
mixing devices lower the mixing dead times to low µs level [286-288]. An alternative to 
assess fast folding is the temperature-jump relaxation [273], as discussed in the previous 
section 4.3.  
The folding kinetics can be tracked by spectral probes that detect various features of 
folding intermediates. For example, one could use NMR to probe the hydrogen/deuterium 
exchange at amino-acid level after rapid mixing [289]. Recent advances in mass 
spectrometry-based protein footprinting have enabled protein folding studies by 
examining solvent accessibility as an indicator of protein conformational changes, as 
monitored by changes in labeling extents measured by LC/MS [290, 291].  
We recently described a pump/probe platform that combines T-jump relaxation and FPOP 
footprinting, allowing tracking of protein fast folding on submillisecond timescale [292, 
293]. The platform incorporates two lasers, with the first laser supplying a fast 
temperature-jump (ns) and the second laser generating HO• to footprint the protein 
irreversibly within 1 µs (Figure 1-8). The delay time between the two lasers, however, is 
tunable and reflects the protein folding time. The platform, interfaced with proteolysis and 
LC-MS/MS analysis, reveals protein folding kinetics at peptide/residue level. To 
demonstrate, a model protein, barstar, was used because it denatures at 0 °C and folds 
with T-jump. Eight different time delays between the two lasers were selected to follow 
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the folding kinetics (i.e., 0.1, 0.2, 0.4, 0.6, 0.8, 1.0, 1.5, and 2.0 ms). We observed that 
the helix1 of barstar, as represented by three residues H17, L20, and L24, exhibits 
decreased HO• modifications during the first 0.1-1 ms of folding; while the modification 
extent of other regions remains unchanged. This observation indicates the involvement 
of helix1 in barstar early folding, as reinforced by previous study that barstar fast folding 
follows a nucleation-condensation mechanism with the nucleus centered on helix1 formed 
in a folding intermediate [294]. The NMR structure (PDB 1BTA) also shows that the three 
FPOP-identified residues are tightly buried in a hydrophobic core in the native state of 
barstar [295]. Further, an intermediate folding state formed 2 ms after initiation of folding 
was also identified with this approach. 
The combination of pump/probe platform and mass spectrometry provides insights into 
the protein folding/unfolding conformational changes occurring in submillisecond 
timescale at residue-specific resolution. This platform can either probe even faster 
biological processes, by narrowing the time delay between the two lasers to even closer, 
or probe slower processes (e.g., late stages of protein folding) by displacing the probe 
laser from the pump. The flexibility of adjustment in time frame allows drawing of a more 
complete picture of protein folding event. 
FPOP has also demonstrated its capability to track folding conformational intermediates 
of large proteins. For instance, in the event of virus infecting a cell, a receptor-binding 
protein and a metastable fusion protein (pre-fusion state) of virus would coordinate 
effectively to facilitate membrane fusion and genomic transfer [296-299]. The receptor-
binding protein, upon activated by receptor, often induces extensive refolding event of 
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fusion protein to form a stable post-fusion state [298, 300]. Understanding of the refolding 
process can be critically important in inhibiting virus infections. Apart from some 
structures available for the pre-fusion and post-fusion states, however, little is known 
about the structural details for the folding intermediates. Recently, a soluble form of 
parainfluenza virus 5 (PIV5) fusion protein was triggered to refold with heating and 
footprinted along the refolding pathway using FPOP [301]. To characterize the 
conformations of refolding intermediates, high-resolution tandem mass spectrometry was 
utilized. The use of heating as the surrogate to induce refolding, and FPOP to footprint, 
make it possible to take “snapshots” of intermediate folding structures. Intact mass 
spectrometry analysis suggests that the metastable pre-fusion state (before heating) is 
overall more solvent exposed compared to post-fusion state, as evidenced by the higher 
FPOP yield in pre-fusion state. Bottom-up analysis monitors the refolding at peptide and 
residue levels, permitting the creation of a detailed model of the refolding event. FPOP 
reveals that, interestingly, changes in solvent accessibility of fusion protein refolding are 
region-dependent. For example, FPOP identifies two regions (represented by peptides 
79-91 and 130-141) with significantly increased modification extent, upon heating from 
21 °C to 45 °C. The product-ion spectra showed, with high confidence that, Leu87, Thr89, 
Ile90, Ile137, and Leu138 are accountable for the differential modifications, indicative of 
the increased solvent accessibility of those residues during refolding, consistent with their 
exposure upon release of fusion protein and the extension towards the target membrane 
[302-304]. 
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To summarize, FPOP footprinting provides structural characterizations with medium-
resolution suitable for both fast protein folding kintics and complicated transient protein 
refolding events. The marriage of folding triggers (e.g., T-jump) and FPOP allows probing 
of the dynamic folding movements under physiologic conditions.  
 
Figure 1-8. Schematic of a custom-build two laser pump/probe system on an FPOP 
platform. The time between the two lasers is adjustable. Reprinted with permission from 
Ref. [292] 
 
1.4.5 Membrane protein 
Membrane proteins interact with, or are part of, biological membranes. They are targets 
of more than half of all modern medicinal drugs [305]. Approximately 20-30% of all genes 
in most genomes encode membrane proteins [306, 307]. Most membrane proteins 
function by interacting with binding partners (other proteins, peptides, or themselves) for 
signaling and intracellular communication, vesicle trafficking, ion transport, and protein 
translocation, the conformations of membrane proteins change during these processes 
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[45, 308]. The determination of membrane protein conformations, however, has remained 
challenging largely due to their hydrophobicity, which makes it difficult to establish 
experimental conditions where the native protein structures are preserved.  
The use of Nanodiscs as a carrier to incorporate membrane proteins into lipid bilayers 
provides near-native membrane environment and controllable stoichiometry of target 
membrane proteins (Figure 1-9 A) [194, 309-311]. This has enabled various biophysical 
analysis including mass spectrometry-based approaches to study membrane proteins 
[312-314]. HDX has been used to characterize membrane proteins in the presence of 
detergent micelles provided the protocols encompass fast cleanup, effective digestion, 
and good solubility of proteins [315-317]. Hydroxyl radical footprinting, on the other hand, 
is not so much constrained because the irreversible labeling provides flexibility in 
proteolysis and chromatography as there is no concern for back-exchange, and more 
importantly, allows efficient lipid removal prior to MS analysis.  
Bearing these merits, hydroxyl radical labeling is emerging as an alternative footprinting 
approach for membrane protein studies. Konermann et al. [318] first demonstrated the 
feasibility of FPOP on a membrane protein, bacteriorhodopsin, in a native lipid bilayer 
environment. Chance and co-workers [150], in the meantime, footprinted membrane 
proteins using synchrotron radiolysis with HO• to locate structural water and characterize 
conformational changes. We recently described an FPOP footprinting of a Nanodiscs-
incorporated membrane protein, light harvesting complex 2 (LH2), to probe its structure 
and topology [196]. Most of LH2 structures are transmembrane helices, the outer-
membrane regions, however, are short and have little higher order structures. FPOP 
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results show that the outer-membrane regions are more heavily labeled by HO• compared 
to the regions embedded in the lipid bilayers (Figure 1-9 B). 
More recently, we reported the use of FPOP to footprint the full-length, post-translationally 
modified oncogenic protein, KRAS4b, in a near-native environment facilitated by 
incorporation of lipid Nanodiscs (see details in Chapter 7). We employed Leu-enkephalin 
to normalize the differential radical dose induced by Nanodiscs, and conducted a time-
dependent FPOP experiment. FPOP suggests the protection of C-terminal tail region of 
Nanodisc-bound KRAS4b, owing to the reduced extent of modifications observed for 
several peptides on the tail upon Nanodiscs binding. Other regions of KRAS4b, however, 
do not show changes of solvent accessibility. This convincingly indicates the proximity of 
C-terminal region to the membrane whereas the majority of the KRAS4b is outside. Such 
protein-membrane association is corroborated by complementary biophysical means 
including neutron reflectivity, NMR, SAX, and SANS. 
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Figure 1-9. (A) Schematic illustration of a Nanodisc with a transmembrane protein 
embedded. Retrieved from https://duonglabdrop.wordpress.com; (B) Representation of 
Nanodiscs-incorporated, FPOP-labeled LH2 transmembrane protein (PDB 1NKZ). 
Regions outside the membrane are heavily modified, whereas regions inside the 
membrane are almost inert to the HO• modifications. 
 
1.5 Conclusion 
FPOP footprinting allows fast, irreversible, and flexible mapping of protein surface solvent 
accessibility. The fast-labeling permits interrogation of protein conformations even if the 
protein unfolds after the reaction because of further oxidation; the irreversible nature of 
hydroxyl radical labeling enables more rigorous sample handling processes downstream 
the footprinting; and the flexibility endowed by incorporation of radical scavengers and 
reporter peptide makes FPOP more quantitative and tunable. Additionally, the current 
FPOP platform can be adapted for protein footprinting with new reagents, affording a 
footprinting toolbox with different labeling reagents targeting different amino acids with 
different selectivity and specificity. FPOP could be broadly applied to a variety of 
biochemical and biomedicinal areas, including problems associated with protein 
therapeutics, protein aggregation, protein fast folding/unfolding and dynamic motions, 
and membrane proteins. 
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Chapter 2 
Dosimetry Determines the Initial Hydroxyl Radical 
Concentration in Fast Photochemical Oxidation of Proteins 
(FPOP) 
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2.1 Abstract 
Fast photochemical oxidation of proteins (FPOP) employs laser photolysis of hydrogen 
peroxide to give hydroxyl radicals that label amino acid side-chains of proteins on the 
microsecond time scale. A method for quantitation of hydroxyl radicals after laser 
photolysis is of importance to FPOP because it establishes a means to adjust the yield of 
HO•, offers the opportunity of tunable modifications, and provides a basis for kinetic 
measurements. The initial concentration of hydroxyl radicals has yet to be measured 
experimentally. We report here an approach using isotope dilution gas 
chromatography/mass spectrometry (GC/MS) to determine quantitatively the initial HO• 
concentration (we found ~ 0.95 mM from 15 mM H2O2) from laser photolysis and to 
investigate the quenching efficiencies for various HO• scavengers.  
2.2 Introduction 
Protein footprinting examines protein structure and conformational changes by monitoring 
solvent accessibility and/or H-bonding by using either modification or cleavage reactions 
[1]. The marriage of mass spectrometry (MS) proteomics methods and protein footprinting 
allows protein structure, function, dynamics, interactions with ligands and stoichiometry 
to be examined [2]. Hydroxyl-radical oxidation is one method of “protein footprinting”, a 
term coined by Chance [3] for synchrotron-induced labeling. Hettich and Sharp [4] had 
earlier explored slow labeling via Fenton chemistry. Although there are other ways to 
produce HO• [5-7], the “fast photochemical oxidation of proteins” (FPOP) method shares 
the advantages that a stable, irreversible covalent modification is installed in nearly 3/4th 
of the amino-acid residues, providing higher coverage than most labeling methods. Given 
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that HO• is comparable in size to a water molecule, FPOP is a probe of solvent 
accessibility.  Moreover, FPOP provides a fast “snapshot” of protein structure (~ 1 µs) 
without concern for rearrangements or loss of label during subsequent sample handling 
and proteolysis, and it can accommodate other radical reagents [8, 9].  
FPOP utilizes a pulsed laser to photolyze hydrogen peroxide to generate two HO• that 
rapidly modify proteins in a flow system [10]. The laser provides a spatially small, high 
flux of light, maximizing the exposure of small plugs of protein solution to radicals and 
ensuring all but a small fraction of the protein in the flow is irradiated only once [11]. FPOP 
is a practical approach, requiring only a modest laser and syringe pump [12-14].  
Missing thus far in the development of FPOP is a method that gives the initial 
concentration of HO•, allowing rational means for tuning. The concentration of HO• is also 
an input to any kinetic analysis to control the approach. Quantitation of HO• generated in 
FPOP is difficult because the radicals are short-lived. Hambly et al. [10] estimated the 
initial concentration of HO• to be 1 mM, consistent with the molar absorptivity of H2O2 and 
the quantum yield of HO•. Chen, using LC/MS, measured preliminarily the [HO•] to be 
0.42 mM [15]. The high speed of oxidative modifications in FPOP, however, can be placed 
on a firmer ground by measuring the initial [HO•] with a routine method. 
Here we report a determination of the initial concentration of HO• upon laser photolysis 
by using isotope dilution GC/MS, which is sensitive, specific [16, 17], and gives good 
accuracy, precision, and correction for analyte loss during handling [18]. We selected 
unlabeled phenylalanine as a “dosimeter molecule” to quantify the HO• and d5-
phenylalanine as the internal standard. Phenylalanine is suitable because it is reactive 
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towards HO• (rate constant of 6.9 × 109 M-1s-1 [19]), and it yields simple oxidation products 
by a mechanism discussed elsewhere [1].  
We measured the initial HO• concentration in FPOP and found that it is comparable to 
our previous estimate [10]. Further, we measured [HO•] available to label proteins as a 
function of both the nature and concentration of the scavenger (i.e., methionine, histidine 
and glutamine). 
2.3 Experimental 
2.3.1 Materials and Reagents 
Unlabeled phenylalanine and d5-phenylalanine were provided by Jan Crowley. L-
Glutamine, L-methionine, L-histidine, catalase, 30% hydrogen peroxide, N,O-
bis(trimethylsilyl)fluoroacetamide (BSTFA), phosphate-buffer saline (PBS) and HPLC-
grade solvents were from Sigma Aldrich (St. Louis, MO) 
2.3.2 Calibration 
A series of solutions containing increasing amounts of d0-phenylalanine (0, 10, 25, 50, 
100 nmol) were dissolved in PBS buffer (10 mM phosphate buffer, 138 mM NaCl, and 2.7 
mM KCl, pH 7.4), mixed with H2O2, and submitted to FPOP without pulsing the laser to 
correct for any analyte losses. Methionine and catalase were added to each vial 
immediately following to simulate FPOP conditions. A constant amount of d5-
phenylalanine internal standard (100 nmol) was then added to each vial.  
After removing the solvent by speed-vac, the samples were treated with BSTFA to form 
trimethylsilyl derivatives that were analyzed by GC/high resolution MS with extracted ion 
	 76	
chromatography and integration of ion peaks for the standard and unknown to give an 
intensity ratio of the analyte and the internal standard.  The ratio was plotted as a function 
of the amount of d0-phenylalanine initially added. 
2.3.3 FPOP Dosimetry Experiment 
Our goal was to determine the yield of HO• when there was no scavenger in the system 
(Figure 2-1) by incorporating the laser pulse for FPOP, as described previously [10]. d0-
Phenylalanine (100 nmol) as dosimeter was dissolved in PBS buffer, and H2O2 peroxide 
was added just prior to syringe infusion; their concentrations were 2 and 15 mM, 
respectively. The sample solution was advanced at a rate of 23 µL/min by a syringe pump 
(Harvard Apparatus, Holliston, MA), The excimer laser power (GAM Laser Inc, Orlando, 
FL) at 248 nm was adjusted to ~40 mJ/pulse at a frequency of 7.0 Hz, affording an 
exclusion volume fraction of 20% (the volume not irradiated by laser, sandwiched 
between plugs of irradiated solution). All collections were in vials containing 500 nM 
catalase and 70 mM methionine, preventing further oxidation by H2O2. A solution 
containing 100 nmol of d5-phenylalanine was added to each vial, the solution dried on a 
speed vac, derivatized with BSTFA, and analyzed by GC/MS to give the amount of d0-
phenylalanine reacted which equals the amount of HO• generated. 
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Figure 2-1. Workflow of FPOP dosimetry experiment. (1) Without scavenger, 100 nmol 
of dosimeter (d0-phenylalanine) was subjected to FPOP, generating tyrosine-like products 
from HO• attack on the aromatic ring; (2) Internal standard (d5-phenylalanine) added to 
vial; (3) BSTFA added for derivatization of both dosimeter and internal standard; (4) 
Products analyzed by GC/MS. 
 
2.3.4 Gas Chromatography/Mass Spectrometry 
Samples were diluted 10:1 before injecting into an Agilent 7200 Q-TOF GC/MS (Santa 
Clara, CA) with a split of 10:1, to avoid column overload and detector saturation. The inlet 
temperature was 280 ºC. The gas chromatograph was an Agilent 7890 equipped with an 
Agilent 19091S HP-5ms column (30 m, 0.25 mm id., 0.25 µm 5% diphenyl 95% 
dimethylpolysiloxane film coating). The GC oven temperature was at 80 ºC for 2 min after 
sample auto-injection and then ramped at a rate of 10 ºC/min to a final temperature of 
300 ºC, which was held for 6 min. All spectra were acquired in the positive-ion EI mode. 
2.4 Results and Discussion 
2.4.1 Dosimetry 
To measure the [HO•], we derivatized the carboxyl and amine groups of phenylalanine 
with trimethylsilyl groups, taking advantage of this well-known protocol [20]. We chose 
fragment ions of m/z 294.1340 and 299.1654 (derivatized d0-phenylalanine and d5-
phenylalanine) because the molecular ions (M+•) of m/z 309.1575 and 314.1889 were not 
detectable [21] (structures and EI mass spectra are in Figure 2-2). Other appropriate 
fragment ions are of m/z 266.1391 and 271.1705; and of m/z 91.0542 and 96.0856.  
To conduct the analysis, we held constant the amount of d5-phenylalanine derivative in 
each sample  (100 nmol), so there was little change in its ion-current peak integral (see 
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Figure 2-3), and increased d0-phenylalanine from 0 to 100 nmol. The ratio of the ion-
current peak integrals (d0/d5) was obtained from extracted ion chromatograms and plotted 
as a function of amount of added d0-phenylalanine. The ions of m/z 294.1340 and 
299.1654 gave a ratio of peak integrals (d0/d5) as a linear function of the amount of d0-
phenylalanine over 0-100 nmol (Figure 2-4). The curve (slope of 0.0061, y-axis intercept 
of 0.015, and an R2 of 0.9970) provided the interpolated concentration of remaining d0-
phenylalanine. By subtracting this amount of d0-phenylalanine from the initial amount, we 
obtained the amount of consumed d0-phenylalanine, which is the amount of HO• from 
each laser pulse that reacted with the dosimeter. From these experiments, the HO• 
concentration that reacted with the dosimeter from each laser pulse was 0.67 ± 0.08 mM 
from a starting solution of 15 mM H2O2, an amount close to our earlier estimate [10].   
We selected two other fragment-ion pairs (m/z 266.1391 and 271.1705; and m/z 91.0542 
and 96.0856) to build two other calibrations (see Figure 2-4) that afforded measured [HO•] 
of 0.69 ± 0.12 and 0.68 ± 0.12 mM, respectively. Two control experiments were included, 
one without laser and the other without H2O2.  
The initial [HO•] should be slightly higher because the measured value is reduced by HO• 
self-recombination, which competes with the reaction of HO• and dosimeter. 
We simulated by kinetic modeling the amount of phenylalanine product to predict an initial 
[HO•]. A search varied the postulated initial [HO•] until the calculated HO• concentration 
that reacted with the dosimeter matched the experimentally determined value (0.67 mM). 
The best fit showed the initial [HO•] to be 0.95 mM. The simulations also included the 
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Haber-Weiss chain reaction, which has little effect. We did not model, however, any 
reaction of •OOH produced in the final step of phenylalanine modification [1].  
 
 
Figure 2-2. Mass spectra of trimethylsilyl derivatives for d0-Phe and d5-Phe, molecular 
ions (M+) were not discernable, the peaks representing [M+-•CH3] were found at m/z 294.1 
and 299.2, respectively. 
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Figure 2-3. GC/MS detection of BSTFA-derivatized d0-phenylalanine (m/z 294.1340) and 
d5-phenylalanine (m/z 299.1654). Each panel represented the EIC of trimethylsilyl 
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derivative. From A to E, amount of d0-phenylalanine was increasing whereas d5-
phenylalanine remained constant. 
 
 
Figure 2-4. Standard calibration curves of d0-phenylalanine based on fragment ions of: 
(A) m/z 294.1340 and 299.1654; (B) m/z 91.0542 and 96.0856; (C) m/z 266.1391 and 
271.1705. The error bars correspond to the ± SE of triplicate measurements. 
	
2.4.2 Effect of Scavenger 
In a typical FPOP experiment, scavengers limit the available [HO•] for footprinting. Thus, 
it is of interest to measure the [HO•] when using scavengers of different nature or 
concentrations, facilitating creation of an improved FPOP platform with scavenger-
tunable [HO•]. Tuning the [HO•] is important because different proteins usually require 
different [HO•] to achieve modifications that are sufficient to reveal structural information, 
yet do not give overoxidation. Moreover, varying the scavenger provides the means for 
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measuring the kinetics of radical modification reactions. To test this, we used different 
concentrations of glutamine (10, 20, 40 mM) as scavenger and measured [HO•] to 
establish a relationship between measured [HO•] and scavenger concentration. 
Furthermore, histidine and methionine were also tested as a function of concentration 
(0.2, 0.8, 2.0 mM) (Figure 2-5). For each scavenger (His, Met, Gln), the measured [HO•] 
decreases as scavenger concentration increases. Moreover, extrapolation of the curves 
to the y-axis, gives approximately the same intercept, [HO•] with no scavenger (i.e., 0.67 
mM) (see Figure 2-5 and Figure 2-6). The equation for each scavenger response curve 
is also given in those figures. The ratios of the rate constants of glutamine, histidine and 
methionine towards HO• (5.4×108 M-1s-1, 4.8×109 M-1s-1, and 8.5×109 M-1s-1 respectively 
[1]) should predict the ratios of the line slopes, and this is approximately correct.  
Discrepancies may be due to differences in our methods and conditions compared to the 
original kinetic studies.  
For different amino-acid scavengers, the rate constants differ by three orders of 
magnitude [1]. Taking advantage of this, we can adjust the [HO•] available for footprinting 
by varying either the nature or concentration of the scavenger. The consequence of this 
adjustment may be significant because the time range available to FPOP can be shifted 
from either ~1 µs to ~100 ns (scavengers of higher reactivity or concentration), or to near 
ms (scavengers of lower reactivity or concentration). A numerical simulation of [HO•] 
concentrations by using different scavengers (Figure 2-6) shows that the lifetime is 
approximately 1 µs when using 20 mM glutamine as scavenger but adjustable to ~0.1 µs 
by using methionine or histidine as scavenger or to 100 µs with alanine as scavenger (we 
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assign the lifetime of the radicals to the time at which their concentration is 100 times less 
than that of the protein).  Adjusting the lifetime of HO• enables FPOP labeling over a wider 
time scale, making FPOP a flexible tool to investigate various folding/unfolding events. 
For example, some proteins fold to a native state by first forming secondary and then 
tertiary structure [22]; whereas other proteins go through hydrophobic collapse first and 
then form tertiary structure [23]. The time-course changes for FPOP is in the range of the 
time scales for the major steps of protein folding, allowing future studies on the details of 
protein folding. 
	
Figure 2-5. Dose-response curves determined from fragment ions of m/z 294.1340 and 
299.1654 for Met, His and Gln. See SI for dose-response curves determined from other 
fragment ions (i.e., m/z 266.1391 and 271.1705; and m/z 91.0542 and 96.0856). The 
error bars correspond to the ± SE of triplicate measurements. Note that the lifetime of the 
radicals is ~ 1 µs when glutamine is 20 mM—see Figure 2-7. 
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Figure 2-6. Dose response curves determined by using fragment ions of (A) m/z 266.1391 
and 271.1705, and (B) m/z 91.0542 and 96.0856. The error bars correspond to the ± SE 
of triplicate measurements. 
 
 
Figure 2-7. Numerical simulation of HO• concentration vs. time. The simulation includes 
the HO• reaction with scavengers, the recombination of HO•, and the Haber-Weiss chain 
reaction. Lifetime of HO• (~100 ns to more than 10 µs) depends on the nature and 
concentration of the scavenger. 
	
2.5 Conclusion 
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The specificity, sensitivity, and precision of isotope dilution GC/MS to identify and quantify 
the dosimeter recommend it for quantifying the initial HO• concentration in FPOP. The 
approach permits optimization of FPOP conditions and adjustment of experimental 
parameters to realize tunable extents of modifications. Our next step is to study the effect 
of tuning, aiming for secure “hard” kinetic data that will allow comparison of results day-
to-day and lab-to-lab.  
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Chapter 3 
Incorporation of a Reporter Peptide in FPOP Compensates 
for Adventitious Scavengers and Permits Time-dependent 
Measurements 
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3.1 Abstract 
Incorporation of a reporter peptide in solutions submitted to fast photochemical oxidation 
of proteins (FPOP) allows for the correction of adventitious scavengers and enables the 
normalization and comparison of time-dependent results. Reporters will also be useful in 
differential experiments to control for the inclusion of a radical-reactive species. This 
incorporation provides a simple and quick check of radical dosage and allows comparison 
of FPOP results from day-to-day and lab-to-lab. Use of a reporter peptide in the FPOP 
workflow requires no additional measurements or spectrometers while building a more 
quantitative FPOP platform. It requires only measurement of the extent of reporter-
peptide modification in a LC-MS/MS run, which is performed by using either data-
dependent scanning or an inclusion list. 
3.2 Introduction 
Interest in elucidating protein higher order structures and the conformational changes 
connecting them continues to grow for both understanding fundamental biophysics and 
the development of therapeutic proteins. Protein conformational changes can be induced, 
for example, by posttranslational modifications (PTMs) [1], mutagenesis [2], 
oligomerization [3], and binding to metal ions, drugs, or to other proteins [4]. Multiple 
biophysical approaches, including circular dichroism (CD), fluorescence spectroscopy, 
and isothermal titration calorimetry, can report that a conformational change has occurred 
[5], but these approaches afford limited structural resolution. X-ray crystallography and 
NMR can provide site-specific information, but the turnaround is slow and the required 
sample quantity is large. The mass spectrometry (MS)-based method of hydroxyl-radical 
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footprinting, established by Chance and co-workers [6] and elaborated as fast 
photochemical oxidation of proteins (FPOP) by Hambly and Gross [7] does offer fast 
turnaround, high sensitivity, albeit at medium structural resolution.  
FPOP utilizes a pulsed laser to photolyze hydrogen peroxide to generate two hydroxy 
radicals (HO•) that rapidly modify protein side chains in a flow system. The laser provides 
a spatially small spot but high light flux, maximizing the exposure of small plugs of protein 
solution to radicals and ensuring that most of the protein in the flow is irradiated only once 
[8]. FPOP is easily implemented, requiring only a laser, optics, syringe pump, and flow 
system [9, 10]. By comparing the extent of modification for two samples (e.g., wild-type 
vs. mutant or apo vs. holo), conformational differences can be established at the peptide 
and even amino-acid levels [11, 12].  
There is always a need to normalize the yields of oxidative modification. For example, the 
presence of adventitious HO• scavengers (e.g., DTT, ATP, TFE, lipids, DMSO) in a 
protein solution may significantly reduce the FPOP-induced modification extent. If the 
scavenger amounts differ between a sample and control, the outcomes may be difficult 
to compare. In antigen-epitope mapping where one compares modification extent of an 
antigen with and without an antibody, one can use a non-interacting (“dummy”) antibody 
to compensate for the many reactions of HO• with the antibody, but reliable comparisons 
are needed to compensate for changes in the test vs. control solutions or when a non-
interacting protein is not available.  
Here we report that the use of a reporter peptide to resolve discrepancies in HO• dosage 
and “normalize” the results. We used leu-enkephalin as the reporter, where the fraction 
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modified is a “ruler” of radical dosage to the protein samples. This enables an important 
extension of FPOP, namely the acquisition of FPOP time-dependent data acquired by 
varying the scavenger concentration to modify the primary HO• lifetime. The extent of 
modification of the sample vs. that of the reporter provides time-dependent data and helps 
resolve conformational differences from readouts of peptide/residue responses at each 
time point.  
A kinetics-type approach should provide assurance that the modification reactions are 
occurring normally and also add statistical weight to the data and confidence to 
comparisons of higher order protein structure, affording an output that is similar to that of 
HDX. Another approach that accommodates adventitious scavengers is by Xie and Sharp 
[13], who proposed an adenine-based dosimeter to monitor and correct the radical dose 
from sample-to-sample in FPOP experiments. 
The reporter-peptide approach should be useful for protein therapeutics where higher 
order structure must be verified [14]. The ALS-linked dimeric protein Cu,Zn superoxide 
dismutase 1 (SOD1) is used here as test case for developing a robust method for 
comparing conformational changes between WT and mutant.  
3.3 Experimental 
3.3.1 Materials 
All experiments were performed using recombinant SOD1 protein expressed and purified 
from BL21-Gold(DE3) PLysS E. coli cells (Stratagene, Inc., Cedar Creek, TX) as 
previously described [15]. The free cysteines in WT SOD1 were replaced  with the 
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C6A/C111S mutations to avoid inter-molecular disulfide-scrambling; the alanine to valine 
mutation (A4V), the most common ALS variant in North America, was introduced into this 
pseudoWT background [16]. All proteins in this study are in apo-form. Leucine enkephalin, 
catalase, L-histidine, L-methionine, 30% hydrogen peroxide, phosphate-buffer saline 
(PBS), triethylammonium bicarbonate buffer (TEAB), HPLC-grade solvents, dithiothreitol 
(DTT), dimethyl sulfoxide (DMSO), trifluoroacetic acid (TFE), iodoacetamide (IAM), and 
sequencing-grade modified trypsin were purchased from Sigma Aldrich (St. Louis, MO, 
USA). 
3.3.2 FPOP Experiment  
A total volume of 100 µL of sample at a final concentration of 8 µM protein, 5 µM leu-
enkephalin, 22.5 mM freshly prepared hydrogen peroxide and at various concentrations 
(0, 0.2, 2.0, 40 mM) of histidine in PBS (10 mM phosphate buffer, 138 mM NaCl, and 2.7 
mM KCl, pH 7.4), was loaded in a 100 µL syringe (Hamilton, Reno, NV, USA) and 
advanced through 150 µm i.d. fused silica tubing (Polymicro Technologies, Pheonix, AZ, 
USA) at a flowrate of 27 µL/min by a syringe pump (Harvard Apparatus, Holliston, MA, 
USA). H2O2 was added just prior to syringe infusion. The excimer laser power (GAM Laser 
Inc., Orlando, FL, USA) at 248 nm was adjusted to ~35 mJ/pulse at a frequency of 7.4 Hz 
controlled by an external pulse generator (B&K Precision, Yorbal Linda, CA, USA). The 
laser beam was focused with a convex lens (Edmunds Optics, Barrington, NJ, USA) to 
an irradiation window of ~2.6 mm, affording an exclusion volume fraction of 22.5% (the 
volume not irradiated, sandwiched between plugs of irradiated solution). Samples were 
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collected in low protein-binding Eppendorfs containing 50 nM catalase and 70 mM 
methionine, preventing further oxidation by residual H2O2 and other oxidative species. 
3.3.3 LC-MS/MS Analysis 
Aliquot of 5 µL of sample was loaded onto a C18 reversed-phase desalting column 
(nanoViper, 100 µm x 2 cm, 5 µm,100 Å; Thermo Fisher Scientific, Waltham, MA, USA), 
desalted with water in 0.1% formic acid at 4.5 µL/min for 10 min, and eluted to a silica 
capillary analytical column that was custom-packed with C18 reverse-phase material 
(Magic, 100 µm ´ 180 mm, 5 µm, 120 Å; Michrom Bioresources, Inc., Auburn, CA), which 
was connected with a metal emitter and mounted on a Nanospray Flex ion source. The 
gradient was delivered at a flow rate of 0.4 µL/min from 2% to 45% solvent B (80% of 
acetonitrile with 0.1% formic acid) with an increment of 0.67%/min, then ramped quickly 
from 45% to 90% at 3%/min, and slowly from 90% to 95% solvent B in 5 min and re-
equilibrated to solvent A (water with 0.1% formic acid) for 6 min. The top 18 abundant 
charged ions were subjected to the high-energy C-trap dissociation (HCD) in the HCD 
cell with data-dependent scanning. 
3.3.4 Data Analysis 
The *.mgf files, converted from the *.raw MS files using ProteoWizzard 3.0, were 
searched using MASCOT (Matrix Science, London, UK) against a custom-built database 
containing the sequence of WT and A4V SOD1. All known hydroxyl radical side-chain 
reaction products [17] with a carbamidomethyl modification (57.0214 Da) to Cys-
containing peptides were added as variable modifications. Quantitation of the extent of 
modification at the peptide or residue level was calculated. Signals from LC-MS for each 
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unmodified peptide (Iun) and its modified species (Iox) were extracted from raw data files 
using Thermo Xcalibur 2.2 software (Thermo Fisher Scientific, Waltham, MA, USA) with 
a mass tolerance of 15 ppm. Calculation of the extent of modification was performed as 
previously reported [10]. 
3.4 Results and Discussion 
FPOP labels rapidly owing to the high reactivity of HO•  [7, 8]. Because the rate constants 
for amino acids reacting with HO• are known [17], the lifetime of HO• is adjustable by 
either scavenging with different amino acids or with a single amino acid at different 
concentrations (see Figure 3-1 for an illustrative numerical simulation of HO• lifetime as 
a function of time). The FPOP reaction time was varied by using histidine as radical 
scavenger for the OH primary radical at 0, 0.2, 2.0, 40 mM. We chose histidine because 
it is a simple amino acid, bio-compatible, soluble, and reactive with radicals. To normalize 
the results, we introduced leu-enkephalin as a reporter peptide prior to irradiation.  
Following FPOP, we analyzed the undigested protein by LC/MS, integrating TI signals 
over an elution time of 0.5 min. The unmodified protein is the most abundant followed by 
a singly oxidized species (+15.9949 Da), a doubly oxidized species (+31.9898 Da), etc. 
(Figure 3-2 A) according to the fraction modified [18]. The kinetics of oxidative 
modification at the protein level are relative to the oxidative modification of reporter leu-
enkephalin (M + 15.9949), determined from the extracted ion chromatograms (EICs) of 
both unmodified and modified leu-enkephalin (mass tolerance of 15 ppm; see Figure 3-
3). As the HO• lifetime becomes longer, the extent of modification of both the reporter leu-
enkephalin and the SOD1 protein increase. Plotting the protein-fraction modified versus 
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the reporter-fraction modified generates a curve whose x-axis reflects the varying HO• 
lifetime and y-axis tracks the protein response as labeling time changes (Figure 3-2 B).   
	
Figure 3-1. Numerical simulations of HO• concentration versus time. Lifetime of HO• 
(spanning from ~60 ns to more than 10 µs) is dependent on the concentration of histidine 
(from 0 to 40 mM). 
	
	
Figure 3-2. (A) Mass spectra from intact measurements of FPOP-labeled WT SOD1 (+16 
charge) obtained by adjusting [His]; (B) Intact protein fraction modified vs. reporter 
fraction modified under various scavenging conditions. The resulting curve is independent 
of the presence of FPOP adventitious scavengers, it demonstrates that incorporation of 
reporter peptide could normalize (or correct for) the FPOP outcome, making possible 
unbiased comparison between one state of protein and another (e.g., apo and holo). The 
error bars correspond to the ± SE of triplicate measurements. 
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Figure 3-3. Extracted ion chromatograms (EICs) of leu-enkephalin, both unmodified and 
modified (+16 Da) peptides were extracted with MS1 tolerance of 15 ppm. Different 
isomers of +16 modified species eluted at different retention times, MS/MS spectra can 
provide the sequence information, which can help to identify the residue that was modified. 
Here we observed that Tyr1, Phe4 and Leu5 of leu-enkephalin were modified. 
	
3.4.1 Correction for Adventitious Scavengers 
Protein samples in FPOP are studied in buffer solutions with near-physiological pH, 
permitting FPOP to be used under reasonably biologically relevant conditions. The 
lifetime of HO• is tunable and should predominantly be controlled by radical scavenger 
concentrations [19]. Sometimes, one is unaware of the presence of adventitious HO• 
scavengers (e.g., DTT, ATP, TFE, lipids, DMSO) that unpredictably scavenge the radical 
dosage and bias comparisons of the modification extents of the two protein states. 
Incorporating the reporter peptide into FPOP workflow allows for correction. Although 
FPOP experiments in the presence of adventitious radical scavengers would show 
reduced protein modification, the corresponding decrease of reporter-fraction modified 
maintains the protein-reporter outcome on the curve, correcting for differential scavenging 
(Figure 3-2 B). 
3.4.2 FPOP Kinetics at the Peptide/Residue Levels 
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To demonstrate time-dependent measurements, we plotted the fraction of leu-enkephalin 
modified at each histidine concentration vs. the corresponding fraction modified for each 
peptide of the protein (here SOD1) on the y-axis. The reporter-fraction modified reports 
HO• lifetime (i.e., longer times give more modification), and the plot shows the time-
dependent SOD1 modification, affording a similar output to that of HDX kinetics data for 
peptides. The response of each peptide of SOD1 as a function of reporter-fraction 
modified allow us to distinguish those reactive or solvent-accessible regions from the 
more protected regions (Figure 3-4). For example, peptides 24-36, 37-69, and 116-128 
exhibit greater fractions modified for both WT and A4V compared to most other peptides, 
indicating that those regions are more solvent-exposed as expected for these loop 
regions of SOD1. The curves for peptide regions of WT and A4V SOD1 should overlap if 
the solvent accessibilities of these peptides are the same for WT and mutant.  The 
nonoverlapping curves for peptides 1-9 and 123-136 (Figure 3-4) indicate a 
conformational change in these regions upon mutation, likely due to destabilization of the 
monomer-dimer equilibrium for the A4V variant [16].  
Although a time dependence is achieved by this simple approach, the increasing yield for 
the reporter does not have a simple relationship to time. Nevertheless, the approach is 
simple and effective for identifying protein regions that change upon perturbation.   
The functional dependence of sample-fraction modified v.s. reporter-fraction modified 
was described using the following Eq 3-1:  
" = $(1 − 1 − ( )*)+*, 	)                              Eq 3-1 
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where y is the sample peptide-fraction modified, x is the reporter-fraction modified, p is 
the asymptotic sample peptide response (assume to be 1), kp/krpt is the ratio between rate 
constants of sample peptide and reporter towards HO•. As described in Eq 3-1, when kp 
is close to krpt, the relationship between y and x is almost linear. 
The reporter response x, is related to the lifetime of •OH following Eq 3-2: 
( = /(1 − 012+*,345)                                                 Eq 3-2 
where r is the asymptotic reporter response, OHT is the HO•-time area (see Figure 3-1), 
which equals to the product of initial HO• concentration and HO• effective lifetime: 
678 = [76 •]<=<><?@	×	BCDD                 Eq 3-3 
Residue-level analysis can also be normalized by using the reporter peptide. We 
identified and quantified with high confidence eleven residues that undergo oxidative 
modification (see Figure 3-5). Referring to the X-ray crystallography structure (1N18), we 
see that most peptides/residues that exhibit higher modification extents (F50 in peptide 
37-69, K122 in peptide 116-128 and K136 in peptide 123-136) are located on loop IV (Zn-
binding loop—residue 49-83) and loop VII (electrostatic loop—residues 121-142) (see 
Figure 3-6) [20].  A detailed interpretation of the results will be part of a more extensive 
biochemical study to be published in the future.  
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Figure 3-4. Response curves of each peptide from WT and A4V SOD1 in an FPOP 
kinetics experiment performed by adjusting different histidine concentrations. The fraction 
modified for peptides from WT and A4V SOD1 were normalized by the reporter fraction 
modified under each scavenging condition. The error bars correspond to the ± SE of 
triplicate measurements. 
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Figure 3-5. Residue level kinetic curves of WT and A4V SOD1. Eleven residues were 
identified with high confidence and plotted as the fraction modified of each residue vs. 
the fraction modified of reporter peptide under each histidine concentration. The error 
bars correspond to the ± SE of triplicate measurements. 
	
	
Figure 3-6. Crystal structure of thermostable pseudo WT SOD1, containing the 
C6A/C111S mutations. Loop IV, i.e., the Zinc binding loop (residue 49-83, yellow) and 
loop VII, i.e., the electrostatic loop (residue 121-142, red) are shown. These two loops 
exhibited a higher extent of modification by FPOP. Residues that are significantly 
modified by FROP are labeled (cyan).  
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3.5 Conclusions 
In conclusion, an advantage of this simple approach is it allows quick location of 
conformational changes when comparing two samples, especially when adventitious HO• 
scavengers are present. Although we used leu-enkephalin, many peptides are candidate 
reporters. Ideally, they should be (1) mildly reactive towards HO•, so as not to affect the 
protein radical dosage while remaining sensitive to the HO• lifetime, (2) minimally 
structured so that its fraction modified won’t be confounded by structural changes; (3) 
soluble but not too hydrophilic to avoid eluting with the solvent front; (4) non-interacting 
with the proteins under study, and (5) readily available. A short peptide with one FPOP-
reactive residue may be preferred to simplify the quantitation of reporter modifications 
and the normalization of the extent of modification.  
The reporter-peptide approach is the first step to realize our vision to obtain quantitative 
measures  of residue and peptide reactivity, analogous to “protection factors” in HDX. 
This will require calibrating a reporter peptide’s rate constant against a standard reaction. 
Chance has identified a similar goal for synchrotron footprinting [21]. This would facilitate 
cross-laboratory comparisons of FPOP results and enable its use to determine coarse-
grained HOS of proteins.  
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Chapter 4 
Using R for Mass Spectrometry-based Proteomics Data 
Visualization and Analysis 
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4.1 Abstract 
Mass spectrometry-based proteomics has developed to the point where time-efficient, 
accurate data processing appears to be one of the bottlenecks. The R programming 
language and its accompanying packages are promising for providing a solution, by 
creating free analytical tools that are dynamic, interactive, and adaptive to the 
downstream analytical processes. The ease of coding, sharing, and communication of R 
Shiny web-based applications have greatly expanded the applicability, allowing people 
specialized in areas other than computer science to participate in creating useful software 
toolkits. 
4.2 Introduction 
Proteomics is the large-scale study of proteins [1, 2]. It has yielded many biological 
insights into diseases, as most biological functions are transmitted through proteins [3]. 
Mass spectrometry-based proteomics is evolving rapidly owing to the development of new 
technologies [4-6]. The data output, however, is becoming increasingly complicated [7-9]. 
The analysis of the large amount, complicated data generated in mass spectrometry-
based proteomic experiments highlight one of the most significant challenges, and is a 
bottleneck in many current proteomic researches [8].  
HPLC coupled to tandem mass spectrometry is quickly emerging as a method of choice 
for large-scale proteomic analysis [10, 11]. These instruments and the accompanying 
workflows can be used to identify and track the relative abundance of molecules, with up 
to tens of thousands of fragment ion spectra per hour of data acquisition [6, 12]. Typically, 
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in a standard bottom-up experiment, peptide mixtures derived from proteolysis of the 
proteins present in the sample are spatially separated by chromatography prior to 
injection into the mass spectrometer. This generates information-rich, time-dependent 
data, consisting of both the unique elution profile (column retention times) as well as 
mass-to-charge ratios (m/z) of individual peptide. Those peptides of interest are subjected 
to fragmentation (e.g., collision induced dissociation (CID), electron transfer dissociation 
(ETD)) followed by database searching for sequence identification; whereas the recorded 
elution profiles are used to determine relative abundances. The fast assignment of the 
fragmentation information, correct inference of the protein species, and faithful 
determination of the abundances in the analyzed samples, however, are subject to a 
number of challenging analytical issues in structural proteomics [4, 13, 14], including 
identification of less-abundant sequence variants, alignment of different experimental 
runs with systematic variations, and development of statistical tools for large-scale data 
interpretation. The work presented in this chapter focuses on a particular type of software, 
namely R, with its add-on packages that extend its functionalities, to show the usefulness 
of R for mass spectrometry-based proteomic data analysis. 
R is a free, open-sourced, comprehensive statistical environment and programming 
language for professional data analysis and graphic display [15]. It was originally created 
by Ihaka and Gentleman at the University of Auckland [16], and since then, been 
developed and maintained by the R-core group. R is currently widely used in public and 
private in a broad range of fields. Unlike other closed-source software, the validity of R 
has been reviewed by many internationally renowned statisticians and computational 
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scientists. The popularity of R can be ascribed to its numerous features including the huge 
collection of statistical algorithms, the capability to easily model and handle data with 
various formats, the cross-platform compatibility, and well-designed documentation. The 
biggest advantages of using R in bioinformatics is its high-quality, dynamic extension 
packages available from multiple repositories specializing in various topics including data 
subsetting, data mining, and graphic analysis [17]. In addition to those packages, there 
are numerous R-based projects concentrating on different life science areas including 
genomics and proteomics [18]. The Bioconductor project, for example, initiated by 
Gentleman [19], is specially focused on computational biology and bioinformatics and 
represents a central repository for more than 100 software, data processing and 
annotating packages, dedicated to the thorough analysis and comprehension of high-
throughput biological data. Additionally, recent developments of R Shiny package 
(https://cran.r-project.org/web/packages/shiny/index.html) have enabled creation of 
powerful interactive web applications without the need to delve into other programming 
languages such as HTML, CSS, and JavaScript. R Shiny allows the development and 
redistribution of software that other developers and users can easily access, making it 
possible to create a user-friendly, interactive, and easy-to-maintain data-processing 
platform for mass spectrometry-based proteomic analysis.   
In this chapter, we discuss several custom-built computational and analytical tools that 
can be considered when performing mass spectrometry-based proteomics analyses, for 
the purpose of achieving more convenient computations, more reliable quantitative and 
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qualitative measurements, and more adaptive data input and output that can facilitate the 
downstream data analyses.  
4.3 Unified API (Application Programming Interface) by mzR 
An LC-MS system incorporates: (1) a chromatography column that separates peptide 
mixtures based on physicochemical properties (e.g., hydrophobicity, hydrophilicity, total 
charge, size) prior to mass spectrometer detection; (2) an ionization source that 
generates gas-phase ions directly from solution; (3) one or more mass analyzers that 
record ions based on m/z; and (4) a detector that registers the relative abundance of ions 
at discrete m/z. For tandem MS, precursor ions are recorded in a full-scan mode, followed 
by conditional ion isolation and fragmentation for product-ion information. The typical 
workflow includes protein digestion by enzymes, peptide fractionation by chromatography, 
and mass spectrometer analysis. The raw data from LC-MS experiment generally consist 
of a list of variables including the scan number (spectra number), the LC retention time, 
the precursor-ion and product-ion m/z values, and the corresponding signal intensities. 
The format of these data, however, is vendor-dependent and not interchangeable (Table 
4-1). Recently, several research groups and HUPO Proteomics Standards Initiative (PSI) 
have developed open XML-based standards, formats and libraries to advocate vendor-
agnostic tools and analytical pipelines [20]. R unifies the data through a package, namely 
mzR [21], by providing an unified programming interface for common file formats including 
mzXML [22], mzML [23], mzData [24], and netCDF formats. A connection to any of these 
file types can be established by using the openMSfile function, which enables queries of 
instrument information and raw data in a consistent way. 
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Table 4-1. Different file extensions of major vendors of LC-MS/MS systems. 
 
4.4 Custom-built Web-based Applications 
A web-based application is any application that uses a website as the interface or front-
end. In contrast to traditional desktop applications, which are installed on a local computer, 
users can access the web application easily from any device connected to the internet by 
using a standard web browser [25]. Web-based applications have become increasingly 
popular, with the rise of widely available internet connection. To create a web-based 
application is, however, not simple, as lots of programming experience in HTML and 
JavaScript is needed. This presents a hurdle in creating web applications, especially for 
people who are not professional programmers. 
To overcome, RStudio released Shiny, which is a means of creating web-based 
applications entirely in R. The client-server communication, HTML, layout and JavaScript 
programming is completely handled by Shiny. Given the nature of the R language, it is 
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possible to program interactive applications with a Shiny Web-browser interface that can 
be accessed either on the localhost (users’ own device) or on another computer accessed 
by means of the internet. The R Shiny applications have the potential to provide great 
convenience and feasibility of data processing to a broader audience who are not 
necessarily experienced web-developers [26].  
4.4.1 The Structure of R Shiny Applications 
Each web-based application comes with an URL. By inputting the specific URL of the web 
application, a reaction from the server is triggered, sending the HTML, CSS, and 
JavaScript code needed to run the application back to the client. The web application then 
executes by itself inside the web browser of the client. A web-based application typically 
consists of a variety of user-interface (UI) elements (e.g., a button, a checkbox, and a 
drop-down list). Each of these elements is interactive. For example, pushing a button can 
trigger an action, allowing the execution of a piece of code, which in turn, changes the 
status of the web application, directing it to retrieve a piece of information from the server 
or draw a graph within the application. This process is commonly known as event-driven 
programming; that piece of code executed based on an event is known as event handler. 
R Shiny web applications follow this typical structure of web-based applications (Figure 
4-1). It is, however, much simpler. Shiny applications are built using two R scripts that 
communicate with each other (i.e., a user-interface script and a server script). The user-
interface script (ui.R) controls layout and appearance; the server script (server.R) 
contains content codes for user input and output by R language, and functions by using 
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user-installed packages. RStudio has provided detailed tutorials and training exercises 
for building Shiny applications [27]. 
The construction of HTML, CSS, and JavaScript codes is, conveniently, done by using 
these two R scripts, as is the generation of event handlers. In addition, upon an update 
of an UI element, all the relevant content code is updated automatically. Therefore, a fully 
functional web-based application can be completely written in R Shiny. 
 
Figure 4-1. The structure of an R Shiny web-based application. 
 
4.4.2 Example of an R Shiny Application: Proteomics Toolkit 
4.4.2.1 Overview of Proteomics Toolkit 
Herein, we discuss the core elements of the ui.R and server.R scripts necessarily needed 
to create a web-based application, by using a custom-built application, namely, 
Proteomics Toolkit (https://benniu-wustl.shinyapps.io/proteomics-toolkit/), as an example. 
This multi-functional application aims at facilitating the mass spectrometry-based 
proteomics and peptidomics analysis and computation. The functionalities include 
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monoisotopic m/z calculation with site-specific PTMs, in silico mass spectrum isotopic 
pattern simulation, in silico protein digestion, and generation of an inclusion list for mass 
spectrometry data-dependent-acquisition (targeted MS analysis, see Chapter 7 where we 
used this kind of MS acquisition mode) [28]. The complete code of Proteomics Toolkit is 
available online through GitHub (https://github.com/benniu720/Proteomics-Toolkit). 
Shown in Figure 4-2 is a screenshot of the user interface panel of Proteomics Toolkit. The 
two tabs on the top (i.e., Peptide Analysis and Protein Analysis, feature the two categories 
of utilities of this web application). Within each tab, there are several sub-tabs (e.g., 
Computations, MS Spectral Simulation, in silico Digestion, Targeted m/z), representing 
the different functionalities this software can achieve. For example, we selected the 
Computations sub-tab from the tab of Protein Analysis in Figure 4-2. By inputting the 
protein amino acid sequence on the top-left (in this case, YGGFLHPERTYNNAASDKLM), 
detailed information including the elemental composition (C101 H150 N28 O31 S1), total 
residue number (20 residues), monoisotopic m/z values at various charge states (from +2 
to +6), and the amino acid composition are computed and output automatically. With this 
amino acid sequence, we can go to the sub-tab of MS Spectral Simulation and calculate 
the isotopic pattern by clicking the “Simulate” button, specifying a user-defined charge 
state. Figure 4-3 shows its normalized isotopic pattern in the +3 charge state. The 
simulation pattern can change accordingly if we choose a different charge state or add a 
PTM to the molecule (from the panel on the left). Additionally, this application allows 
generation of in silico peptides (Figure 4-4), and calculations of the monoisotopic m/z 
values of these peptides with and without user-defined PTMs at various charge states 
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(Figure 4-5).  An output of this peptide list, which can be useful for generating targeted 
inclusion lists [28], is obtainable by clicking the “Download Targeted List!” button. Instead 
of going through a series of repetitive calculations and simulations, users are allowed to 
control and adjust all parameters in Shiny, and, interactively, access the results 
simultaneously. 
 
Figure 4-2. Proteomics Toolkit application. Shown is the display of computed results, 
under the sub-tab of Computations, based on the amino acid sequence input of the 
peptide sequence YGGFLHPERTYNNAASDKLM. The computation includes elemental 
composition, total residue number, monoisotopic m/z from +2 to +6 charge state, and the 
amino acid composition. 
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Figure 4-3. Proteomics Toolkit application under the sub-tab of MS Spectral Simulation. 
Shown is the interactive display of simulated isotopic pattern of the amino acid sequence 
YGGFLHPERTYNNAASDKLM with a charge state of +3. Placing the cursor onto each 
isotopic peak (in red) displays its accurate m/z value and the normalized intensity. 
 
 
Figure 4-4. Proteomics Toolkit application under the sub-tab of in silico Digestion. Shown 
is the peptide list from an in silico proteolysis, where the users can specify parameters 
including cleavage site(s), cleaving terminal (C-/N- terminal), number of missed 
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cleavages, and the minimally allowed peptide length (defaulted as 4). The output is a list 
with peptide sequence, starting and ending residue number, missed cleavage number, 
and the length of peptide. 
 
 
Figure 4-5. Proteomics Toolkit application under the sub-tab of Targeted m/z. Shown is 
a table with the monoisotopic m/z values of the in silico generated peptides with and 
without user-defined PTMs at various charge states (+1 to +5 in this case). The output of 
this table facilitates the generation of an inclusion list in a targeted MS acquisition mode. 
 
4.4.2.2 Structure of ui.R Script and server.R Script of Proteomics Toolkit 
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The ui.R script of Proteomics Toolkit encodes instructions for the application’s layout, 
appearance, and interactive widgets (e.g., sliders, selection boxes, buttons), as shown 
below: 
library(shiny) 
library(DT) 
library(plotly) 
shinyUI(fluidPage( 
 
  navbarPage(title=span(strong("Proteomics Toolkit"), style="font-
family:'rockwell extra bold';color:slateblue; font-size:20pt"), 
    ## The 1st tabPanel is for peptide analysis, see below. 
      tabPanel(title=span(strong("Peptide Analysis"),style="font-
family:'luminari';color:darkgreen;font-
size:13pt"),icon=icon("leaf",lib="font-awesome"), 
        sidebarLayout( 
          sidebarPanel( 
            textInput("seq.pp", label=div(em("Input peptide 
sequence"),style="font-family:'marker felt';color:darkgreen; font-
size:12pt"), placeholder = "for example: YGGFL"), 
            radioButtons("Cys.pp", label=div(em("Carbamiodomethyl on 
Cys ?"),style="font-family:'marker felt';color:darkgreen; font-size:12pt"), 
choices = list("Yes","No"), selected = "Yes"), 
            textInput("ptmFormula.pp", label = div(p(em(span("PTM in 
formula",style="font-family:'marker felt';color:darkgreen; font-
size:12pt"))),  p(em(span('Note:',style="font-family:'marker 
felt';color:darkred; font-size:10pt"), span('A "SPACE" is required between 
every element! The allowed elements are',style="font-family:'marker 
felt';color:darkgreen; font-size:10pt"), span('C, H, N, O, S, P, Br, Cl, F, 
Si.', style="font-family:'marker felt';color:darkred; font-size:10pt")))), 
placeholder = "for example: C5 H8 O2 N Br2"), 
            hr(), 
            div(p(strong(em("Residue-specific PTMs"))), style="font-
family:'marker felt';color:darkgreen; font-size:12pt"), 
            fluidRow(column(7,uiOutput("PTM1.pp")), 
                     column(4, uiOutput("Resi1.pp"))), 
            fluidRow(column(7, uiOutput("PTM2.pp")), 
                     column(4, uiOutput("Resi2.pp"))), 
            fluidRow(column(7, uiOutput("PTM3.pp")), 
                     column(4, uiOutput("Resi3.pp"))), 
            checkboxGroupInput("chkbx.pp",label=div(strong(em("extra 
PTMs")),style="font-family:'marker felt';color:darkgreen; font-
size:12pt"),choices=list("none","Acetyl", "Ammonium-add","Ammonium-
loss","Dehydrated"), selected = "none") 
         
                
          ), 
         
        mainPanel( 
          tabsetPanel(type="tabs",  
                tabPanel(title=span(strong("Peptide Computations"), 
style="font-family:'constantia';color:darkgreen;font-size:10pt"),icon = 
icon("calculator",lib = "font-awesome"), 
                        br(), 
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                fluidRow( 
                           column(5, div(h4(em(p("Peptide Sequence"))), 
style="font-family:'hannotate tc';color:darkgreen")), 
                           column(5, div(h4(em(p("Elemental Composition"))), 
style="font-family:'hannotate tc';color:darkgreen")), 
                           column(2, div(h4(em(p("Res.#"))), style="font-
family:'hannotate tc';color:darkgreen")) 
                          ), 
                fluidRow( 
                          column(5, verbatimTextOutput("text1.pp")), 
                          column(5, verbatimTextOutput("text2.pp")), 
                          column(2, verbatimTextOutput("text3.pp")) 
                     ), 
                  br(), 
                 tableOutput("tb1.pp"), 
                 hr(), 
             fluidRow( 
                column(3, actionButton("act.pp", label=span(strong("AA 
Composition"), style="font-family:'wawati tc';color:darkgreen; font-
size:12pt"), icon = icon("cubes",lib="font-awesome"))),   
                column(8,DT::dataTableOutput("tb2.pp"), offset = 3) 
             ) 
          ),        
          tabPanel(span(strong("MS Spectral Simulation"),style="font-
family:'constantia';color:darkgreen;font-size:10pt"), icon=icon("laptop",lib 
= "font-awesome"), 
                   br(), 
                   div(h4(em(p("Formula (with PTMs)"))), style="font-
family:'hannotate tc';color:darkgreen"), 
                   fluidRow( 
                     column(6, verbatimTextOutput("text4.pp")) 
                   ), 
                   hr(), 
                   fluidRow( 
                     column(4, div(h4(p(em("Charge State to Simulate: "))), 
style="font-family:'hannotate tc';color:darkgreen")), 
                     column(2, numericInput("ecs.pp", label=NULL, 
value=1,width='80%', min=1, step=1)), 
                     column(2, actionButton("sim.pp", label = 
span(strong("Simulate"), style="font-family:'wawati tc';color:darkgreen; 
font-size:12pt"), icon=icon("bar-chart",lib="font-awesome"))) 
                   ), 
                   hr(), 
                   plotlyOutput("Idplot.pp") 
          )                                    
                                             
                                                                 
  )) 
               ) 
        ), 
  ## The 2nd tabPanel is for the protein analysis, see below. 
      tabPanel(title=span(strong("Protein Analysis"), style="font-
family:'luminari';color:purple; font-size:13pt"), icon = 
icon("heartbeat",lib="font-awesome"), 
  sidebarLayout( 
    sidebarPanel( 
      textInput("seq", label=div(em("Input protein sequence"),style="font-
family:'marker felt';color:purple; font-size:12pt")), 
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      radioButtons("Cys", label=div(em("Carbamiodomethyl on 
Cys ?"),style="font-family:'marker felt';color:purple; font-size:12pt"), 
choices = list("Yes","No"), selected = "Yes"), 
      fluidRow( 
        column(7, textInput("ptmFormula", label = div(p(em(span("fixed PTM 
formula",style="font-family:'marker felt';color:purple; font-size:12pt")))), 
placeholder = "e.g., C5 F3 N6")), 
        column(4, uiOutput("ud")) 
      ), 
      hr(), 
      div(p(strong(em("fixed Residue-specific common PTMs"))), style="font-
family:'marker felt';color:purple; font-size:12pt"), 
      fluidRow(column(7,uiOutput("PTM1")), 
               column(4, uiOutput("Resi1"))), 
      fluidRow(column(7, uiOutput("PTM2")), 
               column(4, uiOutput("Resi2"))), 
      fluidRow(column(7, uiOutput("PTM3")), 
               column(4, uiOutput("Resi3"))), 
      checkboxGroupInput("chkbx",label=div(strong(em("extra 
PTMs")),style="font-family:'marker felt';color:purple; font-
size:12pt"),choices=list("none","Acetyl", "Ammonium-add","Ammonium-
loss","Dehydrated"), selected = "none") 
    ), 
     
    mainPanel( 
      tabsetPanel(type="tabs", 
          tabPanel(span(strong("Computations"), style="font-
family:'constantia';color:purple;font-size:10pt"),icon = 
icon("calculator",lib = "font-awesome"), 
         br(), 
      fluidRow( 
        column(5, div(h4(em(p("Protein Sequence"))), style="font-
family:'hannotate tc';color:purple")), 
        column(5, div(h4(em(p("Elemental Composition"))), style="font-
family:'hannotate tc';color:purple")), 
        column(2, div(h4(em(p("Res.#"))), style="font-family:'hannotate 
tc';color:purple")) 
        ), 
      fluidRow( 
        column(5, verbatimTextOutput("text1")), 
        column(5, verbatimTextOutput("text2")), 
        column(2, verbatimTextOutput("text3")) 
        ), 
      br(), 
      fluidRow( 
        column(3, textInput("protein.fromcs", label=span(h4(em(p("from 
charge"))), style="font-family:'hannotate tc';color:purple;font-size:10pt"), 
value=5)), 
        column(3, textInput("protein.tocs", label=span(h4(em(p("to 
charge"))), style="font-family:'hannotate tc';color:purple;font-size:10pt"), 
value=10)) 
      ), 
      tableOutput("tb1"), 
      hr(), 
      fluidRow( 
      column(3, actionButton("act", label=span(strong("AA Composition"), 
style="font-family:'wawati tc';color:purple; font-size:12pt"), icon = 
icon("cubes",lib="font-awesome"))),   
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      column(8,DT::dataTableOutput("tb2"), offset = 3) 
      ) 
          ), 
         tabPanel(span(strong("MS Spectral Simulation"),style="font-
family:'constantia';color:purple;font-size:10pt"),icon = icon("laptop",lib = 
"font-awesome"), 
                  br(), 
               div(h4(em(p("Formula (with PTMs)"))), style="font-
family:'hannotate tc';color:purple"), 
               fluidRow( 
                 column(6, verbatimTextOutput("text4")) 
                 ), 
               hr(), 
              fluidRow( 
              column(4, div(h4(p(em("Charge State to Simulate: "))), 
style="font-family:'hannotate tc';color:purple")), 
              column(2, numericInput("ecs", label=NULL, value=1,width='80%', 
min=1, step=1)), 
              column(2, actionButton("sim", label = span(strong("Simulate"), 
style="font-family:'wawati tc';color:purple; font-size:12pt"), 
icon=icon("bar-chart",lib="font-awesome"))) 
              ), 
              hr(), 
              plotlyOutput("Idplot") 
                  ), 
         tabPanel(span(strong(em("in silico")), 
strong("Digestion"),style="font-family:'constantia';color:purple;font-
size:10pt"),icon = icon("align-right",lib = "font-awesome"), 
                  br(), 
                  fluidRow( 
                    column(3, textInput("cleavSite", 
label=div(h4(em("Cleavage Sites")), style="font-family:'hannotate 
tc';color:purple;font-size:12pt"), placeholder = "e.g., RK")), 
                    column(2, selectInput("side", label=div(h4(em("Side")), 
style="font-family:'hannotate tc';color:purple;font-size:12pt"), 
choices=c("C","N"), selected="C", selectize = TRUE)), 
                    column(2, numericInput("mc", label = 
div(h4(em("Missed")), style="font-family:'hannotate tc';color:purple;font-
size:12pt"), value=1,min=0, step=1, width = "80%")), 
                    column(3, numericInput("thresh", 
label=div(h4(em("Threshold")), style="font-family:'hannotate 
tc';color:purple; font-size:12pt"), value=4,min=0, step=1,width = "50%")) 
                  ), 
                  actionButton("insilico", label=span(strong("in silico 
Digest"), style="font-family:'wawati tc';color:purple; font-size:12pt"), icon 
= icon("sort-amount-desc", lib="font-awesome")), 
                  hr(), 
                  DT::dataTableOutput("tb3") 
                   
                  ), 
         tabPanel(span(strong("Targeted m/z"), style="font-
family:'constantia';color:purple;font-size:10pt"),icon = icon("map-
marker",lib = "font-awesome"), 
                  br(), 
                  fluidRow( 
                    column(3, div(h4(em("Charge from")), style="font-
family:'hannotate tc';color:purple; font-size:12pt", align="center")), 
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                    column(2, numericInput("csfrom", label=NULL,value=1, 
min=1, step=1, width = "80%")), 
                    column(1, div(h4(em("to")), style="font-family:'hannotate 
tc';color:purple; font-size:12pt")), 
                    column(2, numericInput("csto", label=NULL, value=5, 
min=2, step=1, width="80%")) 
                    ), 
                  fluidRow( 
                    column(6, selectInput("target.ptm", label = 
div(h4(em("common Variable PTMs to include")),style="font-family:'hannotate 
tc';color:purple; font-size:14pt"), 
choices=list("none","Oxidation","diOxidation","triOxidation","Carbonyl","Deam
idation(N)","Phosphorylation(S,T,Y)"),selected="none",selectize = TRUE, 
multiple = TRUE)), 
                    column(3, numericInput("lowmz", label=span(h4(em("Lowest 
m/z")), style="font-family:'hannotate tc';color:purple; font-size:12pt"), 
value=150, min=50, max=600, step=1)), 
                    column(3, numericInput("highmz", 
label=span(h4(em("Highest m/z")), style="font-family:'hannotate 
tc';color:purple; font-size:12pt"), value=4000, min=3000, max=5000, step=1)) 
                  ), 
                  hr(), 
                  div(h4(strong(em("User-defined Variable PTM*"))), 
style="font-family:'hannotate tc';color:purple; font-size:12pt"), 
                  fluidRow( 
                   column(3, textInput("NM", label=div(em("PTM name"), 
style="font-family:'hannotate tc';color:purple; font-size:12pt"), 
placeholder="e.g., FMe")), 
                   column(5, textInput("Fml", label=div(em("PTM 
formula"), style="font-family:'hannotate tc';color:purple; font-size:12pt"), 
placeholder="e.g., C16 H26")), 
                   column(3, selectInput("allRes", label=div(em("PTM 
targets"), style="font-family:'hannotate tc';color:purple;font-size:12pt"), 
choices=strsplit("ACDEFGHIKLMNPQRSTVWY", split="")[[1]], multiple=TRUE)) 
                   ), 
              
                  fluidRow( 
                    column(4,actionButton("targeted", label=span(strong("Show 
Targeted List"), style="font-family:'wawati tc';color:purple; font-
size:12pt"),icon=icon("tags",lib="font-awesome"))), 
                    column(4, downloadButton("dld.target", 
label=span(strong(em("Download Targeted List!")), style="font-family:'wawati 
tc';color:purple; font-size:12pt"))) 
                  ), 
                  hr(), 
                  DT::dataTableOutput("tb4") 
               ) 
                   
                   
                   
      ) 
    ) 
  ) 
      ) 
   
  ) 
)) 
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These content codes of user interface are required to stay within the brackets of layout 
functions. For example, layout function fluidPage creates a canvas for the interface and 
utilizes tabPanel function to position the two tabs (i.e., Peptide Analysis, Protein Analysis) 
on top of the page (Figure 4-2). The position and appearance of user-input widgets and 
output results (e.g., table, graph, list) are also specified by different layout functions. 
Although each layout function has its own framework and variables, they all follow the 
same hierarchical structure where element functions are embraced within a positioning 
function, which is within a layout function.  
The server.R script (see complete code https://github.com/benniu720/Proteomics-
Toolkit), on the other hand, plays a vital role in defining instructions for the application 
while maintaining the application speed by minimizing redundant computations. The 
entire server.R script is essentially a shinyServer function that incorporates an input 
object and an output object. It generally involves creating functions that map user inputs 
to various kinds of output. Objects that change depending on input from widgets in the 
ui.R are termed “reactive” (e.g., changes in amino-acid sequence input). Each time the 
input from a widget changes, the value for the reactive object updates to reflect this 
change. For example, each time the amino acid sequence input changes, the output 
including the sequence, elemental composition, total residue number, monoisotopic m/z, 
and amino acid composition change accordingly. 
4.4.3 R Shiny Application: HDX Easy Plotting 
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We present here another R Shiny web-based application, HDX Easy Plotting (URL: 
https://benniu-wustl.shinyapps.io/hdexaminer-assistant/), which was developed to 
simplify the plotting of HDX kinetic curves from HDX-MS experiments (Figure 4-6). The 
raw data obtained from HDX experiments, typically, are submitted to the processing 
software such as HDExaminer and HD WorkBench, for the automatic quantitation of 
deuterium uptake of each identified peptide. The output of quantitation results, however, 
is a massive data table that needs to be manually processed to obtain the HDX kinetic 
curves (Figure 4-7). The application we developed here is adaptive to the output of 
HDExaminer, by taking the data table exported from HDExaminer, then reorganizes, 
computes, and plots the time-dependent curves automatically (Figure 4-8). HDX Easy 
Plotting allows user-specified plotting parameters (e.g., layout size, line transparency, line 
color, point size) and supports output of HDX kinetic curves and downloading of formatted 
data table for further data processing. 
The complete code and a short tutorial for HDX Easy Plotting have been uploaded to 
GitHub (https://github.com/benniu720/HDExaminer-Assistant).  
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Figure 4-6. The screenshot of HDX Easy Plotting application. Output from HDExaminer 
software (*.csv format) can be directly uploaded and converted to a table of peptides, 
kinetic curves, with user-defined experimental and display parameters. 
 
 
Figure 4-7. Typical workflow of data processing of HDX-MS experiments (yellow arrows). 
The raw data are submitted to HDExaminer software for quantitation of deuterium uptake 
for each peptic peptide, followed by an output of a massive data table, from which the 
data needed for plotting HDX kinetic curves are drawn manually. To reduce the redundant, 
repetitive work, we developed the HDX Easy Plotting application, which can automatically 
generate kinetic curves by taking the output from HDExaminer software directly (blue 
arrows).  
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Figure 4-8. An example of the HDX kinetic curves generated by using HDX Easy Plotting 
application. Shown are 9 kinetic curves corresponding to different peptides. 
 
4.4.4 R Shiny Application: MS/MS Spectrum Analysis & Assignment 
Mass spectrometry-based proteomics methods largely rely on product-ion (MS/MS) 
spectra to provide sequence information of peptide [29, 30]. One should, however, 
scrutinize each product-ion spectrum for accurate identification of product-ion species 
(e.g., y-ion and b-ion). The identification and annotation of fragment ions in MS/MS can 
be difficult and laborious, given the large number of peaks in each spectrum, the different 
identity and location of PTMs, and possible neutral losses. We developed the R Shiny 
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application, namely, MS/MS Spectrum Analysis & Assignment, to automatically identify 
and annotate species from any product-ion (MS/MS) spectrum from a bottom-up 
proteomic experiment. The URL of this application is https://benniu-
wustl.shinyapps.io/ms2-autoassign/. 
The application of MS/MS Spectrum Analysis & Assignment contains two modules: in 
silico Fragments, which generates a table of daughter-ion based on user input of amino 
acid sequence and site-specific modification (Figure 4-9); Peaks Matching, which takes 
the mass spectrometry data file (in *.mzXML format), displays spectral information with a 
given scan number (e.g., retention time, precursor m/z, charge state) (Figure 4-10), and 
annotates the spectrum with user-specified parameters (Figure 4-11). Within the first 
module, a new table of product ions can be generated by checking the Neutral Loss 
Search, which allows the input of neutral species being lost and recalculation of the m/z 
values of y-/b-series ions. In Chapter 7, we utilized this functionality to identify 
successfully the y-series fragment ions of a peptide with a C-terminal farnesylation PTM, 
which is typically manifest as a neutral loss of 204 Da (corresponding to C15H24) [31]. 
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Figure 4-9. A screenshot of MS/MS Spectrum Analysis & Assignment application. Shown 
is the in silico fragments module that computes m/z of the b-/y-series ions, based on the 
input of an amino acid sequence, location of the modification, formula of the modification, 
neutral loss identity, etc. 
 
 
Figure 4-10. By providing a spectrum scan number, the module of Peak Matching can 
display the corresponding spectral information including retention time, m/z value and 
charge state of precursor ion.  
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Figure 4-11. An example of annotated product-ion (MS/MS) spectrum using MS/MS 
Spectrum Analysis & Assignment application.  
 
4.5 Conclusion and Future Work 
R with its many built-in functions and packages is suitable for mass spectrometry-based 
proteomic analysis. Specifically, R Shiny package greatly facilitates the interactive data 
analysis and visualization by means of web browsers, allows developments of analytical 
toolkits that precisely fit users’ needs, and provides conveniences in maintenance and 
updating. Demonstrated in this chapter are three web-based applications focused on 
mass spectrometry-based computations and data processing. There are, however, more 
applications under development in this field, for the purpose of faster, more convenient, 
and more accurate analysis. For example, there is a need for developing an analytical 
model to benchmark the curvature and overlapping extent of HDX kinetic curves, from 
which important binding interfaces are inferred; however, the interpretations of curves by 
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naked-eye can be different from individual to individual, lab to lab. We are currently 
developing an R-based model to classify the time-dependent curves from HDX 
experiments with machine-learning algorithms. The goal is to predict accurately the 
important binding interfaces of an unknown complex, given a set of HDX kinetic data. The 
workflow includes the training and optimization of model using sets of HDX data of a 
ligand-binding protein whose binding interfaces are known; optimized model is then 
applied to unknown HDX datasets for curve analysis and prediction (Figure 4-12). 
  
Figure 4-12. Workflow for prediction of important binding interfaces from a set of HDX 
kinetic curves. Models with different machine learning algorithms are trained by 
incorporating sets of HDX data with known binding interfaces, and tested with cross 
validation. The best model (the one showing the highest prediction accuracy) is then used 
for the prediction of important binding interfaces for new HDX data set of unknown binding 
systems. 
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Chapter 5 
Fast Photochemical Oxidation of Proteins (FPOP) Locates 
the Unfolding of ALS-inducing Mutant Variant G93A SOD1 
Caused by Destabilization with Trifluoroethanol 
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5.1 Abstract 
Destabilization of Cu, Zn superoxide dismutase (SOD1) mutants may lead to protein 
aggregation and ultimately amyotrophic lateral sclerosis (ALS). The mechanism and 
protein conformational changes during this process, however, remain unclear. To study 
SOD1 at the molecular level and in solution, destabilization coupled with structural studies 
are needed. Here we destabilized a mutant variant of human SOD1 (G93A) with 
trifluoroethanol (TFE) and used both top-down native ESI and Fast Photochemical 
Oxidation of Proteins (FPOP) to characterize the structural changes of G93A SOD1 
induced by destabilization. The structural changes upon destabilization include 
dissociation of SOD1 dimer and local partial unfolding. The use of TFE followed by protein 
footprinting and native MS should permit continuing inquiries into the high propensity of 
aggregation of the many mutant SOD1 proteins. 
5.2 Introduction 
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that specifically 
targets the motor neurons in the spinal cord, brain stem, and cortex [1]. It is the most 
common motor neuron disease, with a lifetime risk of approximately 1 in 2000 [2]. 
Currently there is no cure or effective treatment for this disease, commonly known as Lou 
Gehrig’s disease in the United States [3]. Approximately 90% of ALS have no known 
cause and are termed sporadic ALS (sALS). For the remaining 10%, there is a familial 
history (familial ALS or fALS). Among these fALS cases, about 25% are associated with 
the CuZnSOD (SOD1) gene on chromosome 21 where numerous site mutations are 
currently known as ALS-causing mutations [4].  
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SOD1 is an antioxidant enzyme found in the nucleus, peroxisomes, mitochondrial 
intermembrane space of eukaryotic cells and in the periplasmic space of bacteria [5]. Its 
function is to catalyze the dismutation of superoxide anion into H2O2 and O2 [6]. The 
human enzyme is a 32-kDa homodimer, with one copper and one zinc binding per 153-
residue subunit. The X-ray crystal structures of SOD1 from many species have been 
solved, mostly in the fully metallated state, showing that the structures are highly 
conserved [7]. Each SOD1 monomer is built upon a β-barrel motif comprising eight anti-
parallel β sheets and possesses large functionally important electrostatic and zinc loops 
Figure 5-1).  
Loop IV or the Zn-binding loop (ZBL, amino acids 49-83) contains His63, His71, and His80 
as well as D83 that coordinate Zn2+ (Figure 5-1). That binding along with the disulfide 
formation between Cys57 and Cys146, contribute to the structural stability of SOD1 [8]. 
The Cu ion, coordinated by His46, 48, 120, and the bridging His63 between Zn and Cu is 
the heart of the enzymatic activity of SOD1 to catalyze the disproportionation (Eq 5-1) [9, 
10]. The two-step process of reduction of cupric ion to form dioxygen (Eq 5-2), and 
reoxidation of cuprous ion to form hydrogen peroxide (Eq 3). Those reactions (Eq 5-2 and 
5-3) have near diffusion-limited rates at physiological pH, and the activity is nearly pH-
independent over a wide range [7]. 
2"#$ + 2&' →	"# + &#"#     Eq 5-1 "#$ +	*+#',-."/	 → 	"# +	*+',-."/   Eq 5-2 "#$ + 2&' +	*+',-."/	 → 	&#"# +	*+#',-."/ Eq 5-3 
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Despite the normal catalytic function of SOD1, multiple studies of both transgenic mice 
and humans provide convincing evidence for the gain-of-function toxicity of SOD1 upon 
mutation [11, 12]. Proteinaceous inclusions rich in mutant SOD1 are in tissues from ALS-
SOD1 transgenic mice and ALS patients, and in cell-culture models, supporting the 
hypothesis that SOD1-related fALS is a disorder caused by unfolding and aggregation 
[13, 14]. Although over 150 different site mutations in the SOD1 gene are linked to fALS 
[15], it remains unclear how this large distribution of mutations results in the same disease. 
These mutations, throughout the entire SOD1 sequence, are responsible for dramatically 
different catalytic activities and metal-binding affinities. Depending on location, these 
mutations fall into two types: metal-binding-region (MBR) mutations and wild-type-like 
(WTL) mutations. The former directly compromise the protein’s ability to bind metals, 
reducing the catalytic activity of SOD1; the latter maintain the metal-binding capability, 
and these proteins have activity levels similar to that of the wild-type SOD1 [16]. This 
further confirms the gain-of-function toxicity of mutant SOD1. 
Although the toxic function acquired by mutant SOD1 is well-acknowledged, the 
molecular mechanism and the species responsible for this toxicity are unsettled [1, 4]. As 
for other neurodegenerative diseases (e.g., Alzheimer’s disease (AD), Parkinson’s 
disease (PD), Huntington’s disease (HD) [17-19]), the fibrils or insoluble inclusions 
observed in ALS are unlikely to be toxic because they are formed in a relatively late stage 
of the disease [20]. Controversy still exists, however, regarding the identity of the cytotoxic 
species [2, 4, 15]. Clearly monomeric SOD1 plays an important role in its aggregation. 
For example, SOD1 aggregates found in spinal cords extracted from human A4V SOD1 
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patients and from various ALS mouse models react with antibodies that specifically 
recognize the monomer [11, 21]. Further, the monomeric, reduced apo-SOD1 can initiate 
aggregation of dimeric holo-SOD1 at physiologic conditions [22].  
One way to connect the monomer and the aggregates is the misfolding and aggregation 
hypothesis, which involves a three-state equilibrium (Eq 5-4) among native dimeric SOD1 
(D), monomeric SOD1 (M), and unfolded or partially unfolded SOD1 (U) [23-25]. This 
hypothesis has prompted a variety of biophysical studies of the effects of the mutations 
on the stability and folding mechanism of SOD1 [26-29].  
20 ⇌ 22 ⇌ /    Eq 5-4 
Matthews et al. [30] determined the effects of ALS-inducing mutations on the population 
of folded and unfolded monomeric species (M or U), by perturbing with urea and following 
with a global stability analysis with far-UV circular dichroism (CD). Quantification of 
stability changes induced by mutations shows a 2- to 10-fold increase in the population 
of folded monomeric states and an 80- to 480-fold increase in the population of the 
unfolded monomeric states, as compared to those formed with wild-type SOD1. This 
strongly suggests that the disease-provoking property of ALS mutations is likely related 
to the conformational equilibrium [31]. Other evidence suggests that the ALS-inducing 
SOD1 mutations manifest a common shift of the folding equilibrium towards denatured 
and partially unfolded apo monomers by either disrupting the dimer interface, perturbing 
the monomer structure, or compromising the formation of mature (e.g., holo, disulfide-
bonded) dimers [32-35]. This common pattern implicates that the seed for SOD1 
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cytotoxicity is the immature form of SOD1, which may have increased propensity to self-
associate through high-order nucleation reactions [36].  
ALS mutations convey the most prominent effect on the immature form of SOD1, 
destabilizing the metal-free and disulfide-reduced polypeptide and promoting unfolding at 
physiological temperature; these destabilized states readily form oligomers under 
physiological concentrations [37]. Indeed, destabilizing the protein can be done in a 
number of ways, including perturbing the dimer interface [33], adding trifluoroethanol 
(TFE) [27, 38], reducing disulfide bonds [22], removing metal-ions [30, 39], altering the 
post-translational modifications (PTMs) [40], or simply heating [27, 41]. Recent studies 
under destabilizing solution conditions (i.e., upon addition of TFE or increase of 
temperature) indicate that fALS mutations decrease SOD1 stability and increase the rates 
of unfolding, forming ALS-like aggregates in vitro with various morphologies by populating 
the aggregation-prone monomeric species [27] (Figure 2). Therefore, destabilized fALS-
associated SOD1 mutants can trigger an equilibrium shift, increasing aggregate formation 
[27, 37]. The mechanism and molecular basis, however, for shifts in destabilization and 
protein conformational changes during this process remain unclear. 
The TFE-induced SOD1 aggregates, in particular, show greatest resemblance to in vivo 
ALS aggregates in terms of the tinctorial properties [42], thus we used addition of TFE to 
destabilize the G93A SOD1 mutant variant, which is among the most extensively studied 
ALS-inducing mutation as it was the first mutation to be modeled in mice [13]. As 
described in previous chapters, mass spectrometry is evolving as an alternative tool to 
study protein high order structures (HOS), with fast turnaround, low sample consumption, 
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and near-native solution environments [43, 44]. Herein, we adopted both top-down and 
bottom-up MS approaches to uncover the effect of TFE destabilization of the SOD1 
protein, to localize the conformational changes in molecular level, and to shed some light 
upon the mechanism of aggregates formation. 
 
Figure 5-1. Crystal structure of human SOD1 (PDB code 1N18), a native dimer. Shown 
is only one monomeric subunit, which comprises two major function loops (i.e., 
electrostatic loop and zinc binding loop) and one 3-barrel formed by 8 3-sheet strands. 
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Figure 5-2. Electron microscopy of in vivo SOD1 aggregates induced by TFE (A-C) and 
heat (D-F). Reprinted with permission from Ref. [27] 
 
5.3 Experimental Section 
5.3.1 Materials and Methods 
All experiments were performed using recombinant apo-SOD1 protein expressed and 
purified from BL21-Gold(DE3) PLysS E. coli cells (Strategene, Inc., Cedar Creek, TX, 
USA), as previously described [26]. The two free cysteines Cys6 and Cys111 were 
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mutated to Ala and Ser, respectively, to avoid intermolecular disulfide scrambling; the 
glycine to alanine mutation (G93A) was introduced into this pseudo WT background [30]. 
L-Histidine, L-methionine, 30% hydrogen peroxide, leucine enkephalin acetate hydrate, 
catalase, trifluoroethanol (TFE), urea, dithiothreitol (DTT), iodoacetamide (IAM), 
ammonium acetate, formic acid (FA), trifluoroacetic acid (TFA), HPLC-grade solvent, and 
phosphate buffer saline (PBS) were purchased from Sigma-Aldrich Chemical Co. (St. 
Louis, MO). Sequencing-grade trypsin was purchased from Promega Co. (Madison, WI). 
5.3.2 Native ESI Measurement of the Intact Protein 
A freshly prepared G93A SOD1 protein stock solution (40 µM protein, in 10 mM potassium 
phosphate, pH 7.2) was stored in 4 °C refrigerator. An aliquot of the stock solution was 
submitted to buffer exchange by using Vivaspin® 500 (Sartorius, Goettingen, Germany); 
the desired buffer solution is 200 mM ammonium acetate. After buffer exchange, the 
resulting solution was aliquoted into two portions; to destabilize the protein, 18% (v/v) 
TFE was added to one portion. The final concentration of G93A was 5 µM. Samples were 
subjected to a 1-h incubation at room temperature before submitting the protein to a top-
down measurement. To perform top-down native ESI analysis, 5 µL of the protein sample 
was loaded onto a Borosilicate Emitter with extra coating (Thermo Fisher Scientific, 
Waltham, MA); the emitter was interfaced with a Thermo Exactive Plus EMR mass 
spectrometer (Thermo Fisher Scientific, Waltham, MA). The capillary voltage was 1.0-1.3 
kV, and the source temperature was 37 °C. The mass spectrometer was operated in full-
scan mode with a mass resolving power of 70,000. 
5.3.3 FPOP Footprinting 
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A stock solution of G93A SOD1 was aliquoted, with one aliquot treated with 18% (v/v) 
TFE for destabilization, and another aliquot untreated. Both TFE-treated and untreated 
samples were subjected to a 1-h incubation at room temperature, then immediately 
buffer-exchanged to 10 mM PBS. To perform FPOP, the total volume of 50 µL of solution 
containing 5 µM G93A SOD1, 8 µM leucine enkephalin (reporter peptide), 20 mM 
hydrogen peroxide, and histidine as radical scavenger, was loaded onto a 100 µL syringe 
(Hamilton, Reno, NV) and advanced using a syringe pump (Harvard Apparatus, Holliston, 
MA). The reporter-incorporated FPOP was conducted as described previously [45]. The 
excimer laser (GAM Laser Inc., Orlando, FL) was adjusted to 25 mJ/pulse at a frequency 
of 7.4 Hz and focused to an irradiation window of 2.7 mm. The solution flow rate was 
adjusted to ensure a 25% exclusion volume fraction to avoid exposing a “plug” of solution 
to more than one set of radicals [46, 47]. Control samples were handled in the same 
manner without laser irradiation. To adjust different labeling times and measure the time-
dependent response of TFE-untreated G93A SOD1, various histidine concentrations (0, 
0.2, 2.0, 40 mM) were used in FPOP. At each histidine concentration, three replicates 
were drawn from the stock solutions for FPOP labeling. All TFE-treated G93A samples 
were footprinted at a histidine concentration of 0.2 mM. After labeling, samples were 
submitted to catalase and methionine treatment to remove any left-over H2O2, aliquoted, 
and submitted to global analysis and bottom-up analysis. 
5.3.4 Global Analysis 
The protein-level FPOP modification can be determined by using a MaXis 4G Q-TOF 
(Bruker, Bremen, Germany) coupled to a custom-built, online sample-handling device. In 
	
	
	 141	
brief, 10 µL of footprinted G93A SOD1 (~50 pmol) was loaded onto a C8 reversed-phase 
trapping column (ZORBAX Eclipse XDB, 2 ´ 15 mm; Agilent Technologies, Santa Clara, 
CA) for a three-minute desalting with 200 µL/min water containing 0.1% (by volume) TFA. 
The desalted protein was then eluted from the trapping column with a 10-min linear 
gradient from 2% to 95% solvent B (acetonitrile with 0.1% FA) at 200 µL/min. 
5.3.5 Bottom-up Analysis 
All samples were submitted to acetone precipitation for clean-up, and then resuspended 
with 8 M urea, treated with DTT (10 mM) and IAM (20 mM) sequentially, and diluted with 
10 mM PBS buffer (pH 7.5) prior to trypsin digestion. DTT and IAM were used to break 
disulfide bonds and cap the free cysteines. Samples were then incubated with 20:1 
protein: enzyme (by weight) for 12 h (37 °C, 350 rpm). The digestion was quenched by 
adding 1% (by volume) FA. After digestion, 20 µL digests from each sample were loaded 
in autosampler vial for bottom-up analysis. The LC-MS/MS analyses were conducted 
back-to-back with the UltiMate 3000 Nano LC system and a Thermo Q Exactive Plus 
Hybrid Quadruple-Orbitrap mass spectrometer (Thermo Fisher Scientific, Waltham, MA). 
Aliquots of 5 µL digests were drawn from autosampler vial and loaded onto a C18 
reversed-phase trapping column (Acclaim® PepMap100, 100 µm ´ 2 cm, 5 µm, 100 Å; 
Thermo Fisher Scientific, Waltham, MA) at 4.5 µL/min with water in 0.1% FA for a 10-min 
desalting. Peptides were separated using a custom-packed C18 reversed-phase column 
(Magic, 100 µm ´ 160 mm, 5 µm, 200 Å; Michrom Bioresource Inc., Auburn, CA) and 
eluted with an 80-min gradient delivered at 500 nL/min. The mass spectral scan range of 
precursor ions was set from m/z 380 to 2200 for all samples with high mass resolving 
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power of 70,000; the mass spectrometer was operated in non-targeted data-dependent-
acquisition (DDA) mode (i.e., 18 most abundant precursor ions eluting per scan were 
subjected to the high-energy C-trap dissociation (HCD) in the HCD cell for product-ion 
spectra). Dynamic exclusion was activated for 8 s following each scan to enable selection 
and fragmentation of low abundance peptides. The maximum injection time (IT) for full 
MS scan was set to 200 ms, and 150 ms for each MS/MS scan. 
5.3.6 Data Analysis 
The *.raw MS files were searched directly using Byonic (Protein Metrics Inc., San Carlos, 
CA) against a custom-built database containing the sequence of G93A SOD1 [48]. All 
known HO• side-chain reaction products were added to the variable modification database 
for searching for HO•-modified samples [49]. The alkylation of sample with IAM, which 
adds a carbamidomethyl group (MW = 57.0214 Da) to Cys-containing peptides, was 
added as fixed modification for searching. The searching tolerance window was 15 ppm 
for precursor ions, and 50 ppm for product ions. Residues Lys and Arg were selected as 
fully specific cleavage sites as is the rule for tryptic proteolysis. The quantitation of fraction 
modified was based on ion abundances from extracted ion chromatograms (XICs). The 
fractions modified at peptide and residue level were calculated as follows. Time-
dependent signals from LC-MS for each unmodified peptide and its modified species were 
extracted from raw data files by using XcaliburTM Software (Thermo Fisher Scientific, 
Waltham, MA) with a mass tolerance of 15 ppm. The peak integrals of both unmodified 
species (IunMod) and modified species (IMod) were readily attainable. The fraction modified 
for each peptide was determined according to Eq 5-4: 
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   Fraction modified= IModIMod+IunMod 	×100%    (Eq 5-4)  
5.4 Results and Discussion 
5.4.1 Native MS Reveals Conformational Changes of SOD1  
Native mass spectrometry (sometimes referred to as native electrospray Ionization (ESI)) 
is a soft ionization method extensively used for generation of gas-phase ions of 
macromolecules [50] for detection by mass spectrometers. Those charged analytes 
produced by ESI can either be analyzed as an ensemble of molecular ions (typically M + 
H+), or fragmented by activation in the gas phase, both of which provide important insights 
on the structural properties of the molecules [51]. In the scenario of analyzing protein 
complexes (e.g., soluble protein aggregates), one seeks to introduce the charged 
analytes into the mass spectrometer under mild conditions so that the non-covalent 
interactions within the complexes can be retained, and the stoichiometry established. 
Typical ESI spraying conditions (partially organic, acidic solutions with high temperature), 
however, would denature/unfold the proteins, leaving their basic side chains exposed to 
solvent, thereby causing a loss of stoichiometric information [52]. In contrast, native ESI 
(native MS) preserves the native state of proteins by spraying them from aqueous solution 
containing a volatile salt (e.g., ammonium acetate) under low temperature and neutral pH 
[53, 54]. As a consequence, the protein, prior to spraying, is “native”, and ESI will 
introduce the protein, at least for a short time, in its native state (some refer to this as 
kinetically trapping the native state in the gas phase).  The result will render protein ions 
carrying fewer charges compared to regular ESI, owing to the fewer basic residues 
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exposed in the folded form. Those ions will manifest themselves as a narrower spread of 
a charge-distribution envelop than seen in denaturing ESI.  
Similar to many of other SOD1 mutant variants, G93A SOD1 is natively a dimer [55]. The 
native ESI spectrum of G93A SOD1 (Figure 5-3 A) shows three peaks, corresponding to 
the differently charged dimeric G93A species (i.e., +10, +11, and +12 charge states). We 
saw no monomeric or higher oligomeric states of G93A, indicating convincingly that G93A 
SOD1 is predominantly dimeric in the absence of TFE. The native ESI spectrum upon 
addition of TFE, however, looked dramatically differently (Figure 5-3 B). The expanded 
charge-state distribution centered at low m/z (therefore, higher charge states) suggests 
a large increase of protein surface area, exposing more residues that are solvent 
inaccessible in the native state. Upon deconvolution, we found that these peaks all refer 
to the monomeric G93A species (Figure 5-3 B). Therefore, we conclude that, by adding 
TFE, the dimeric G93A SOD1 is destabilized and dissociates, forming monomeric species. 
To reveal the extent of unfolding or partial unfolding of G93A SOD1 as a result of 
destabilization, however, a more detailed picture of the monomeric species formed upon 
dimer dissociation is needed, as illustrated by footprinting and bottom-up analysis that 
provide localized structural information. 
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Figure 5-3. Native ESI spectra of G93A SOD1. (A) Without addition of TFE, G93A SOD1 
is predominantly a dimer. The observed three peaks correspond to the +10, +11, and +12 
charged dimeric G93A; (B) Under the same spraying condition, however, with the addition 
of TFE, the dimer peaks diminish, all major peaks correspond to monomeric G93A 
species. The expanded charge state distribution of monomers indicates an increase of 
solvent-accessible area.  
 
5.4.2 Differential Scavenging of HO• in SOD1 Footprinting 
The first obstacle in footprinting SOD1 is to compensate for various radical scavenging 
reactions that compete with the labeling of the protein itself. In FPOP, hydroxyl radicals 
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not only react with the protein and radical scavengers (e.g., histidine, phenylalanine, 
glutamine) [56], but also with other species in the solution including ligands, buffer 
components, detergents, and, in this case, TFE, which is known to show high reactivity 
with hydroxyl radicals [57]. The presence of these scavengers, some adventitious, affects 
the lifetime of hydroxyl radicals, giving rise to unpredictable and misleading extents of 
modifications. We incorporated leucine enkephalin as a reporter peptide to disentangle 
the complication of differential scavenging by allowing us to characterize the footprinting 
(modification extent) at various labeling times (discussed in Chapter 3) [45].  
To minimize the scavenging of radicals by TFE and maximize the extent of modifications 
on the protein, we performed buffer exchange after the destabilization of SOD1 and 
immediately prior to FPOP footprinting. The MS analyses of intact, FPOP-labeled (using 
0.2 mM histidine as radical scavenger) G93A SOD1 show that, without buffer exchange, 
the protein was poorly labeled in the presence of TFE (Figure 5-4 A). The yield of FPOP 
under identical conditions increases significantly by performing buffer exchange prior to 
labeling with 10 mM PBS (Figure 5-4 B). Correspondingly, the reporter peptide fraction 
modified also increases, from 11% to 25% after removal of the TFE in the solution (Figure 
5-4 D). This clearly demonstrates the radical-scavenging role of TFE and the necessity 
to perform buffer exchange to obtain quantifiable levels of protein modifications. A 
comparison of reporter peptide fraction modified between the TFE-treated and untreated 
samples, both of which undergoing buffer exchange prior to FPOP labeling with 0.2 mM 
histidine (Figure 5-4 D), shows that the reporter in TFE-treated samples had less 
modifications (25% vs. 38%), indicating a shorter labeling time for the TFE-treated 
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samples despite buffer exchange. Interestingly, the FPOP modification extent of G93A 
SOD1 increases at this labeling time compared to that of the TFE-untreated sample 
(Figure 5-4 B, C, and Figure 5-5 F). This indicates that TFE treatment causes G93A SOD1 
to become more solvent-exposed. This phenomenon also implicates that, a direct 
comparison regarding the FPOP modification extent between TFE-treated and untreated 
G93A SOD1 will still be biased, even after buffer exchange as there is likely residual TFE 
in the protein solution, giving different labeling times for apparently the same conditions. 
To secure a more unbiased comparison, we measured the time-dependent responses of 
TFE-untreated G93A SOD1, and used the modification extent of reporter peptide to 
compensate for the differential scavenging. 
 
Figure 5-4. Mass spectra of intact, FPOP-labeled G93A SOD1 (+15 charge state) with 
0.2 mM histidine as scavenger. Labeling time of each condition is different owing to the 
presence of TFE, as reported by different fraction modified of reporter peptide. (A) The 
presence of TFE scavenges hydroxyl radicals, giving low yield of FPOP modifications; (B) 
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The yield of FPOP modifications increases with removal of TFE by buffer exchange; (C) 
TFE-untreated sample shows noticeably lower FPOP modifications, indicating a more 
solvent-accessible structure of G93A SOD1 with TFE treatment; (D) Reporter peptide 
fraction modified of abovementioned three conditions. The error bars correspond to the ± SE of triplicate measurements. 
 
5.4.3 Reporter-peptide Enables Measurements of Footprinting Kinetics 
A time-dependent measurement is possible by varying the FPOP labeling times by 
scavenging the radicals by using different concentrations of histidine. As the 
concentration of scavenger (His) increases, the radical lifetime becomes shorter; 
therefore, there will be less modifications on both the reporter peptide and the protein. 
Such time-dependent modification extents can be readily revealed in protein-level 
measurements (shown in Figure 5-5 A-E are the mass spectra of intact, TFE-untreated 
G93A SOD1 (+15 charge state), footprinted by FPOP at different times controlled by using 
various histidine concentrations (i.e., 0, 0.2, 2.0, 40 mM)). We quantified the modification 
extent of G93A SOD1 under each condition, and plotted a time-dependent curve (Figure 
5-5F). The fraction unmodified of TFE-untreated protein decreases as the time for labeling 
is increased by lowering the concentration of histidine; the near-linear correlation 
indicates that the modifications occur normally (Figure 5-5 F). In contrast, the point 
representing the TFE-treated G93A SOD1 (blue triangle in Figure 5-5 F) is clearly an 
outlier, with a fraction unmodified at protein level of 29% and reporter fraction modified of 
25%. Its deviation from the line indicates that TFE-treated G93A SOD1 has changed 
conformation [45].  
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To examine the local conformational changes induced by TFE, we first submit the protein 
to footprinting followed by proteolysis, compare the FPOP outcomes between TFE-
treated and untreated samples, and quantify the extent of modification for both reporter 
peptide and the G93A digests, at the same labeling times. By plotting the fraction modified 
of reporter peptide at each histidine concentration versus the corresponding fraction 
modified of tryptic peptides from the protein digest on the y-axis, we can determine the 
regional time-dependent FPOP modifications for the TFE-induced G93A at different 
labeling times. The fraction modified of reporter peptide (x-axis) serves as a “timer” of 
labeling times, enabling a kinetic output similar to that of HDX curves for peptides [58]. 
All curves were fitted with a custom algorithm written in R [59]. In this way, we were able 
to obtain the time-dependent response of FPOP modifications for 10 representative 
peptides of TFE-untreated samples (native dimer), spanning the entire G93A sequence 
(Figure 5-6). Although this means of varying footprinting time is simple, the relationship 
between the modification extent of the reporter peptide and time is more complicated [45].  
Most peptides show an apparent linear increase of modification extent as a function of 
time. Peptides 24-36, 37-69, 116-128, and 123-136 exhibit curvature in their kinetic plots, 
showing a high rate at short times as would be expected for regions showing relatively 
higher modification extents. We assign those regions with high FPOP modification extents 
to be solvent accessible, or to contain residues that are very reactive towards •OH [49], 
or both. The plots reach a plateau at approximately 40% of reporter modification probably 
because the concentration of radicals has significantly decreased at long times (Figure 5-
6). 
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Figure 5-5. (A-E) Mass spectra of intact, TFE-untreated G93A SOD1 footprinted by 
FPOP at different labeling times as adjusted by varied histidine concentrations; (F) Time-
dependent curve obtained by plotting the fraction unmodified of TFE-untreated G93A vs. 
reporter peptide fraction modified (black circles); the point representing TFE-treated 
G93A (blue triangle) is not on the curve.   
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Figure 5-6. Kinetic curves of 10 peptides from TFE-untreated G93A SOD1 in a time-
dependent FPOP measured in triplicates, performed by adjusting different histidine 
concentrations. We used the curve of peptide 37-69 as an example to demonstrate that, 
such time-dependent measurements allow determination of FPOP yields at any given 
labeling time within the curve. The error bars correspond to the ±  SE of triplicate 
measurements. 
 
5.4.4 FPOP and Protein Flexibility 
To test the hypothesis that reactive regions are those that are highly solvent and flexible, 
we extracted the b-factor values per-atom from SOD1 X-ray structure (PDB code: 3GZP) 
and averaged those values on a per-residue basis (Figure 5-7 A illustrates the residue-
specific b-factor values of SOD1).  Regions that exhibit larger b-factor values have higher 
flexibility in the protein tertiary structure and should be reactive in FPOP [60, 61], and we 
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see agreement between those b-factors and the measured FPOP labeling extent. For 
example, region spanning 122-143, which represents one of the major functional loops of 
SOD1 (i.e., electrostatic loop), shows pronounced FPOP yields (as is the case of peptide 
116-128, 123-136 in Figure 5-6). Although this region is replete with FPOP-unreactive 
residues (e.g., Gly, Ala, Asp, Glu), Lys122, Lys128, and Lys136 are found most reactive 
and report the high solvent accessibility.  The X-ray structure shows that the side chains 
of these three Lys’s point into solution (Figure 5-7 B), and the large b-factors of this region 
point to its high flexibility (Figure 5-7 A). Similarly, the high FPOP yields for peptide 37-69 
correspond to the high flexibility of the Zn-binding loop (amino acid 50-84), as is indicated 
by those relatively higher b-factor values (Figure 5-7 A). Interestingly, the region spanning 
from 23-36, which is relatively protected because it packs together to form a 3-sheet (3-
strand 3) and is part of the 3-barrel, also undergoes a high FPOP yield. Detailed FPOP 
analysis shows that reactions at Trp32 nearly accounts for all modifications of peptide 23-
36 (tryptophan is very reactive towards hydroxyl radicals, with a near-diffusion-rate of 1.3 
´ 1010 M-1s-1 [49]). The crystal structure shows that the side chain of Trp32 is pointed 
outward from the 3-barrel (Figure 5-7 C), making this residue readily available to hydroxyl 
radicals.  
In contrast to these regions represented by peptides with high FPOP yields, those regions 
at the of N- and C- termini and that of 80-115 undergo low extents of FPOP modification 
(Figure 5-6), pointing to low solvent accessibility of reactive residues (Figure 5-7 A). 
These regions undergo protection either due to the formation of a dimer interface or of a 
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compact 3-barrel. Taken together, FPOP footprinting results corroborate b-factors from 
crystal structure that describe the solvent accessibility of SOD1 molecule. 
 
Figure 5-7. (A) Averaged residue-specific b-factor values plotted versus the residue index. 
Two regions showing high b-factor values are the zinc binding loop (residues 50-84) and 
the electrostatic loop (residues 122-143); (B, C) Zoom-in views of the SOD1 crystal 
structure (3GZP) show that the side chains of Trp32, Lys122, Lys128, and Lys 136 point 
to solution. 
 
5.4.5 Effects of Destabilization Determined by FPOP 
As discussed previously (in Chapter 3), one of the advantages of measuring kinetics in a 
differential scavenging system is that, it permits comparisons of two time-dependent 
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curves representing the proteins from two conditions; each curve comprises several 
different points corresponding to the FPOP yield at various labeling times [45]. It is not 
possible to take measurements under consistent labeling times, owing to the presence of 
adventitious scavengers. The time-dependent responses (as shown in Figure 5-6), 
however, allow us to determine the FPOP yield at any given labeling time, affording the 
opportunity to compare the FPOP results between TFE-treated and untreated samples, 
although their labeling times are different. 
To compare the FPOP outcome between TFE-treated and untreated samples and to 
assess the structural differences, quantitation of FPOP yields between the two conditions 
at a constant labeling time is required. Using the observation that the labeling time of the 
TFE-treated G93A corresponds to 25% fraction modified of the reporter (Figure 5-4 D), 
we can readily determine from each kinetic curve the FPOP response of TFE-untreated 
G93A at the same “time point” (corresponding to 25% modification of the reporter peptide, 
(Figure 5-6)). Based on this approach, we can assess the FPOP yields between the TFE-
treated and untreated G93A SOD1, at a constant labeling time (Figure 5-8 A).  
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Figure 5-8. (A) Comparison of FPOP yields of TFE-treated and untreated G93A SOD1at 
peptide level under the same labeling time, as guaranteed by the same reporter fraction 
modified. Peptides showing differential modification extents are labeled with stars (yellow 
stars for peptides in dimer interface; blue stars for peptides in 3-barrel). The error bars 
correspond to the ± SE of triplicate measurements; (B) FPOP results mapped onto the 
crystal structure of dimeric G93A SOD1 (PDB code 3GZP), the site mutation is annotated 
(blue arrow). Regions identified with same FPOP yields are colored red; regions showing 
differential FPOP yields are colored as described in A. 
 
5.4.6 FPOP Confirms Dimer Dissociation 
Comparing the regional modification extents between TFE-treated and untreated G93A, 
we note that regions represented by peptides 24-36, 37-69, 116-128, and 123-136 show 
statistically similar fraction modified (Figure 5-8 A). For the N-terminus (represented by 
peptides 1-9, 4-23, and 10-23) and the C-terminus (represented by peptide 144-153), the 
FPOP yields for TFE-treated G93A are higher than those for TFE-untreated G93A (Figure 
5-8 A). The native dimeric SOD1 protein uses both its N-terminus and C-terminus as a 
dimer interface [62]. The FPOP reactivity changes indicate increased solvent-accessibility 
of the G93A dimer interface region after adding TFE, consistent with formation of the 
monomer. This observation is in accord with the results from native MS (Figure 5-3 B), 
whereby the predominant form of TFE-treated G93A SOD1 is the monomer. Furthermore, 
Hough et al. [33] showed, with solution X-ray scattering, that there is an increased 
tendency for SOD1 dimer to open the dimer interface with heat-induced destabilization of 
SOD1. It is also possible that the decreased interface stability can increase the population 
of poorly packed and malleable monomeric SOD1 species, elucidating one of the toxic 
SOD1 misfolding pathways [35]. 
5.4.7 FPOP Locates Unfolding Sites 
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Besides the dimer interface represented by the four peptides (yellow starred in Figure 5-
8 A), a second region located away from the dimer interface and represented by peptides 
80-91 and 92-115 (blue stars, Figure 5-8 A), also shows statistically significant increases 
of FPOP yields upon destabilizing the protein with TFE. The X-ray crystal structure of 
G93A SOD1 indicates this region is comprised of 3-strand 5 and 6, which forms part of 
the closely-packed 3-barrel (Figure 5-8 B).  Therefore, it should be solvent inaccessible 
for the untreated protein, and this is in agreement with the low FPOP yields (<7%) of both 
peptides 80-91 and 92-115 when TFE is not added. The FPOP yields of these regions, 
however, increase dramatically for the samples treated with TFE. The overall yields at the 
region represented by peptide 80-91, which incorporates the entire 3-strand 5 and part of 
the adjoining loop (Figure 5-9 A), increase from 2% to 6% (Figure 5-9 C). This increase 
suggests a local, destabilization-induced unfolding event, producing a more solvent 
exposed conformation of the 80-91 region. Examination of the product-ion spectra reveals 
hydroxyl-radical modifications of +16 on His80, Val81, and Lys91(Figure 5-10). Those 
differentially modified species are nicely separated as shown by their different retention 
times in the chromatography (Figure 5-9 B). 
The region represented by peptide 92-115 comprises the 3-strand 6 (amino acids 95-101) 
and the full adjoining loop between strand 6 and 7 (amino acids 102-115, Figure 5-11 D). 
Its FPOP yields increases significantly from 6% to 32% upon treatment with TFE (Figure 
5-11 A), indicating pronounced unfolding and increasing solvent accessibility. Detailed 
residue-level analysis identifies with high confidence that Val97 and His110 are two of the 
amino acids being modified (Figure 5-11 B), although there are other residues modified 
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at lower yields. The product-ion spectra of peptides containing these latter modified 
residues do not afford unambiguous sequence information owing to the co-elution of 
isomeric modified species. Surprisingly, quantitation of the FPOP yields of Val97 and 
His110 show that the fraction modified of His110 remains nearly unchanged before and 
after adding the TFE; whereas Val97 exhibits a yield increase of nearly one order of 
magnitude (Figure 5-11 B). Val97 belongs to strand 6, which is part of the 3-barrel formed 
along with other seven strands. The crystal structure shows that Val97 is largely buried 
in the native form of G93A dimer, as its side-chain points toward the inward part of the 3-
barrel (Figure 5-11 D). This agrees with the FPOP results as Val97 is only 1.5% modified 
in the absence of TFE. Nevertheless, the pronounced increase of the Val97 yield strongly 
indicates the unfolding of the natively protected conformation, exposing Val97 to solvent 
and making it susceptible to hydroxyl radical attack. His110, on the other hand, is located 
on the adjoining short loop region between strand 6 and 7, with its side-chain pointing 
outward, according to the X-ray crystal structure (Figure 5-11 D).  Therefore, the solvent 
accessibility of His110 is only marginally different even upon local unfolding. This 
difference underscores the ability of FPOP to make comparisons of subtle changes in 
folding [63]. 
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Figure 5-9. Structure, extracted ion chromatograms, and FPOP quantitation of peptide 
80-91. (A) G93A SOD1 crystal structure with zoom-in view of peptide 80-91 (colored in 
blue) and residues His80, Val81, and Lys91 (colored in yellow); (B) Extracted ion 
chromatograms (XICs) of unmodified and +16 modified peptide 80-91. The differently 
modified isomers (modifications on H80, V81, and K91) are separated 
chromatographically based on their respective hydrophobicity; (C) Quantitation of FPOP 
yields of peptide 80-91 between TFE-treated and untreated condition shows an overall 
increase from 2% to 6% with addition of TFE; (D) Quantitation of FPOP yields of residues 
His80, Val81, and Lys91 before and after TFE treatment. All error bars correspond to the ± SE of triplicate measurements. 
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Figure 5-10. Product-ion spectra corresponding to +16 modified peptide 80-91 locating 
the FPOP modification on His80 (A) and Lys91 (B). 
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Figure 5-11. Structure, extracted ion chromatograms, and FPOP quantitation of peptide 
92-115. (A) Quantitation of FPOP yields of peptide 92-115 between TFE-treated and 
untreated condition shows significant increase from 6% to 32% upon TFE treatment; (B) 
Quantitation of FPOP yields of Val91 and His110, both residues account for most 
modifications of peptide 92-115; (C) XICs of unmodified and +16 modified peptide 92-115 
of TFE-treated G93A; (D) Crystal structure with zoom-in view of peptide 92-115 (colored 
in blue) and residues Val91 and His110 (colored in yellow); (E) XICs of unmodified and 
+16 modified peptide 92-115 of TFE-untreated G93A. All error bars correspond to the ± 
SE of triplicate measurements. 
 
5.4.8 Regions of Oligomeric Interaction 
The comparison of FPOP results between TFE-treated and untreated G93A SOD1 
unveils the rupture of dimer interface (N-terminal and C-terminal region, covering 3-
strand 1, 2, and 8), and the local unfolding of 3-strand 5 and 6. Both processes may lead 
to the exposure of structurally promiscuous interfaces that are normally buried in the 
protein’s interior, increasing the propensity for self-association, as hypothesized by others 
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[30, 33, 35, 39, 64, 65]. Furukawa et al. [65] experimentally identified a protease-resistant 
core structure within various fALS-inducing mutant SOD1 aggregates, and found three 
regions (amino acids 1-30, 90-120, and 135-153) that likely form a scaffold core in the 
aggregates. This finding is in good agreement with the FPOP results, reinforcing that the 
N-terminal region, C-terminal region, and 3 -strand 5 and 6 may be essential to 
aggregation (Figure 5-12).  
Contemporaneous with this hypothesis, Nordlund and Oliveberg [64] suggested from 
folding kinetic analysis and j-value analysis [66] that the N-terminal strands 31-3 is the 
seeds for SOD1 aggregation and that the regions of SOD1 most susceptible to unfolding 
under physiological conditions are strands 35, 36, and 38. These latter strands serve as 
structural protective caps preventing the hydrophobic edges of N-terminal strands from 
becoming exposed. In several ALS-provoking mutant variants, however, this protection 
mechanism is completely missing owing to early unfolding of these protective caps. Ding 
and Dokholyan [39] came to a similar conclusion on the basis of all-atom DMD simulations 
for SOD1 monomers, localizing strands 5, 6, and 8 as possessing some of the highest 
propensities for local unfolding. These findings support a hypothesis of sequential local 
unfolding events, where the strands 35, 36, and 38 would undergo earliest unfolding, 
followed by the exposure of sticky edge strands of N-terminus. 
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Figure 5-12. Secondary structure representation of SOD1, the eight anti-parallel 3 
strands are shown as arrows with numbers representing the starting and ending residue 
index of each strand. The 3 strands that show increased FPOP yields with TFE treatment 
are colored green. 
 
5.5 Conclusions 
SOD1 destabilization is accompanied by not only dimer dissociation but also local 
unfolding, leading to re-organization of molecular conformations that are prone to 
aggregation. Our MS-based approaches combine top-down native ESI and protein 
footprinting (FPOP) coupled with bottom-up analysis to characterize the TFE-destabilized 
G93A SOD1 at both the protein and peptide/residue levels. The results from the two 
approaches are consistent with evidence from other studies, allowing us to draw a picture 
of the TFE-destabilized G93A SOD1 that exposes its dimer interface and undergoes 
partial unfolding on the 3-barrel. Our data are consistent with a previous conclusion that 
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SOD1 follows the misfolding and aggregation mechanism, whereby the exposure of 
hydrophobic cores facilitate SOD1 self-association; inhibition of such exposure may be 
useful in alleviating the ALS symptoms. 
Our current FPOP results identify loss-of-structure on both regions without differentiating 
which one comes first. To dissect the unfolding events, however, a two-laser “pump/probe” 
platform [67, 68] may be useful, allowing T-jump destabilization of SOD1 proteins followed 
by hydroxyl radical footprinting to track the conformational changes. 
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Chapter 6 
Mass Spectrometry and Protein Footprinting in 
Characterizing EGF Receptor Intracellular Domain (EGFR-
ICD) 
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6.1 Abstract 
The epidermal growth factor (EGF) receptor is regulated by several mechanisms: 
stimulation by ligand binding and self-phosphorylation, inhibition by heterologous 
phosphorylation and downregulation by ligand binding. It mediates many cellular 
response in normal biological processes and in pathological states. The C-terminal tails 
of all EGF receptor molecules have important regulatory functions. Phosphorylated tails 
can recruit various adapter proteins via their SH2 (Src homology domain 2) or PTB 
(phosphotyrosine binding domain) domains. Details about those interactions, however, 
remain ambiguous, owing to the intrinsic disorder of C-terminal tail. Here, we report 
protein footprinting techniques (hydrogen-deuterium exchange, hydroxyl radical labeling) 
coupled to mass spectrometry to characterize the conformations of EGF receptor and 
complex, by probing their protein surface solvent accessibility. Both HDX and FPOP data 
agree with the molecular modeling results performed by our collaborators in Washington 
University Medical School, that the C-terminal tail domain of EGF receptor is largely 
disordered. We further found that HDX is insufficient to distinguish the Cbl-bound and 
unbound states of EGF receptor, because the ligand binding kinetics are fast. 
6.2 Introduction 
The EGF receptor is a transmembrane glycoprotein that constitutes one of the four 
members of the ErbB family of tyrosine kinase receptor (TKR). Other members of ErbB 
group include ErbB2, ErbB3, and ErbB4 [1]. All of these tyrosine kinase receptors share 
the same structural components: an extracellular ligand-binding domain, a single-pass 
transmembrane domain, an intracellular tyrosine kinase domain, and a C-terminal tail 
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domain encompassing nine tyrosine residues that can be phosphorylated. In its inactive 
state, the receptor exists primarily as a monomer [2]; upon binding ligand, however, the 
receptor undergoes an extensive conformational change that allows the formation of 
back-to-back dimers by the extracellular domains [3, 4]. 
The dimerization of the extracellular domains results in the formation of activating 
asymmetric dimers of the intracellular kinase domains, where the activity of one kinase 
domain is stimulated to phosphorylate tyrosine residues on the C-terminal tail of its 
partner subunit [5-7]. The phosphorylated tyrosines on the EGF receptor serve as binding 
sites for numerous signaling proteins that contain SH2 and/or phosphotyrosine-binding 
domains [8, 9]. Some of these proteins possess enzymatic activity (e.g., Cbl); others, 
such as Grb2 or Shc, function as adapter proteins that bridge other proteins with the EGF 
receptor. For instance, Grb2 recruits Gab1 to the EGF receptor as scaffolding protein; 
phosphorylation of Gab1 by the EGF receptor permits Gab1 to recruit further additional 
signaling proteins, such as PI3K-R1 or Shp2 [10, 11]. The recruitment of these signaling 
proteins eventually trigger the activation of various downstream signaling pathways, 
which are closely associated with cell proliferation, mobility, apoptosis, etc. The mutation 
and overexpression of EGF receptor are associated with a variety of cancers, making this 
prototypical dimerization-activated receptor tyrosine kinase a prominent target of cancer 
drugs. 
The C-terminal tail of EGF receptor, although playing a vital role in the downstream 
signaling transduction, has thus far eluded definitive structural and mechanistic 
characterization [12]. No crystal structures are so far available for the C-terminal tail 
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domain because that region is highly flexible and membrane-associated [13-15]. As an 
alternative to X-ray crystallography, mass spectrometry (MS) may be a useful means for 
protein structure characterizations [16-19]. 
Recent developments have demonstrated that labeling of protein solvent-accessible 
regions bring insights into the high order structures (HOS) of a protein. This enables the 
differentiation of flexible regions from rigid regions; for example, a flexible loop region may 
show more labeling than a closely-packed !-sheet because the loop is more solvent 
exposed. More importantly, in a two-state comparison, one could localize the protein-
ligand interactions, including protein-small molecule, protein-peptide, and protein-protein 
interactions [13, 20-24]. Chemical footprinting methods coupled to MS can identify 
peptides/residues with altered reactivity as a result of binding. Various chemical labeling 
approaches are available (e.g.,  hydrogen deuterium exchange (HDX) [20, 23], hydroxyl 
radical footprinting (FPOP) [25, 26], carbene labeling [27], and some other probes that 
are amino-acid residue-specific [24, 28]).  
Keppel et al. [29] recently demonstrated the intrinsic disorder in C-terminal tail of both 
EGF receptor and HER3 receptor tyrosine kinase via HDX-MS. Numerous molecular 
dynamics studies have also suggested the high flexibility of C-terminal tail [30, 31]. The 
intrinsic disorder and extended confirmation of the tail is believed to be important for its 
functions by increasing the capture radius and reducing the thermodynamic barriers of 
binding to downstream signaling proteins. One of our major goals with EGF receptor is to 
localize the binding site(s) of these signaling proteins on the C-terminal tail. The fast 
dynamics on the disordered tail, however, pose great challenges to the HDX-MS-based 
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conformational characterizations, because of the relatively long labeling time scale; thus, 
the labeling samples an ensemble of averaged dynamic conformations [32]. Fast 
photochemical oxidation of proteins (FPOP), on the other hand, provides opportunities to 
probe rapidly changing protein conformations. The short-lived hydroxyl radicals enable 
irreversible labeling of residue side-chains on the microsecond time scale; allowing the 
mapping of protein surface solvent accessibility in a near-native environment [33-35]. 
Interfaced with the bottom-up mass spectrometry, FPOP interrogates residue-specific 
modifications. 
Characterizing the EGF receptor intracellular domain with FPOP is challenging in many 
ways: (i) Sample complexity:  numerous species from up-stream processing, including 
APT, DTT, Tween20, and liposome, coexist in solution with the protein. Therefore, an 
efficient sample cleanup approach is required prior to the mass spectrometric analysis; 
(ii) Protein conformation heterogeneity: this tyrosine kinase receptor has nine 
phosphotyrosine residues on the C-terminal tail domain. Whether or not these residues 
are phosphorylated, or to what extent each of these residues are phosphorylated, is 
closely associated with a variety of different tail conformations, and, therefore, with 
various downstream signaling transductions.  (iii) Data analysis: hydroxyl radical labels 
14 out of 20 amino acids, this labeling is mostly manifested as post-translational 
modifications (PTMs) of +16, +32, etc., although other PTMs are also possible (e.g., -30 
for Asp, -10 for His) (see Chapter 1 Table 1-1) [36]. The incorporation of phosphorylation 
group as one extra PTM would greatly complicate the data processing regarding the 
quantitation of FPOP yields (this will be discussed later in this chapter). Allowing for all 
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these challenges, we started our research by identifying the phosphorylation sites and 
quantifying the phosphorylation extent using bottom-up mass spectrometry. Following 
this we tested the feasibility of using FPOP to probe the conformation of EGF receptor 
intracellular domain. Our work demonstrates that the phosphorylation extent on the C-
terminal tail is heterogeneous, and through FPOP footprinting, we confirmed that the C-
terminal tail of EGF receptor is intrinsically disordered.  
6.3 Experimental 
6.3.1 Materials 
Leucine enkephalin acetate hydrate, L-histidine, L-methionine, 30% hydrogen peroxide, 
catalase, acetone, urea, dithiothreitol (DTT), iodoacetamide (IAM), 2-amino-2-
(hydroxylmethyl)-1,3-propanediol (Tris base), 36.5-38.0% hydrochloric acid, ammonium 
acetate, formic acid (FA), trifluoroacetic acid (TFA), HPLC-grade solvent, and phosphate 
buffered saline (PBS) were purchased from Sigma-Aldrich Chemical Co. (St. Louis, MO). 
Sequencing-grade trypsin was purchased from Promega Co. (Madison, WI). The EGF 
receptor protein and signaling protein Cbl were expressed, purified, phosphorylated in the 
laboratory of our collaborator, Dr. Linda Pike. 
6.3.2 FPOP Footprinting 
A total volume of 50 µL of solution containing ~2 µM protein, 5 µM Leu-enkephalin, 20 
mM H2O2, and histidine at various concentrations in PBS, was loaded in a 100 µL syringe 
(Hamilton, Reno, NV) and advanced using a syringe pump (Harvard Apparatus, Holliston, 
MA). The excimer laser (GAM Laser Inc., Orlando, FL) was adjusted to 21.5 mJ/pulse at 
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a frequency of 7.4 Hz and focused to an irradiation window of 2.67 mm. The solution flow 
rate was adjusted to ensure a 25% exclusion volume fraction to avoid repeated exposure 
of radicals. Samples after FPOP were submitted to acetone precipitation and trypsin 
digestion, followed by bottom-up MS analysis. 
6.3.3 Bottom-up Analysis 
The LC-MS/MS analyses were conducted back-to-back with the UltiMate 3000 Nano LC 
system and a Thermo Q Exactive Plus Hybrid Quadruple-Orbitrap Mass spectrometer 
(Thermo Fisher Scientific, Waltham, MA). Aliquots (5 µL) of digests were drawn from 
autosampler vial and loaded onto a C18 reversed-phase trapping column (Acclaim® 
PepMap100, 100 µm ´ 2 cm, 5 µm, 100 Å; Thermo Fisher Scientific, Waltham, MA) at 4.5 
µL/min with water in 0.1% FA for a ten-minute desalting. Peptides were separated using 
a custom-packed C18 reverse-phase column (Symmetry, 100 µm ´ 200 mm, 5 µm, 100 
Å; Waters Inc., Milford, MA) and eluted with a 76-min gradient delivered at 500 nL/min. 
The scan range of precursor ions was set from m/z 380 to 2200 for all samples with high 
mass resolving power of 70,000. Dynamic exclusion was activated for 8 s following each 
scan to enable fragmentation of low abundant peptides. The maximum injection time (IT) 
for full mass spectral scan was set to 200 ms, and 150 ms for each MS/MS scan. 
6.3.4 FPOP Data Analysis 
The *.raw MS files were searched directly using Byonic (Protein Metrics Inc., San Carlos, 
CA) against a custom-built database containing the sequence of EGFR-ICD and Cbl. All 
known HO• side-chain reaction products were added to the variable modification 
database for searching of HO•-modified peptides [36, 37]. The quantitation of FPOP 
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yields was based on ion abundances from extracted ion chromatograms (XICs). For more 
detailed data analysis, please see Chapter 5.  
6.3.5 Hydrogen Deuterium Exchange (HDX) 
Stock solution of 8 µM EGFR-ICD and 16 µM Cbl were prepared. Samples were 
equilibrated at 25 °C for 30 min before HDX analysis (1:2 ratio). Continuous labeling with 
deuterium was initiated by diluting 10 µL of the stock solution into 40 µL of D2O. HDX was 
measured at 5, 10, and 30 s. Two proteases, pepsin (immobilized) and fungal XIII (2 
mg/mL), were used for protein digestion to achieve high peptide coverage. The exchange 
reaction was quenched by mixing with 60 µL of 4 M urea, 2% formic acid at ~4 °C. The 
mixed solution was then passed through a custom-packed pepsin column (2 x 20 mm) at 
200 µL/min. The peptic digests were then trapped onto a reversed phase C8 column 
(Agilent, Santa Clara, CA, USA) and desalted with a 3-min flow at 200 µL/min of water 
with 0.1% formic acid, followed by separation using a 2.1 x 50 mm reversed phase C18 
column (1.9 µm Hypersil Gold; Thermo Fisher Scientific, Waltham, MA, USA) with an 9.5 
linear gradient of 2% to 40% acetonitrile in 0.1% formic acid at 50 µL/min. MS detection 
was performed on an LTQ-Orbitrap (Thermo Fisher Scientific, Santa Clara, CA, USA) 
operating in the data-dependent mode, where the six most abundant ions from each scan 
were selected for MS/MS analysis. 
6.3.6 HDX Data Analysis 
The *.raw MS files were submitted to MassMatrix for peptide identification and outputted 
as *.csv files with identified peptides. Both *.csv and *.raw files were input into 
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HDExaminer software to calculate the centroid masses of isotopic envelopes (m) and 
deuterium uptake level (D%).  
6.4 Results and Discussion 
6.4.1 Need for Sample Cleanup 
Protein samples commonly contain substances that interfere with downstream application 
[38]. During our work of bottom-up mass spectrometry to separate spatially each tryptic 
peptide of EGF receptor, we observed large amounts of polymer-based contaminants 
coeluting with protein digests. The main component appears to be Tween20 (a 
polyethylene glycol containing detergent) originally present in the protein sample [39]. 
The signals corresponding to these polymer contaminants were more intense than the 
protein digest signals by approximately 1000-fold, indicating that the EGF receptor signals 
are seriously suppressed in a typical data-dependent MS acquisition mode, resulting in 
poor protein sequence coverage [40] (Figure 6-1 A shows the total ion chromatogram 
(TIC) of EGF receptor tryptic digests without sample cleanup). Those intense peaks 
eluting from 25 min to 40 min correspond to polymeric species with different replicates of 
PEG units (Figure 6-1 B shows a mass spectrum within that 25-40 min time window).  The 
spectrum contains equally distanced peaks (Dm = 44, -O-CH2-CH2-) that are 
characteristic of PEG-containing polymer species that coelute with peptides from the EGF 
receptor [41]. Besides Tween20, there are other substances that would potentially 
interfere with the downstream processing as well. As far as we knew, the sample also 
contains b-glycerophosphate, DTT, ATP, EDTA, MgCl2, vanadate salts. 
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To overcome such sample complexity, an effective sample cleanup method was 
necessary prior to the LC-MS analysis. Several strategies exist for eliminating 
contaminants from samples. One way of doing it is to exchange sample solutions into 
appropriate buffers by dialysis or gel filtration (desalting columns) [42, 43]. Another 
strategy for removing undesirable substances is to add a compound (acetone, 
trichloroacetic acid, methanol, chloroform, etc.) that causes protein to precipitate [44, 45]. 
After centrifugation to pellet the precipitated protein, the supernatant containing the 
interfering substances is removed and the protein pellet is resuspended in a buffer that is 
compatible with the downstream analysis. Figure 6-1 C shows the TIC of EGF receptor 
tryptic digests after acetone precipitation. Compared with the TIC before precipitation 
(Figure 6-1 A), those polymeric contaminants can be eliminated effectively by acetone 
precipitation. The multiple peaks at different retention times correspond to tryptic peptides 
from EGF receptor that eluted from the C18 reversed phase column. 
Given that protein precipitation would denature the protein, one should perform such 
sample cleanup after labeling. It would be challenging to use a protocol involving protein 
precipitation with HDX, as samples are likely to undergo significant back-exchange during 
sample handling. The irreversible nature of FPOP footprinting, however, is compatible 
with protein precipitation, as decays of labeling or scrambling are not issues [44, 46]. It 
should also be noted that protein precipitation is subjected to sample loss; however, we 
determined that the loss of protein is not significant as the protein signals in LC-MS 
measurement did not drop noticeably (data not shown). 
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Figure 6-1. (A) Total ion chromatogram (TIC) of EGF receptor trypsin digests without 
sample cleanup, loaded amount 2.5 pmol; (B) Mass spectrum containing all scans from 
25 to 40 min elution window in the TIC of EGF receptor without sample cleanup; (C) TIC 
of EGF receptor trypsin digests after acetone precipitation, loaded amount 2.5 pmol. 
 
6.4.2 Identification and Quantitation of Phosphorylation 
An activated EGF receptor dimerizes and auto-phosphorylates the C-terminal tail, which 
contains nine tyrosine residues (Figure 6-2). The phosphorylation status of these tyrosine 
residues determines the binding of numerous signaling proteins [6, 9, 11, 30]. Besides 
the nine phosphotyrosine in the C-terminal tail, there are also Thr and Ser residues that 
are also susceptible to the auto-phosphorylation, although the down-regulation effect of 
Ser/Thr phosphorylation is believed to be less significant [47]. Herein, we sought to use 
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a bottom-up mass spectrometry approach to provide a quick identification and 
quantitation of phosphorylation for EGF receptor intracellular domain (EGFR-ICD). To do 
this, we prepared solutions of EGFR-ICD in triplicate that were identical in every respect, 
except for the different phosphorylation time (0 min vs. 10 min). After submitting samples 
(50 pmol) to acetone precipitation and trypsin digestion, we immediately loaded one 
aliquot of tryptic digests onto a C18 column for LC-MS/MS analysis. We relied on the 
product-ion spectra for phosphorylation identification, as the phosphorylation is 
manifested as a PTM with addition of 79.9663 Da (corresponding to addition of -HPO3). 
Figure 6-3 shows the comparison of product-ion (MS/MS) spectra of the 
unphosphorylated (A) and singly phosphorylated (B) peptide of GSTAENAEYLR (amino 
acid 1165-1175). We observed a mass shift of 80 Da, starting from the y3 ion, for the 
entire y-series product ions in the product-ion spectrum of the singly phosphorylated 
species, pinpointing the phosphorylation at Tyr1173. To quantify the extent of 
phosphorylation, the ion chromatograms (XICs) corresponding to both unphosphorylated 
and phosphorylated peptides are extracted.  The peak integrals of XICs are used to 
represent the abundance of each peptide species, and we calculate the extent of 
phosphorylation as the ratio of these integrals [25, 26] (Figure 6-4 shows the XICs of 
monoisotopic mass of peptide 1165-1175 (+2 charge state) based on the precursor mass 
threshold of 15 ppm). The m/z values used for the signal extraction are 605.7886 
(unphosphorylated), 645.7717 (singly phosphorylated), and 685.7549 (doubly 
phosphorylated). We did observe the signal, although it is not intense, corresponding to 
the doubly phosphorylated species for this peptide.  Residues Tyr1173, Ser1166, and 
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Thr1167 are phosphorylated at low level as well. The peptide after being submitted to 10-
min phosphorylation conditions shows phosphorylation extent of approximately 90%; 
whereas the one from 0-min condition only has a basal level phosphorylation of 1%.  
One needs to be cautious about the extent of phosphorylation determined in this manner, 
because the incorporation of a phospho-group onto a peptide might inevitably alter its 
ionization efficiency, leading to a biased quantification result [48, 49]. The biased range 
regarding the ionization efficiency between the phosphorylated and unphosphorylated 
peptides was previously shown to be within 20% [50], indicating that our quantification 
results are within a reasonable range. Stable isotope labeling experiments (e.g., SILAC) 
are available for a more accurate quantitation of phosphorylation extent [51, 52], but we 
are faced with more serious analytical problems prior to considering such. 
A bar-graph representing the residue-specific phosphorylation quantitation result 
between the 0-min and 10-min phosphorylation EGFR-ICD (Figure 6-5) shows, besides 
the nine tyrosines in C-terminal tail, that there is also phosphorylation of tyrosines in the 
kinase domain and also of Ser/Thr. The protein shows an average basal level of 
phosphorylation of approximately 10%; most residues exhibit no phosphorylation at zero 
time except Tyr920, S967, Tyr1086 and Tyr1148 phosphorylations are relatively high. We 
measured the average phosphorylation extent to be ~75% after 10-min of 
phosphorylation. Thus, we can conclude that the difference regarding the phosphorylation 
extent between the unphosphorylated and phosphorylated samples is significant.  
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Figure 6-2. Representation of activated and dimerized EGF receptor. The nine 
phosphotyrosine residues on the C-terminal tail are annotated; these sites serve as the 
binding sites for multiple signaling proteins including Cbl, Grb2, Shc, SHP2. 
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Figure 6-3. Product-ion (MS/MS) spectra of EGFR-ICD tryptic peptide GSTAENAEYLR, 
amino acid 1165-1175. (A) The y ion series observed for the doubly charged 
unphosphorylated peptide 1165-1175 of m/z 605.79; (B) the y ion series for the doubly 
charged singly phosphorylated peptide 1165-1175 of m/z 645.78.  All y ions after y3 
shows a mass shift of 80 Da that represents phosphorylation at Tyr1173. 
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Figure 6-4. Comparison of extracted ion chromatograms (XICs) of peptide 1165-1175 
between unphosphorylated sample and 10-min phosphorylated sample. Monoisotopic 
m/z of 605.7886 (unphosphorylated), 645.7717 (singly phosphorylated), and 685.7549 
(doubly phosphorylated) were used.  
 
 
Figure 6-5. Bar-graph showing the differences in phosphorylation extents for major 
identified residues for 0-min and 10-min reaction.  
 
6.4.3 HDX Not Suitable for Probing the C-terminal Tail Binding 
Hydrogen deuterium exchange (HDX) was recently adapted to demonstrate that the C-
terminal tail of EGFR-ICD is intrinsically disordered [29]. To test whether HDX-MS can be 
used to probe the binding between C-terminal tail and signaling proteins, we did a 
preliminary HDX study on EGFR-ICD binding with Cbl, one of the signaling proteins of 
MW ~40 kD. The binding of Cbl with the C-terminal tail is believed to be very dynamic; 
therefore, as a preliminary study we performed HDX at three short time points (5, 10, and 
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30 s), making single measurements. An overview of the HDX results (Figure 6-6) show 
the outcome, suggesting, in accord with previously determined results [29], no significant 
differential uptake between the Cbl-bound and unbound state. Almost all peptides show 
same level of deuterium uptake for all three time points, with one exception of region 974 
to 991, which shows ~15% differential deuterium uptake after 5 s of HDX. This difference 
attenuates with 10 s HDX, and eventually diminishes at 30 s (Figure 6-6 B, C). The binding 
between Cbl and EGFR occurs, either directly through the pY-binding module contained 
in Cbl that binds to pY1045 of the tail, or indirectly through binding of a Grb2:Cbl complex 
to either pY1068 or pY1086, via the SH2 domain of Grb2 [53-55]. The peptides containing 
those phospho-tyrosine residues, however, show overlapping HDX kinetic curves. This 
suggests that the binding between EGFR C-terminal tail and Cbl has faster on-and-off 
rates than those of HDX [56], indicating the current HDX platform is not fast enough to 
capture the deuterium uptake differences between the two states. 
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Figure 6-6. (A-C) HDX result of EGFR-ICD binding to Cbl under three different incubation 
times (5s, 10s, and 30s). Each point represents a single determination of HDX experiment. 
 
6.4.4 FPOP Probing Solvent Accessibility of EGFR-ICD 
To test the feasibility of FPOP to explore the binding between signaling proteins and the 
C-terminal tail of EGFR-ICD, we first examined the intrinsic disorder of the EGFR-ICD C-
terminal tail without any binding using FPOP footprinting. This experiment can show 
extensive footprinting if the region is indeed flexible, and disordered and it can be useful 
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in determining the optimal FPOP labeling conditions for any follow-up studies and. We 
carried out the FPOP experiments as described previously [57]. Given the sample 
complexity in this study, we incorporated Leu-enkephalin as the reporter peptide to 
measure the quenching effect of adventitious scavengers (see Chapter 3 for details about 
reporter peptide) [58]. Phosphorylated EGFR-ICD samples were aliquoted into two 
portions, with one portion submitted to FPOP labeling directly, and the other to buffer 
exchange (to 10 mM PBS buffer) prior to FPOP, both experiments used 1 mM His as the 
radical scavenger. After FPOP, we quantified the fraction modified of reporter peptide 
based on LC-MS (XICs representing the unmodified and +16 modified Leu-enkephalin 
are in Figure 6-7 A and B). The reporter peptide shows a huge difference in FPOP yield, 
indicating that the high radical-scavenging nature of the protein solution when there is no 
buffer exchange.  The concentration of adventitious scavengers clearly is reduced by 
buffer exchange, as is clearly demonstrated by the dramatic increase of FPOP yields of 
reporter peptide from 3% to 28% (Figure 6-7 C). Such increases of FPOP yield is also 
occur on the EGFR-ICD, given that we observed a consistently increased fraction 
modified of EGFR-ICD tryptic peptides after buffer exchange (Figure 6-8). Our FPOP 
results suggest that, owing to the existence of adventitious radical scavengers, it is 
necessary to perform a buffer exchange (or other suitable purification) prior to FPOP 
footprinting so as to obtain a high and unbiased level of FPOP yields on the EGFR-ICD 
or, for that matter, on any protein. 
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Figure 6-7. (A) XICs of unmodified and +16 modified Leu-enkephalin when there is no 
buffer exchange, the +16 species is minor compared to the unmodified species; (B) Same 
as (A), but after buffer exchange prior to FPOP labeling; (C) Quantification of FPOP yields 
on reporter peptide shows dramatic increase from 3% to 28% with buffer exchange.  
 
 
Figure 6-8. Quantification of FPOP yields for EGFR-ICD tryptic peptides with and without 
buffer exchange. In agreement with the reporter peptide results, almost all peptides show 
increased yields after buffer exchange. The red dashed line separates the kinase domain 
peptides (left) and C-terminal tail peptides (right). 
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6.5 Data Interpretation 
6.5.1 Normalization of Reactivity Towards Hydroxyl Radical 
The experimental protocol of protein footprinting includes steps to label the protein 
(backbones or side chains), then enzymatically digest the protein to peptides, and 
quantify the extent of labeling per peptide [59]. When proteins bind to ligands (e.g., 
peptide, metal, another protein), protein footprinting is especially powerful for mapping 
the interfaces between the domains of macromolecules and mapping conformational 
changes due to ligand binding [37, 60, 61]. In the absence of a ligand, however, protein 
footprinting can also be useful to probe the solvent accessibility of proteins. By 
quantitating and comparing the extent of modifications, one can differentiate those flexible, 
dynamic regions from those that are protected. For example, HDX-MS can provide local 
information about different regions of the EGFR-ICD protein and readily distinguish folded 
or structured, globular regions from intrinsically disordered regions [29]. As is well 
established, the C-terminal tail domain exchanges very rapidly and reaches a plateau 
(~80% deuterium uptake) before 5 s of exchange, whereas the kinase domain doesn’t 
reach a maximum even after 2 h of exchange.  
Nevertheless, with hydroxyl radical labeling, such direct comparison of modification 
extents between one region of a protein and the other does NOT straightforwardly infer 
the flexibility and rigidity of the structure. As shown in Eq. 6-1, the fraction modified of 
peptide in FPOP is not only associated with its solvent accessibility but also related to its 
reactivity with hydroxyl radicals. The reactivity of amino acids towards HO•, however, can 
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be different by three orders of magnitude, from E7 to E10 M-1s-1 [37]. This indicates that 
the second term in Eq. 6-1 is highly variable and dependent on the nature of the amino-
acid residue when it comes to making comparisons between different regions of a protein, 
as their amino acid sequences can be quite different. Thus, a proper normalization of the 
overall reactivity of peptides towards HO• is necessary to compare the solvent 
accessibility among various regions of a protein based on the respective FPOP yields. It 
is noteworthy, however, in the typical scenario of two-state comparison experiments (e.g., 
apo- vs. holo-), such normalization step is not required because the amino acid 
sequences under comparisons are the same providing the oxidizing potential of the two 
solution is the same for both solutions (except for the protein under study). 
"#$%&'#	)*+,%&-.	/-'&)&#'	 ∝ 1-23#.%	4,,#55&6&2&%7 ∗ (:3#*+22	;#+,%&3&%7)   Eq. 6-1 
To normalize the overall reactivity of each peptide and obtain the solvent accessibility, we 
compute the summation of HO• rate constants towards all residues within each peptide, 
this represents the peptide-specific overall reactivity. The FPOP yields of each peptide is 
then divided by the overall reactivity (Eq. 6-2). The resulting “solvent accessibility” should 
be able to reflect the solvent accessibility of peptides (i.e., larger number corresponds to 
higher level of flexibility).    
1-23#.%	+,,#55&6&2&%7	 ∝ 	 =>?@AB>	CDEF@AGH	IGBACA>BJKIIE@AGH	GC	D>LABK>	D>EF@AMA@N    Eq. 6-2 
We can apply the reactivity normalization to the EGFR-ICD FPOP results (Figure 6-8), 
and obtain a plot representing the EGFR-ICD peptide-specific solvent accessibility 
(Figure 6-9). Although the FPOP yields are quite different with and without buffer 
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exchange, both conditions give very similar solvent accessibility output (Figure 6-9). 
Nevertheless, we were surprised to find that the C-terminal tail (amino acids 1008-1186) 
does not show dramatically increased solvent accessibility compared to the kinase 
domain (amino acids 663-962); as a matter of fact, on the basis of these measurements, 
the kinase domain appears to have similar flexibility as does the C-terminal tail. This 
contradicts with the usual idea that the C-terminal tail is largely disordered [6, 29, 30].   
 
Figure 6-9. Solvent accessibility output of EGFR-ICD measured by FPOP with the 
reactivity normalization with buffer exchange (A) and without buffer exchange (B) prior to 
labeling. 
 
6.5.2 Is the Kinase Domain of EGFR-ICD a Radical Sink? 
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A detailed comparison of the amino acid content of the kinase domain (amino acids 663-
962) and C-terminal tail domain (amino acids 1008-1186) shows that the distribution of 
FPOP-reactive residues is largely uneven (Table 6-1). In particular, kinase domain 
contains 11 methionines, 6 tryptophans, and 24 arginines, a set of residues that are highly 
reactive towards HO•.  The C-terminal tail of EGFR-ICD consists of residues that are 
mostly less reactive; that is, it contains no methionines, 1 tryptophan, and only 5 arginines. 
It is reasonable that in the “micro environment” of a protein surface, the kinase domain 
competes with the C-terminal tail in reacting with hydroxyl radicals. Consider the bulky 
size and higher reactivity, the kinase domain can be viewed as an “attached” radical 
scavenger of the C-terminal tail domain, and the result is a diminished oxidation of the 
tail. The measured FPOP yields concur with this argument (Figure 6-8). The averaged 
oxidation extent among the 9 peptides identified in C-terminal tail domain of EGFR-ICD 
is 5%, which is far lower than 12%, the averaged oxidation extent of kinase domain, 
despite our understanding that the kinase domain is more compact than the C-terminal 
tail. 
 
Table 6-1. The numbers of hydroxyl radical reactive residues in kinase domain and C-
terminal tail domain of EGFR-ICD. The kinase domain contains a large number of FPOP-
reactive residues. 
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6.5.3 Should Met-Containing Peptides be Excluded for FPOP Comparisons? 
Methionine residues, bearing its sulfur-containing side chain, are among the most reactive 
residues towards HO• [37]. FPOP modification of methionine gives rise to primarily 
methionine sulfoxide (+16 Da mass shift), which can be further oxidized to methionine 
sulfone (+32 Da mass shift). Another minor product with a -32 Da mass shift has also 
been reported, probably due to aldehyde formation at the O-carbon [37].  
From Figure 6-8, we see that all the methionine-containing peptides showed significantly 
higher modification extents (>30%), compared to those containing no methionine. 
Product-ion (MS/MS) spectra suggest the high yields come from methionine oxidation. 
Especially in the kinase domain, methionine oxidations are nearly the predominant 
modifications accounting for most of the FPOP yields. Among the 18 peptides identified 
within kinase domain, eight contain methionine and show more oxidation compared to the 
others (Figure 6-8). Furthermore, even in the control experiments where there is no laser 
irradiation, we find large amounts of +16 and +32 oxidized peptide species, which are 
largely due to Met oxidations. Figure 6-10 illustrates the XICs of tryptic peptide 976-1007 
from EGFR-ICD, where we saw abundant singly and doubly oxidized peptide species for 
both samples that were footprinted with FPOP and samples in the no laser control. All 
major peaks correspond to Met oxidations. The yields for samples submitted to FPOP 
shows 26% modification extent; nevertheless, that same peptide shows 15% oxidation 
extent even without turning on the laser! Similar phenomena were nearly exclusively 
observed for other methionine-containing peptides of EGFR-ICD. Methionine is 
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susceptible to oxidation by other oxygen-reactive species (including hydrogen peroxide) 
[62]. Thus, the high-level background oxidation of methionine is likely due to the protein 
exposure to H2O2 prior to the laser irradiation.  Therefore, that basal oxidation extent 
should be excluded when it comes to quantitation of FPOP yields. These methionine 
oxidations are likely to present a skewed picture of the measured high solvent 
accessibility of the kinase domain (Figure 6-9). 
An alternative explanation for the unusually high methionine oxidations in the kinase 
domain of EGFR-ICD, is that the precursor hydrogen peroxide binds to the kinase prior 
to laser irradiation. The catalytic pocket of kinase may be enriched in H2O2, and when the 
laser pulse occurs, the high concentration of H2O2 gives also a locally high concentration 
of methionine. Although there are few studies regarding the binding between H2O2 and 
EGFR kinase domain, it could be instructive by considering the catalase binding with H2O2. 
Multiple researches have suggested that Arg and His of catalase would preferentially form 
hydrogen bonds with H2O2, as the first step of catalysis [63, 64]. Table 6-1 shows that the 
kinase domain is abundant with these residues, especially Arg; therefore, it is likely that 
H2O2 can form the kinase-H2O2 complex, giving rise to local enrichment in the EGFR 
kinase, which leads to the predominant methionine oxidation in kinase domain. 
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Figure 6-10. Extracted ion chromatograms (XICs) of unmodified, +16, and +32 modified 
peptide 976-1007, under conditions of FPOP (left) and control (right). High extents of 
methionine oxidation observed for both conditions. 
 
6.5.4 FPOP Outcome with Removal of Met-Containing Peptides 
Perhaps the simplest way to avoid getting confounded by questionable methionine 
oxidations is to dismiss those methionine oxidations. One of the advantages of hydroxyl 
radical labeling is its multiple targets, whereby about three quarters of amino acids can 
be modified [37]. Theoretically speaking, any modified residue should faithfully report the 
protein solvent accessibility. This has been demonstrated by various residue-specific 
labeling approaches. For example, with glycine ethyl ester (GEE) labeling, glutamate and 
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aspartate are the only two residues modified; this approach also probes protein solvent 
accessibility [13]. The iodine species produced from photolysis of 4-iodobenzoic acid, 
which selectively is incorporated in His and Tyr residues, also allows interrogation of the 
high order structures of proteins [28].  
Similarly, in FPOP, residues other than methionine can serve as probes of the solvent 
accessibility. To do this, we performed the normalization steps as mentioned in 6.5.1 by 
using peptides containing no methionine residues. As opposed to the results in Figure 6-
8, where all peptides are selected for comparison, Figure 6-11 shows the solvent 
accessibility map of EGFR-ICD with removal of methionine-containing peptides. Figure 
6-11 indicates, presumably correctly, that the C-terminal tail of EGFR-ICD is more solvent 
accessible compared to the kinase domain, pointing to its higher flexibility.  
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Figure 6-11. Solvent accessibility output of EGFR-ICD measured by FPOP with 
normalization of reactivity of peptides containing no methionine residue, with buffer 
exchange (A) and without buffer exchange prior to labeling (B). The C-terminal tail 
domain shows more solvent accessibility in both conditions. 
 
6.6 Conclusions 
In this chapter, we show that bottom-up mass spectrometric analysis can be useful in 
locating phosphotyrosine residues of EGF receptor protein. Besides tyrosine, we found 
some serine and threonine are also phosphorylated. We quantified the extent of 
phosphorylation, and found out the average phosphorylation extent of the EGFR-ICD is 
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~75%, suggesting that an ensemble of different conformations exists for the C-terminal 
tail.  
To confirm the intrinsically disordered C-terminal tail of EGFR-ICD and establish EGFR-
ICD binding to Cbl, we performed HDX and compared the Cbl-bound and unbound states. 
HDX revealed that the C-terminal tail of EGFR-ICD is highly flexible, however, we found 
that the current HDX platform is too slow to characterize the binding between the tail and 
Cbl, likely owing to the fast on-and-off rate in the binding. We then applied FPOP and 
used leu-enkephalin as reporter peptide to optimize the labeling conditions. Interestingly, 
we found unusually high extent of background oxidation of methionine in the kinase 
domain, which may be due to the direct oxidation by H2O2 prior to laser irradiation. These 
excessive methionine oxidations bias the comparison of solvent accessibility between the 
kinase domain and C-terminal tail domain of EGFR-ICD, and could lead to biased 
conclusions that the kinase domain has more solvent accessibility than the C-terminal tail. 
We may be able to simply dismiss those methionine-containing peptides, and solely rely 
on the rest of residues to report the solvent accessibility. In fact, by doing so, the FPOP 
outcome concurs with previous HDX results that the C-terminal tail domain shows more 
solvent accessibility and is more disordered than the kinase domain [29] (Figure 6-6).  
6.7 Future work 
Our next step is to characterize the binding between the EGFR-ICD tail and signaling 
proteins (e.g., Cbl, Grb2). A variety of labeling techniques can be used. The excessive 
methionine oxidations of FPOP is less an issue in this context because there is no 
methionine residue in the C-terminal tail domain of EGFR-ICD. Therefore, we expect 
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FPOP can readily probe the binding interface and report on conformational changes in 
the C-terminal domain as a result of binding. The current HDX platform is limited by its 
time-scale; thus, a faster HDX platform is needed. We should consider the work of Weis 
and co-workers [65] who developed a simple apparatus for millisecond quench-flow HDX, 
which is effective for characterizing disordered proteins. An alternative is to use carbene 
labeling [27, 66], the labeling time scale of which is in nanosecond.  Carbenes do not 
react extensively with Met, and they favorably target Asp and Glu, two residues that are 
abundant in the tail region.  Another possibility is the CF3•, which was recently discovered 
by the Gross laboratory to be a general footprinting reagent that does NOT modifiy Met. 
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Chapter 7 
Protein Footprinting Elucidates the Protein-Membrane 
Association of Nanodiscs-Incorporated KRAS4b Proteins 
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7.1 Abstract 
KRAS4b protein is a member of the RAS family that regulates signaling pathways 
essential for cell growth, it becomes functional when interacting with the inner surface of 
a plasma membrane. This protein is frequently mutated in cancer. Previous studies 
suggest that KRAS4b primarily interacts with a membrane through its farnesylated 
hypervariable region (HVR). Because little is known about the structure of the protein-
membrane complex and the specific protein-lipid interactions, we describe here 
incorporating KRAS4b into a Nanodisc, affording a system more amenable to biophysical 
assays such as Mass Spectrometry footprinting and NMR. We footprinted Nanodiscs-
bound and unbound KRAS4b protein by taking advantage of Fast Photochemical 
Oxidation of Proteins (FPOP) and glycine ethyl ester (GEE) labeling at the residue-level, 
taking advantage of the irreversible nature of these modifications. The irreversibility 
provides flexibility in removing the lipids and proteolyzing the protein to provide a coarse-
grained picture of this important protein-membrane interaction. One aim is to establish a 
platform suitable for conformation studies of other membrane proteins. 
7.2 Introduction 
RAS proteins are members of the small GTPase family that regulate essential cellular 
functions including proliferation, differentiation, apoptosis, and mobility, by switching 
between inactive GDP-bound state and active GTP-bound state [1-5]. The three most 
commonly expressed RAS proteins in human are NRAS, HRAS, and KRAS, among which 
KRAS is found as two splice variants designated as KRAS4a and KRAS4b [6, 7]. The 
catalytic domain of RAS proteins (G-domain, amino acids 1-166, Figure 7-1 A) share 
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highly homologous sequences and structures; their hypervariable regions (HVR, amino 
acids 167-C termini, Figure 7-1 B), on the other hand, differ markedly in sequence and 
post-translational lipidation [3, 8] (Figure 7-2). Such lipidation of RAS proteins, including 
palmitoylation and farnesylation (Figure 7-2), facilitates the membrane binding of RAS, 
provides a way to reversibly regulate protein localization and interactions [9, 10]. RAS 
mutations, typically at codons 12, 13, and 61, are associated with approximately 30% of 
all human cancers [11]; the mutations of KRAS alone, however, account for 85% of all 
the oncogenic RAS mutations [12, 13]. This makes KRAS a good anticancer target; 
however, no clinically effective inhibitors are available so far [14].  
KRAS4b is found frequently mutated in human colorectal and lung cancers, and in almost 
all pancreatic cancers [15]. The HVR of KRAS4b, which undergoes post-translational 
farnesylation, proteolytic cleavage and carboxymethylation at the C-terminal cysteine 
Cys185 [16], contains a polybasic lysine motif and anchors KRAS4b to anionic lipid rafts 
on the intracellular side of the plasma membrane [2, 17] (Figure 7-2). This membrane 
localization is critical for KRAS4b downstream signaling pathways, offering potential 
therapeutic strategies for inhibition of oncogenic signaling [18, 19]. Although the 
significance of KRAS4b-membrane association is well acknowledged [2, 20-22], there is 
no atomic-level structure revealing how KRAS4b interacts with the membrane.  
The major challenge is determining the structural and biochemical properties of 
membrane-associated proteins that are difficult to crystallize. Thus, the membrane-
anchored structural information is from some electrostatic calculations [23, 24], or low-
resolution analyses including infrared spectroscopies [25] and fluorescence [26]. Within 
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the last decade, solid-state NMR, as a technique well suited for structural and dynamic 
studies of membrane-associated peptides and proteins, was first applied to provide the 
structural basis of membrane insertion of lipidated RAS [27-29]. Recently extensive 
molecular dynamics simulations have been focusing on both isolated RAS HVR-lipids 
interactions and full-length, post-translationally modified RAS-membrane interactions [2, 
30-33], these studies complement the experimental results and have unraveled some of 
the basic structural and thermodynamic features of RAS-membrane interactions.  
An additional problem for studying membrane proteins is the need to work in aqueous 
media and solubilize the protein in its native environment (i.e., lipid bilayers). Nanodiscs 
provide one solution to this problem. They are nano-sized, disc-shaped, phospholipid 
bilayers wrapped by two molecules of an amphipathic alpha-helical protein [34] (Figure 
7-3 A).The use of a Nanodisc as a carrier to incorporate recalcitrant membrane proteins 
into lipids bilayer can preserve the structure and activity of membrane proteins [35]. 
Nanodiscs are ideal surrogates for cell membranes and allow lipid compositions to be 
specified flexibly. Nanodiscs are prepared by mixing together phospholipid/detergent 
micelles and membrane scaffold proteins (MSP), followed by detergent removal (Figure 
7-3 B). The size of Nanodiscs is dependent on the length of the MSP and the 
stoichiometry of lipids used in the self-assembly process [36]. Incorporating KRAS and 
membrane proteins in Nanodiscs would make it more amenable to a variety of techniques 
that have been developed for soluble proteins. In our case, it facilitates the mass 
spectrometry (MS)-based conformational characterizations of KRAS4b proteins. 
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The MS-based protein footprinting techniques provide peptide and residue-level 
information to elucidate protein-protein or protein-ligand interactions. Typical strategies 
include labeling of a protein in two or more states (e.g., bound versus unbound) followed 
by enzymatic digestion of labeled proteins, and comparisons of the peptidal fraction 
modified between states. Decreased fraction modified of bound state relative to that of 
unbound state is often observed, owing to reduced solvent-accessibility at interacting 
regions. Two representative MS-based protein footprinting approaches are hydrogen-
deuterium exchange (HDX) and hydroxyl radical labeling. HDX has been extensively used 
for soluble proteins, as it monitors the deuterium exchange extent of amide backbones 
which reports the solvent accessibility; however, for membrane-bound proteins, HDX 
becomes challenging owing to low protein solubility, poor digestion efficiency, and 
increased back-exchange [37, 38]. Besides, as discussed in Chapter 6, it can be 
challenging to characterize membrane proteins using HDX because these proteins are 
dynamic. Numerous laboratories have made progresses in overcoming these difficulties 
[39-41]. Hydroxyl radical labeling, firstly established by Chance and co-workers [42] and 
elaborated as fast photochemical oxidation of proteins (FPOP) by Hambly and Gross [43], 
is advantageous because the labeling is fast and irreversible, enabling more rigorous 
sample handling downstream of the labeling process prior to MS detection, such as 
sample cleanup, proteolysis, and chromatography. Konermann et al. [44] first 
demonstrated the feasibility of FPOP on membrane proteins with bacteriorhodopsin in a 
natural lipid bilayer environment, they observed more oxidative modifications on solvent-
accessible loop regions compared to the radical-inaccessible transmembrane regions. 
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We recently reported the use of FPOP footprinting of a Nanodiscs-incorporated 
membrane protein light harvesting complex 2 (LH2), to probe its conformation and 
topology [45].  
In this chapter, we describe the use of FPOP to footprint full-length, post-translationally 
modified KRAS4b protein in a near-native environment facilitated by its incorporation in 
lipid Nanodiscs. An important feature of FPOP is the adjustable labeling time controlled 
by different concentrations of radical scavengers [46]. We took advantage of this feature 
and added a reporter peptide prior to labeling by hydroxyl radicals, to normalize the 
labeling yield and enable a kinetic-type output. We also employed a residue-specific 
footprinting, glycine ethyl ester (GEE) labeling, to corroborate the FPOP outcome.  
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Figure 7-1. (A) Crystal structure of KRAS4b with HVR truncated (amino acid 1-166), PDB 
4l8g; (B) Sequence alignment of amino acids in NRAS, HRAS, KRAS4a, and KRAS4b. 
The catalytic domain (residues 1-166) of the four isoforms shares highly conserved 
sequence identity (~89%), whereas the HVR domain (residues 167-185/6) has low 
sequence identity (8%). Cys residues in blue denote the palmiltoylated Cys, and the 
terminal Cys with farnesylation is colored in red. The HVR of KRAS4b is characteristic of 
its polybasic lysine motif.  
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Figure 7-2. Post-translationally lipidated cysteine residues in HVR of NRAS, HRAS, 
KRAS4a, and KRAS4b. The NRAS, HRAS, and KRAS4a contain the palmitoylated 
cysteine residues besides the terminal cysteine farnesyl methyl ester; the KRAS4b, on 
the other hand, has a polybasic lysine stretch additional to the terminal cysteine farnesyl 
methyl ester.  
 
 
Figure 7-3. (A) A schematic representation of a Nanodisc. The two alpha-helical 
membrane scaffold protein molecules are shown in blue and green. The polar head 
groups of the bilayer phospholipids are shown in orange. The hydrophobic tails are in 
light tan. Reprinted from Shih, A. Y. et al. Nano Lett. 7, 1692-96 (2007); (B) A cartoon 
representation of the process of Nanodisc assembly. Retrieved from 
https://www.labome.com/method/Nanodiscs-Membrane-Protein-Research-in-Near-
Native-Conditions.html#ref1. 
 
7.3 Experimental and Methods 
7.3.1 Material 
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Leucine enkephalin acetate hydrate, L-histidine, L-methionine, 30% hydrogen peroxide, 
catalase, acetone, urea, dithiothreitol (DTT), iodoacetamide (IAM), 2-amino-2-
(hydroxylmethyl)-1,3-propanediol (Tris base), glycine ethyl ester (GEE), 1-ethyl-3-
(dimethylaminopropyl)-carbodiimide (EDC), 36.5-38.0% hydrochloric acid, ammonium 
acetate, formic acid (FA), trifluoroacetic acid (TFA), HPLC-grade solvent, and phosphate 
buffered saline (PBS) were purchased from Sigma-Aldrich Chemical Co. (St. Louis, MO). 
Sequencing-grade chymotrypsin was purchased from Promega Co. (Madison, WI). The 
POPC and POPS lipids were purchased from Avanti Polar Lipids (Alabaster, AL) in 
chloroform and used without further purification.  Lipid concentration was determined by 
Avanti using total phosphate analysis. Bio-Beads SM-2 was purchased from Bio-Rad 
(Hercules, CA). 
7.3.2 Production of Farnesylated and Methylated KRAS4b  
Farnesylated and methylated KRAS4b (KRAS-FMe) was expressed and purified as 
described previously (Gillette et al., 2015, Scientific Reports). Specifically, FNL-Tni cells 
were infected with baculovirus that was engineered to express farnesyl transferase 
subunits A and B in addition to His6-maltose binding protein tagged KRAS4b (1-185). Cell 
pellets were lysed mechanically by three passes at 4,000 psi (Microfluidizer M-110EH, 
using a high-pressure instrument Microfluidics Corp, Newton, MA).  Lysate was clarified 
by ultracentrifugation (70K x g, 30 min) and stored at -80°C until purification. Clarified 
lysate was adjusted to 35 mM imidazole and loaded onto an IMAC (immobilized metal 
affinity chromatography) column. The equilibration buffer for the column was 20 mM 
HEPES, pH 7.3, 300 mM NaCl, 5mM MgCl2, 1 mM TCEP, 35 mM imidazole and 1:1000 
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protease inhibitor. Bound proteins were eluted using a gradient of gradient 35 mM to 500 
mM imidazole. Pooled fractions were dialyzed to 20 mM MES, pH 6.0, 200 mM NaCl, 5 
mM MgCl2, 1 mM TCEP.  After overnight dialysis at 4°C, the dialyzed sample was diluted 
1:1 (v/v) with 20 mM MES, pH 6.0, 5 mM MgCl2, and 1 mM TCEP (to reduce the NaCl to 
100 mM) and immediately loaded to an SP Sepharose column equilibrated in 20 mM MES, 
pH 6.0, 100 mM NaCl, 5 mM MgCl2, and 1 mM TCEP.  Bound proteins were eluted with 
a gradient of 100 mM to 650 mM NaCl.  Pooled fractions were digested with Tev protease 
to remove the His6-maltose binding protein fusion tag. The digested sample was loaded 
on an IMAC column to separate farnesylated and methylated KRAS4b from the His6-
MBP and His6 tagged Tev protease.  Protein from this step was dialyzed to a final storage 
buffer of 20 mM HEPES, pH 7.3, 300 mM NaCl, 5 mM MgCl2, 1 mM TCEP, dispensed in 
small (250 ul or less) aliquots, flash frozen in liquid nitrogen and stored at -80°C. 
7.3.3 Membrane Scaffold Protein (MSP del H5) 
E. coli BL21 DE3 (pRARE) cells harboring plasmid R712-X04-3 (expressing His6-tev-
pMSPdelH5) were grown in Terrific Broth liquid medium at 37°C and induced with 0.5 mM 
IPTG for 3 hr.  Cells were lysed mechanically by three passes at 10,000 psi through a 
high-pressure instrument (Microfluidizer M-110EH, Microfluidics Corp, Newton, MA). 
Lysate was clarified by ultracentrifugation (70K x g, 30 min) and stored at -80°C until 
purification.  The protein was captured from the lysate by IMAC, dialyzed to a final buffer 
of 20 mM Tris, pH 7.5, 100 mM NaCl, and 0.5 mM EDTA, dispensed in 1 ml aliquots, and 
stored at -80 °C. 
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7.3.4 Nanodisc Preparation and Incorporation 
The Nanodiscs were prepared based on a published protocol with minor modifications 
[1]. Briefly, POPC and POPS stock lipids in chloroform were mixed together in 70:30 
POPC/POPS ratio and slowly dried using a low flow of argon gas while incubating in a 
bead heat bath at 37 °C. The dried lipid was reconstituted to 65 mM with 130mM cholate 
in 20 mM HEPES, 100 mM NaCl, and 0.5 mM EDTA buffer, and mixed with MSP delH5 
in a 30:1 lipid to protein ratio.  The mixture was mixed on a Nutator at 4 °C for 1 hour, and 
then 1 g/mL of washed bio-beads was added and incubated at 4 °C for additional 4.5 
hours on a Nutator.  Afterwards, the Nanodiscs were removed from the biobeads by 
careful pipetting and further purified using gel filtration chromatography on an AKTA FPLC 
with a GE Superdex 200 increase column (10x300 mm) running with the buffer containing 
20 mM HEPES and 100 mM NaCl at 0.5 mL/min flow rate. 
The Nanodiscs and KRAS4b-FMe were dialyzed into PBS buffer (pH 7.4) using Slide-A-
Lyzer™ MINI Dialysis Device (MWCO 10kDA, Thermo Scientific, Waltham, MA).  
Afterwards the Nanodiscs and KRAS4b-FMe in PBS buffer were concentrated to 100 µM 
using Amicon Ultra 0.5mL centrifugal filters (MWCO 3kDA, EMD Millipore, Billerica, MA). 
The nanodisc-bound KRAS4b-FMe complex was formed by incubating 100 µM KRAS4b-
FMe with an equimolar equivalent of Nanodiscs at room temperature with gentle vertexing 
for 10 min. A control sample of unbound KRAS4b-FMe was incubating with PBS buffer in 
the absence of Nanodiscs in the same manner [36]. 
7.3.5 FPOP Footprinting  
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Freshly prepared Nanodisc-bound and unbound KRAS4b-FMe were stored in a 4 °C 
refrigerator and used on the day of footprinting. A total volume of 50 µL of solution 
containing 5 µM protein, 8 µM Leu-enkephalin, 20 mM H2O2, and histidine at various 
concentrations (0.1, 1.0, 5.0, 20 mM) in PBS, was loaded in a 100 µL syringe (Hamilton, 
Reno, NV) and advanced using a syringe pump (Harvard Apparatus, Holliston, MA). That 
volume was flowed and submitted to approximately 1000 laser shots. The FPOP protocol 
was conducted by incorporating a reporter peptide, as previously described (Chapter 3) 
[47]. The excimer laser (GAM Laser Inc., Orlando, FL) was adjusted to 23 mJ/pulse at a 
frequency of 7.4 Hz and focused to an irradiation window of 2.9 mm. The solution flow 
rate was adjusted to ensure a 25% exclusion volume fraction to avoid repeated exposure 
of radicals [48, 49]. Each replicate was collected in a low protein-binding Eppendorf 
containing 50 nM catalase and 70 mM methionine, preventing further oxidation by 
residual H2O2 and other ROS. Control samples were handled in the same manner without 
laser irradiation. Each collection was aliquoted into two portions, with one portion directly 
submitted to online desalting followed by MS analysis of the intact (undigested) protein; 
and the other portion underwent acetone precipitation, dissolution, proteolysis, followed 
by bottom-up MS analysis as described below [50, 51]. 
7.3.6 GEE Labeling 
Fresh batch of Nanodisc-bound and unbound KRAS4b-FMe were prepared to guarantee 
sample quality, and stored at 4 °C in a refrigerator until the day of labeling. GEE labeling 
experiments were conducted as described previously [52]. An aliquot of 10 µL of protein 
samples (5 µM in PBS) was incubated with 1 µL of GEE (2 M) and 1 µL of EDC (50 mM) 
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at room temperature for various times (2, 6, and 10 min) to achieve time-dependent 
carboxylic acid labeling [53]. The reaction was quenched by adding 12 µL of ammonium 
acetate (1 M). All experiments were performed in triplicate. Directly following modification, 
samples were precipitated with acetone and submitted to proteolysis. 
7.3.7 Proteolysis  
Sample pallets from precipitation were resuspended with 8 M urea, treated with DTT (10 
mM) and IAM (20 mM) sequentially, and diluted with 50 mM Tris buffer (pH 8.1) prior to 
chymotryptic digestion. DTT and IAM were used to break disulfide bonds and cap the free 
cysteines. All samples were incubated with 10:1 protein: enzyme (by weight) for 12 h 
(37 °C, 350 rpm). The digestion was quenched by adding 2% (by volume) FA. After 
digestion, 20 µL of digests from each sample was loaded in autosampler vial for bottom-
up analysis. 
7.3.8 Intact Measurements 
FPOP modifications of reporter peptide and that of KRAS4b-FMe at protein level were 
determined by using a MaXis 4G Q-TOF (Bruker, Bremen, Germany) coupled to a 
custom-built, on-line sample-handling device. In brief, 10 µL of labeled protein with 
reporter peptide (~50 pmol) was loaded onto a C8 reversed-phase trapping column 
(ZORBAX Eclipse XDB, 2 ´ 15 mm; Agilent Technologies, Santa Clara, CA) for a three-
minute desalting with a flow of 200 µL/min water containing 0.1% (by volume) TFA. The 
desalted protein and reporter were then eluted with a two-step linear gradient at 200 
µL/min. Specifically, the gradient was delivered from 2% to 10% solvent B (acetonitrile 
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with 0.1% FA) for 3 min to elute the reporter peptide, then quickly increased to 100% 
solvent B in 5 min during which time the protein elutes. 
7.3.9 Bottom-up Analysis 
The LC-MS/MS analyses were conducted back-to-back with the UltiMate 3000 Nano LC 
system and a Thermo Q Exactive Plus Hybrid Quadruple-Orbitrap Mass spectrometer 
(Thermo Fisher Scientific, Waltham, MA). Aliquots of the digests (5 µL) were drawn from 
autosampler vial and loaded onto a C18 reversed-phase trapping column (Acclaim® 
PepMap100, 100 µm ´ 2 cm, 5 µm, 100 Å; Thermo Fisher Scientific, Waltham, MA) at 4.5 
µL/min with water containing 0.1% FA for a ten-minute desalting. Peptides were 
separated by using a custom-packed C18 reversed-phase column (Symmetry, 100 µm ´ 
200 mm, 5 µm, 100 Å; Waters Inc., Milford, MA) and eluted with a 76-min gradient 
delivered at 500 nL/min. The scan range of precursor ions was set from m/z 380 to 2200 
for all samples with high mass resolving power of 70,000. Automatic gain control was 
used to prevent over-filling of the trap. Two different MS acquisition methods were set for 
the FPOP-labeled and GEE-labeled samples respectively. For FPOP-labeled samples, 
MS was operated in non-targeted data-dependent-acquisition (DDA) mode (i.e., the 18 
most abundant precursor ions corresponding to peptide elution per scan were subjected 
to the high-energy C-trap dissociation (HCD) in the HCD cell to obtain product-ion mass 
spectra. The normalized collision energy was set to 35%. Dynamic exclusion was 
activated for 8 s following each scan to enable fragmentation of low abundant peptides. 
The maximum injection time (IT) for a full mass spectral scan was set to 200 ms, and 150 
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ms for each MS/MS scan. For GEE-labeled samples, MS was operated in targeted DDA 
mode.  
7.3.10 Targeted Data Acquisition 
The protein amount used in GEE labeling was 5 times less that that used in FPOP (50 
pmol vs. 250 pmol), given that GEE produced relatively simple modified products, a 
targeted DDA acquisition mode was adopted for GEE-labeled samples to ensure good 
identification and sequence coverage [54]. To be specific, an inclusion mass list 
comprising all precursor ions of interest was created and saved as CSV format via a 
custom-built web application [55]. The file was then imported into the global parent mass 
list. Details of inclusion list creation are described in Chapter 4. For each full mass spectral 
scan, the ten top most abundant ions matching to an m/z with a threshold of ±7.5 ppm on 
the inclusion list were selected for HCD fragmentation. Monoisotopic precursor-ion 
selection was enabled. The maximum IT for product-ion scans was set to 500 ms. 
Dynamic exclusion was turned off to maximize the number of product-ion mass spectra 
obtained for each “matched” precursor-ion.  
7.3.11 Data Analysis 
The *.raw MS files were searched directly using Byonic (Protein Metrics Inc., San Carlos, 
CA) against a custom-built database containing the sequence of KRAS4b [16]. All known 
HO• side-chain reaction products were added to the variable modification database for 
searching the HO•-modified samples [56]. The two possible forms of modifications from 
GEE labeling [52] (i.e., amide form (mass shift of 57.0215 Da) and hydrolyzed form (mass 
shift of 85.0528 Da)), were added to the variable modification database for searching of 
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GEE-modified samples. The farnesylation and methylation of Cys185, which results in 
mass increase of 218.2035 Da, was added as variable modifications. The alkylation of 
the sample with IAM to add a carbamidomethyl group (added mass of 57.0214 Da) to 
Cys-containing peptides, was included as a fixed modification for searching. The search 
tolerance window was 15 ppm for precursor ions, and 50 ppm for product ions. Y, F, W, 
M, L were selected as fully specific cleavage sites in accord with chymotrypsin proteolysis.	
The quantitation of fraction modified was based on ion abundances from extracted ion 
chromatograms (XICs). Time-dependent signals from LC-MS for each unmodified peptide 
and its modified species were extracted from raw data files using XcaliburTM Software 
(Thermo Fisher Scientific, Waltham, MA) with a mass tolerance of 15 ppm. The peak 
integrals corresponding to both unmodified species (IunMod) and modified species (IMod) 
are readily attainable. The fraction modified for each peptide was determined as per Eq 
7-1: 
Fraction modified= IMod
IMod+IunMod
                      Eq 7-1 
In a few cases where assignment to a single site was ambiguous, either owing to 
interference from isomers co-elution or incomplete fragmentation in MS/MS, the 
modification was assigned to a set of possible residues.  
7.4 Results and Discussion 
7.4.1 Need for Reporter-incorporated FPOP 
Hydroxyl radicals are extraordinarily reactive and short-lived [57]. The lifetime of hydroxyl 
radicals in FPOP, which is closely associated with fraction modified of samples, is 
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predominantly affected by the identities and/or concentrations of radical scavengers [46]. 
In the FPOP footprinting of Nanodiscs-bound and unbound KRAS4b-FMe, we used 
hydroxyl-radical scavengers under identical conditions for both unbound and bound 
states.  Nevertheless, multiple species from Nanodiscs (e.g., MSP, phospholipids) are 
likely to give “differential scavenging”, affording a less modified fraction for the Nanodisc-
bound samples, and consequently a biased comparison between the two states when a 
simple one-labeling-FPOP experiment was performed. To illustrate and compensate for 
differential scavenging, we varied the FPOP labeling time by using different 
concentrations of histidine at 0.1, 1.0, 5.0, and 20 mM, and introduced Leu-enkephalin in 
FPOP as a reporter peptide (Figure 7-4). The yield of hydroxyl radical under each 
condition can be reported as the fraction modified Leu-enkephalin (y-axis). Despite 
identical histidine conditions, the fraction modified of reporter peptide from Nanodiscs-
bound samples was constantly less than that from Nanodiscs-unbound samples. This 
straightforwardly indicates that the dose of HO•, and therefore the radical lifetime, in 
Nanodiscs-bound samples was intrinsically lower due to the presence of Nanodiscs, 
clearly indicating a differential scavenging effect that became less pronounced at higher 
concentrations of histidine. At 20 mM of histidine, where the scavenging by Nanodiscs is 
overwhelmed by that of histidine, the fraction modified of reporter between the two states 
is similar (Figure 7-4). Extensive scavenging in FPOP by a high concentration of 
scavenger, however, is not the solution to differential scavenging as it would provide little 
labeling of the proteins. The reporter peptide, on the other hand, can “compensate” for 
the different modification extents for different states as we adjust among various radical 
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lifetimes. The outcomes are “FPOP kinetic curves” that describe the time-dependent 
response of FPOP modification for each peptide; here the time domain is proportional in 
a complex way to the fraction modified of reporter peptide [47]. 
 
Figure 7-4. Fraction modified of Leu-enkephalin (reporter peptide) under different FPOP 
labeling times as adjusted by varying scavenger concentrations (histidine concentrations: 
0.1, 1.0, 5.0, 20 mM). The error bars correspond to ± SE of triplicate measurements. 
 
7.4.2 Analyses of the Intact Reporter and Protein 
Following footprinting, we analyzed the Leu-enkephalin and undigested KRAS4b-FMe by 
LC-MS, integrating their respective TIC signals over an elution window of 0.5 min. The 
reporter peptide eluted earlier than protein because it is less hydrophobic. To determine 
the fraction modified of reporter, signals corresponding to the unmodified and singly-
oxidized Leu-enkephalin were extracted with a mass tolerance of ±7.5 ppm (Figure 7-5). 
The resulting XIC of singly-oxidized Leu-enkephalin appeared as one Gaussian-shaped 
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peak, suggesting co-elution of different isomers of singly-oxidized species, given that Tyr1, 
Phe4, and Leu5 of Leu-enkephalin have been previously identified to be modified in 
FPOP (Chapter 3) [47]. We did not, however, observe significant doubly-oxidized Leu-
enkephalin signals. Integrals of the resulting two XIC peaks can be obtained using the 
Data Analysis Software (Bruker, Bremen, Germany). The fraction modified of reporter 
peptide was calculated per Eq 7-1. 
Measurements of the intact KRAS4b-FMe at various histidine conditions demonstrate the 
effectiveness of adjusting FPOP reaction times. The ESI mass spectra of the most 
abundant charge state (+27) show clearly the effect of varying the time (Figure 7-6). 
Within each spectrum, the peaks corresponding to the unmodified protein are followed by 
that of singly-oxidized species (+15.9949 Da), doubly-oxidized species (+31.9898 Da), 
etc., as a consequence of one or more substitutions of H for OH. The control experiments 
show that the protein itself was slightly oxidized before laser irradiation; this portion of 
background oxidation is subtracted from total FPOP modifications. As the histidine 
concentration increases, the labeling time decreases, and the fraction modified of 
KRAS4b-FMe at the protein level decreases accordingly. 
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Figure 7-5. FPOP labeling extent quantitation of Leu-enkephalin. (A) Extracted ion 
chromatograms (XICs) of unmodified (dark green) and singly-oxidized (red) reporter 
peptide. Integrals of XICs of unmodified and modified species allow quantitation of 
fraction modified of reporter peptide; (B) Mass spectra of unmodified and singly-oxidized 
reporter peptide. 
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Figure 7-6. Mass spectra from measurements of intact, FPOP-labeled KRAS4b-FMe 
(+27 charge) obtained by adjusting histidine concentrations. 
 
7.4.3 Time-dependent FPOP at Peptide and Residue Level 
Varied labeling times of FPOP allow the measurements of kinetics. In an effort to 
normalize the differential scavenging and compare the FPOP outcomes between 
Nanodiscs-bound and unbound KRAS4b-FMe at peptide/residue level, we plotted the 
	 229	
fraction modified of Leu-enkephalin at each histidine concentration versus the 
corresponding fraction modified for each chymotryptic peptide of the protein (y-axis). The 
fraction-modified of reporter peptide acts as a “ruler” of HO• lifetime (i.e., longer times 
yield more modification), so the resulting FPOP-reporter kinetic plots reveal the time-
dependent KRAS4b-FMe modification, enabling an output resembling that of the familiar 
HDX kinetics data for peptides. It is noteworthy, however, that the dependence between 
the time and yield of reporter peptide does not follow a simple, linear relationship, as has 
been elaborated previously [47]. For each peptide, the two curves representing different 
protein states (Nanodiscs-bound and unbound) should overlap if the solvent-
accessibilities of them are the same (Figure 7-7). The shadowed region corresponds to 
the 0.95 confidence intervals for each curve. Regions where the curves diverge are those 
for which solvent accessibility and/or conformations change. The FPOP-reporter kinetics 
reveal, at KRAS-FMe peptide level that, most regions (from N-terminus to 157) share 
similar solvent-accessibility between the Nanodiscs-bound and unbound states, 
indicating that a majority of this protein is not involved in an association with a lipid 
membrane. Nevertheless, decreases in modification extent (solvent-accessibility) do 
reveal for various labeling times that region spanning from residues 158-185, as 
represented by three peptides: 158-170, 171-185, and 181-185 are membrane-
associated (Figure 7-7). The significantly reduced reactivity in this region demonstrates 
that it is this region that is in close proximity to the membrane.    
The use of LC-MS/MS enables the separation of HO•-modified peptides based on their 
hydrophobicity and the measurement of their differential solvent accessibility.  
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Furthermore, with MS/MS, we can also identify some amino-acid site-specific 
modifications. To demonstrate, we show the extracted ion chromatograms (XICs) and 
precursor-ion spectra of the unmodified and singly-oxidized species of peptide 20-40 
(Figure 7-8 A, B). The multiple chromatographic peaks observed for the oxidized species 
(+15.9949) correspond to the isomers eluting at different time. Manual interpretation of 
the product-ion spectra localizes modifications on residues H27, F28, and Y32 (Figure 7-
8 C, and Figure 7-10). With high confidence, we identified other residue-specific oxidative 
modifications (Figure 7-9). More than half of these identified residues have side-chains 
that are either sulfur-containing (M72, M170) or aromatic (H27, F28, Y32, Y64, F78, 
Y137), not surprising because those residues are highly reactive towards HO•. Other 
residues including L52, L120, I142, K176-179, K182, K184, and C185 also undergo 
detectable modifications. These “magnified” residue-specific views improve the spatial 
resolution of the interacting region. For example, for peptide 158-170, Met170 is the major 
residue showing differential labeling between the two states. Another region, represented 
by C-terminus peptide 171-185, containing the farnesylation and methylation on Cys185, 
shows protection upon Nanodiscs binding. Given the amino acid composition, this peptide 
is relatively less reactive towards HO•; however, it shows more modification (>10%) in the 
absence of Nanodiscs, indicating its solvent accessibility (Figure 7-7). We identified 
oxidative modifications on K176, K177, K178, and K179 for this peptide. The product-ion 
spectra show mixed signature ion species (Figure 7-10), indicating the co-elution of 
singly-oxidized isomers. Besides peptide 171-185, a shorter peptide 181-185, resulted 
from chymotrypsin non-specific cleavage at C-terminal of Lys180, was also identified. The 
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C-terminal farnesyl group renders this five-residue peptide, which otherwise might be 
eluted with solvent front, rather hydrophobic, and FPOP results show divergence in 
between the two states. K182, K184, and C185 were found to be labeled on this peptide.  
It is worth mentioning that, the farnesyl group (-C15H24) often is lost as a neutral (204.1878 
Da) in MS/MS experiments of peptides that contain it [58, 59].  Failure to account for this 
neutral loss could lead to misinterpretation of spectra or even loss of sequence coverage. 
For example, without accounting for the neutral loss of farnesyl group, we could only 
identify some b-series ions for the C-terminal peptide 171-185, which contains the 
farnesylated and methylated Cys185 (Figure 7-11 A). Because all y-series ions are shifted 
by the neutral loss of farnesyl group, the identification is greatly improved by considering 
the farnesyl group as neutral loss on Cys185 (Figure 7-11 B), using our custom-built web-
application software (See Chapter 4 for details).  
Overall, the FPOP results show that the G-domain of KRAS4b-FMe is not involved in the 
interaction with Nanodiscs; the HVR domain, on the other hand, shows noticeable 
protection when the protein is incorporated in a Nanodisc. This result is in agreement with 
the proposal that the HVR of KRAS protein targets the negatively charged phospholipids 
of the plasma membrane via its polybasic lysine motif [60], and that prenylation of HVR 
helps anchor the protein to plasma membrane [10, 61]. Recent studies using extensive 
atomic scale MD simulations of KRAS4b HVRs at an anionic lipid bilayer composed of 
DOPC and DOPS (mole ratio 4:1) illustrate that the KRAS4b preferentially tethers the 
membrane in the liquid phase and spontaneously inserts the farnesyl moiety into the 
loosely packed phospholipid bilayers [62].  
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Figure 7-7. Response curves of each peptide from Nanodiscs-bound and unbound 
KRAS4b-FMe in FPOP time-dependent measurements performed by varying the 
histidine concentrations (0.1, 1.0, 5.0, and 20 mM). The error bars correspond to ± SE of 
triplicate measurements. The shadowed region of each curve represents the confidence 
interval region corresponding to one SE.  
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Figure 7-8. MS/MS of peptide 20-40 illustrates the MS detection of unmodified and 
modified peptide species, the chromatographic separation of various modified species, 
and localization of the modified residue. (A) XICs of unmodified and singly-oxidized 
peptide 20-40; (B) mass spectra of precursor ions (+3 charge) corresponding to 
unmodified and singly-oxidized peptide 20-40; (C) MS/MS spectrum corresponding to 
singly-oxidized peptide 20-40 identifies His27 modification.  
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Figure 7-9. Residue level kinetic curves of Nanodiscs-bound and unbound KRAS4b-FMe. 
Residues were identified with high confidence and plotted as the fraction modified of each 
residue vs. the fraction modified of reporter peptide under each histidine concentration. 
The error bars correspond to ± SE of triplicate measurements. The shadowed region of 
each curve represents the confidence interval region corresponding to one SE.  
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Figure 7-10. Product-ion (MS/MS) spectra of various peptides used to locate the sites of 
FPOP modification.  
 
 
Figure 7-11. Annotated product-ion (MS/MS) spectra corresponding to the FPOP-
modified peptide 171-185 for which the Cys185 is both farnesylated and methylated. (A) 
Only b-series ions are identified when the neutral loss of farnesylation is not included; (B) 
All y-ions and molecular ions reveal the neutral loss of farnesylation from the C-terminus. 
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7.4.4 Glycine Ethyl Ester (GEE) Footprinting 
To corroborate the findings in the reporter-incorporated FPOP experiments, we employed 
GEE footprinting as the second approach.  This footprinting specifically modifies solvent-
accessible carboxyl side-chain of aspartate (D) and glutamate (E) by an amidation 
reaction with glycine ethyl ester. GEE footprinting was previously validated and first used 
to probe protein orientation of a membrane-associated protein [52, 63]. As mentioned 
earlier, we used the targeted DDA acquisition mode to increase the number of product-
ion spectra per peptide. Similar to FPOP, we took time-dependent GEE measurements 
not only to provide assurance that the modification reactions occur normally but also to 
add statistical weight to the two-state comparison. We quantified the extent of 
modification based on verified XIC features corresponding to the unmodified and modified 
chymotryptic peptides at various labeling times (Figure 7-12 show the fraction modified 
of each peptide at various labeling times). For most peptides, the fraction modified 
increases monotonically with labeling, suggesting the absence of GEE-induced protein 
unfolding [53].  Peptides 83-96 and 158-170, however, showed that the fractions modified 
reach a plateau with no time-dependence, indicating that these reactions are complete 
even prior to the earliest labeling time point (i.e., 2 min).  
To illustrate better the differential fraction modified in between the Nanodiscs-bound and 
unbound KRAS4b-FMe, we present the GEE footprinting results as time-dependent plots 
(Figure 7-13). The curves should overlap for regions that exhibit similar solvent 
accessibility in the bound vs. unbound states, whereas they will diverge if there are local 
changes in conformation or solvent accessibility. Most regions of KRAS4b-FMe 
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(represented by 7 peptides: 29-40, 41-53, 83-96, 97-111, 97-113, 114-137, and 142-157) 
report no differences for the two states (Figure 7-13), in accord with the FPOP results, 
indicating nearly identical solvent accessibility with and without the Nanodiscs.  These 
regions must be remote from the lipid bilayer. Peptide 158-170, however, clearly has more 
protection in the bound state (Figure 7-13), indicating this region is involved in the protein-
membrane association, in agreement with FPOP.  
Besides the HVR, a second region represented by peptide 54-64 also showed reduced 
solvent accessibility in the bound state (Figure 7-13). This region is part of the P loop and 
Switch II loop of KRAS protein (Figure 7-1 A), which plays roles in binding of regulators 
and effectors [3, 8]. The peptide, abundant with Asp and Glu, undergoes significant 
modification in the unbound but less so in the bound state. A close look at the XICs and 
product-ion spectra showed well-resolved modifications on D54, D57, E62, and E63 
(Figure 7-14, product-ion spectra not shown). This reduced modification does not occur 
with FPOP. The difference between FPOP and GEE may be due to changes in orientation 
of the acidic side changes. Indeed, there are documented residual orientation changes 
induced by either ligand binding or site mutation [64-66], and the changes here may be 
transparent to FPOP because acidic residues are relatively unreactive with OH radicals. 
An alternative explanation is the region represented by this peptide may exist as a crevice 
formed upon Nanodiscs incorporation between this peptide and membrane, or between 
this peptide and belt proteins. This crevice region should be more accessible to FPOP, 
given the small size of hydroxyl radicals, but its openings to solvent may be too small for 
EDC and the GEE molecules. 
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With the exception of region 54-64, GEE footprinting largely corroborates FPOP, showing 
with high confidence that the HVR of KRAS4b-FMe interacts with Nanodiscs. Combining 
both footprinting results, we conclude at residue level that the interacting region at least 
encompasses residues E162, E168, M170, K176, K177, K178, K179, and extends to the 
C-terminus of KRAS4b-FMe (including K182, K184, and C185, Figure 7-15), where the 
C185 farnesylation allows insertion of prenyl group into membrane. These findings agree 
well with recent molecular dynamics calculations that pinpoint residue-level interactions 
of KRAS4b with the POPC/POPS bilayer [17].  
 
Figure 7-12. Time-dependent GEE labeling results of Nanodiscs-bound (dark grey) and 
unbound (light grey) KRAS4b-FMe presented as bar-graph, where the x-axis represents 
the peptides and y-axis represents the GEE modification extents. The error bars 
correspond to ± SE of triplicate measurements.  
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Figure 7-13. Response curves of each peptide from Nanodiscs-bound and unbound 
KRAS4b-FMe in a GEE kinetics measurements performed by controlling different labeling 
times (2, 6, and 10 min). The error bars correspond to ± SE of triplicate measurements. 
The shadowed region of each curve represents the confidence interval region 
corresponding to one SE.  
 
 
 
Figure 7-14. Extracted ion chromatograms (XICs) of unmodified and GEE-labeled 
peptide 54-64. Each of the four acidic residues is modified by GEE, the corresponding 
peptide species were separated chromatographically. 
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Figure 7-15. (A) Representation of Nanodiscs-bound KRAS4b-FMe, where the HVR 
domain (red) interacts with the membrane bilayers, leaving the G-domain (dark grey) 
extended outside the Nanodiscs; (B) Zoom-in view of HVR interacting with the Nanodiscs 
determined by FPOP and GEE labeling. Residues differentially modified by FPOP are 
labeled blue, residues modified by GEE are labeled green. 
 
7.4.5 Complementary Biophysical Approaches  
In order to gain more insights in to the structure and orientation of KRAS4b bound to 
membrane, our collaborator utilized multiple other technologies including neutron 
reflectivity (NR), paramagnetic relaxation enhancement (PRE)-NMR, SAXS, and MD 
simulations, in addition to mass spectrometry. The outcome from these measurements 
are complementary to the footprinting results.  
The neutron reflectivity is a technique in which neutrons at thermal energies are used to 
probe the near surface structure of a system [67]. Neutrons are incident on a surface at 
a grazing angle less than 3°; at such small angles, the potential for scattering can be 
approximated by a continuous value called scattering length density (SLD). The very 
small angles of incidence can be sufficient to cause the neutrons to be totally reflected 
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from the surface, and the position of this transition compared to total reflection yields 
information about the average SLD of the material [68, 69]. In this experiment, the NR 
measurements were conducted for KRAS4b-FMe bound to tethered lipid bilayers, it 
provides one dimensional information perpendicular to the bilayer based on the neutron 
SLD profiles (Figure 7-16). The KRAS4b-FMe is found to have an extended conformation 
directed away from the lipid bilayer.  
Complexes of the element Gadolinium (Gd) are widely used in NMR to enhance the 
paramagnetism. Because Gd is strongly paramagnetic, owing to its seven unpaired 
electrons in the 4f shell (Figure 7-17 A) [70], its electrons are not involved with bonding, 
so paramagnetism is maintained even in molecular complexes [71]. The PRE-NMR of the 
KRAS4b-Nanodiscs, enabled by assembling the Nanodiscs containing a Gadolinium-lipid 
chelate (Figure 7-17 B), shows significantly decreased NMR signals of 15N KRAS4b-FMe, 
for C-terminal region starting from Met170. This observation indicates the proximity of this 
C-terminal region to the membrane. 
Small angle X-ray scattering (SAXS) is a powerful biophysical method providing 
information about the sizes and shapes of proteins and complexes in a broad range of 
molecular weights [72]. Our collaborators used SAXS to measure the scattering profile 
with variable D2O to highlight lipid and protein components, then fitted the data to 
determine radius of gyration and protein shape. The SAXS outcome confirms the 
presence of extended conformation of KRAS4b-FMe on a Nanodisc. 
Molecular dynamic (MD) simulations report on the physical movements of atoms and 
molecules, under the influence of defined physical forces [73]. It gives a view of the 
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dynamical evolution of the system by allowing the atoms and molecules to interact for a 
certain period of time [74]. MD simulation is particularly useful and informative when 
studying membrane proteins because these proteins are generally insoluble and dynamic, 
limiting the access to high-resolution characterizations by X-ray crystallography and NMR. 
The ensemble MD simulation results agree qualitatively with the NR and SAXS data that 
KRAS4b-FMe protein is oriented perpendicular to the membrane with minimal direct 
contacts to the bilayers.  
 
Figure 7-16. (A) Schematic showing the tethered lipid bilayers prepared for neutron 
reflectivity experiments; (B) The geometry of a typical reflectivity experiment showing the 
incident and reflected angles, and the incident and reflected wave factors. Retrieved from 
https://www.ncnr.nist.gov/programs/reflect/NR_article/.  
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Figure 7-17. (A) Electron structure of the Gd atom. Retrieved from http://mri-
q.com/paramagnetic-relaxation.html; (B) Schematic of Nanodiscs containing Gd-lipid 
chelate and 15N labeled KRAS4b-FMe. 
 
7.5 Conclusion 
Interacting KRAS protein with lipid Nanodiscs allows characterization of proteins in a 
near-native environment. Unlike reversible HDX, the irreversible nature of FPOP and 
GEE modifications enables more rigorous sample handling prior to MS detection.  This 
ability to remove the lipids post footprinting is particularly advantageous for membrane-
bound proteins as it avoids problems in proteolytic digestion and column separation that 
must be done fast with HDX.  
This mass spectrometry-based platform is suitable for differential studies of unbound and 
membrane-bound proteins, as enabled by the use of Nanodiscs and protein footprinting 
(i.e., FPOP and GEE). We were able to make meaningful two-state comparisons 
(Nanodiscs-bound and unbound KRAS4b-FMe) using time-dependent footprinting 
approaches. The incorporation of reporter peptide in FPOP normalizes the differential 
radical dosages between the two states, facilitating the use of FPOP to probe membrane-
bound proteins and to allow unbiased FPOP comparisons.  
Characterization of membrane-bound protein structures has always been challenging as 
evidenced by the small fraction of X-ray structures that are available. For KRAS proteins, 
the HVR is truncated prior to crystallization, removing the important HVR regions 
responsible for membrane association. Therefore, a platform involving Nanodiscs 
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incorporation and irreversible footprinting is promising because it not only provides 
coarse-grained pictures of protein-membrane interactions, but it also offers opportunities 
to determine interactions of membrane-bound proteins with other proteins and ligands. 
We plan future studies to characterize the interactions between Nanodiscs-bound KRAS 
and its effector proteins; such interactions are pivotal in regulating downstream signaling 
[2, 16]. 
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The mass spectrometry-based hydroxyl radical footprinting, which has been further 
elaborated as Fast Photochemical Oxidation of Proteins (FPOP) in Gross’s lab, is 
advancing rapidly as a method of choice to unravel protein-ligand, protein-protein 
interactions. Expanding the applicability of FPOP is closely associated with the 
accompanying developments of methodology, establishing a foundation for a more robust, 
flexible, and quantitative footprinting platform. 
To improve the current FPOP platform, we measured quantitatively by using an isotope-
dilution GC/MS approach (reported in Chapter 2) the amount of HO• generated after each 
laser pulse. The determined initial hydroxyl radical concentration, 0.95 mM per laser pulse, 
serves as a key input and reference to any kinetic measurements and simulations in the 
future. We also demonstrated the possibility of the changing of effective dose of HO• by 
using different identities/concentrations of radical scavengers. This paves the way for the 
idea of incorporating a reporter peptide in FPOP, to compensate for the adventitious 
radical scavengers. 
In Chapter 3, we described the incorporation of Leu-enkephalin as a reporter peptide in 
FPOP. The fraction modified of the reporter peptide allows not only the tracking of the 
labeling time under different sample solution conditions, but also the time-dependent 
measurements, which enable comparisons of FPOP outcome between two curves, as 
opposed to two points, adding statistical weights to the analysis. The incorporation of a 
reporter provides helps to establish unbiased FPOP footprinting comparisons and brings 
to the method broader applications and more demanding conditions. 
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FPOP is typically applied in an experiment through a comparative analysis of two or more 
protein states where differences in labeling extent is indicative of differences in solvent 
accessibility due to mutations or binding.  
In Chapter 5, we compared the FPOP labeling extent of TFE-treated and untreated G93A 
SOD1, at both protein level and peptide/residue level to elucidate the effect of TFE-
induced SOD1 destabilization. We found that upon destabilization structural changes in 
the protein occur including disruption of its dimer interface and local unfolding, evident by 
the significant increase of FPOP labeling extent with addition of 18% TFE. We proposed 
that the exposure of hydrophobic regions upon destabilization promote the self-
association of G93A SOD1 molecules, facilitating its gain-of-function cytotoxicity. 
In Chapter 6, we utilized both FPOP and HDX to characterize the conformations of EGF 
receptor proteins and complex. Results from both footprinting methods agree with 
previous MD simulation results that the C-terminal tail region of EGF receptor is 
intrinsically disordered. We found, however, that FPOP is a better approach for probing 
the binding interface between the EGF receptor and adaptor proteins (e.g., Cbl), owing 
to the fast ligand binding kinetics. 
The combination of the FPOP platform and Nanodiscs permits interrogation of membrane 
protein conformations. In Chapter 7, we reported the marriage of the two techniques, 
enabling the characterization of the KRAS4b-membrane association. The FPOP results 
confirmed, with spatial resolution at the peptide and residue level, that the KRAS4b 
protein interacts with membrane through its C-terminal region, whereas the majority of 
KRAS4b is outside the membrane. We hope that a thorough understanding of the RAS-
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membrane insertion will help decipher the oncogenic properties of RAS proteins and 
provide insight into the design of cancer therapeutics. 
The successful method developments and applications of FPOP are bound with 
informatics tools that provide a fast, labor-saving, and interactive data-processing 
platform. Chapter 4 illustrated the potential of using R programming language to develop 
goal-oriented, user-friendly web applications, aiming at facilitating the output, 
visualization, and processing of mass spectrometry-based proteomic data. 
We envision more methodologies on the basis of the current FPOP platform. For example, 
to adjust better the FPOP labeling times and to parameterize FPOP, a systematic study 
with varied parameters (e.g., laser intensity, H2O2 concentration, scavenger 
identity/concentration, buffer components, etc.) should be conducted, based on the 
dosimetry experiments and reporter-incorporated FPOP. To complement the labeling 
coverage, new labeling reagents in addition to the hydroxyl radical are to be developed. 
Those labeling reagents should take advantage of the fast, irreversible nature of FPOP 
and aim to modify/label FPOP-silent residues including Gly, Ala, Ser, Thr, and Asn.  
FPOP combined with other techniques/devices brings in new opportunities and 
approaches to solve problems in biochemistry and biomedicine. For example, the 
pump/probe experiment, achieved by using a second IR laser for temperature-jump, 
should provide useful characterization input in studying the heat-induced destabilization 
and aggregation of SOD1 proteins. The combination of asymmetrical flow field-flow 
fractionation (AF4) and FPOP should allow on-line separation of macromolecules prior to 
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footprinting, affording good potential for characterizing heterogeneous protein aggregates 
(e.g., Aβ aggregates) with FPOP.   
